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Chapter 1
Evolution of Protein Function
“[. . . ] a general physiology which can describe the essential char-
acteristics of matter in the living state is an ideal [. . . ] we can
strive toward [. . . ] by a study of the vital functions in all their
aspects throughout the myriads of organisms.” [1, p. 4]
—August Krogh, 1929
Abstract Chapter 1
The question how protein function evolves is a fundamental prob-
lem with profound implications for both functional end evolutionary
studies on proteins. Here, we review some of the work that has ad-
dressed or contributed to this question. We identify and comment
on three different levels relevant for the evolution of protein func-
tion. First, biochemistry. This is the focus of our discussion, as
protein function itself commonly receives least attention in studies
on protein evolution. We distinguish three basic ways in which pro-
tein function evolves: by altering interactions, by changing product
outcome or reaction biochemistry in enzymes, or by modification of
protein biophysical properties. Second, genetics. This is the level
responsible to generate variation, which acts as the substrate of evo-
lution. Third, evolution. Evolutionary forces constantly sieve the
pool of random mutations. Of particular interest here are evolution-
ary models at gene family level, as these provide a framework to
integrate functional aspects. We conclude with two major observa-
tions. First, functional evolution is extremely dynamic. Not only
do we find frequent transitions between distinct functional classes,
but most mutational paths realising them are also short. Second and
related, functional evolution is more likely than expected. We find
the map between sequence and function to be degenerate, i.e. vari-
ous sequences are able to perform the same function, and the same
sequence able to carry out different functions. Finally, this review
points us to protein switches as a promising model system, and we
introduce the Rab family of small GTPases as the object of study in
the remainder of this thesis.
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1.1 Introduction
P roteins are essential macromolecules involved in virtually all cel-lular and organismic processes of life. Various biological disciplines
including biochemistry, cell biology and physiology study the functions
and activities of proteins and how these relate to cellular and organismal
traits.
Shortly after the first protein sequences became available in the early
1950s, comparing sequences (and later structures) became one of the
means to interrogate protein function [2]. Given sequences from the same
proteins that evolved in different species (i.e. orthologs), identical regions
may be important for a function shared amongst these proteins, for in-
stance an enzyme active site. Conversely, if the function differs between
species and one seeks to explain these differences, the responsible regions
may be expected in varying parts of the protein. Hence, evolution informs
about protein function.
With the advent of molecular evolution, the comparative study of sim-
ilarities and differences amongst proteins was given a formal evolution-
ary basis. Like species, related proteins descend from common ancestors.
They retain similarities and accumulate differences as a consequence of
shared history and in response to various evolutionary forces. The observ-
able result of this process is sequence divergence, ultimately caused by
mutations whose evolutionary fate is intimately connected to their func-
tional consequences. Hence, function informs about protein evolution.
In conclusion, protein function and evolution are inextricably linked1.
Arising from this, a fundamental question with profound implications for
1The stringent definition of biological function, the modern history view [3] or se-
lected effect definition, is actually an evolutionary concept: “the functions of a trait
or feature are all and only those effects of its presence for which it was under positive
natural selection in the (recent) past and for which it is under [. . . ] purifying selection
now” [4].
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comparative approaches in both functional and evolutionary studies is:
how does protein function evolve?
Studying protein evolution is essential to understand life in its full
diversity at the molecular level. In recent years, the massive accumulation
of data has made a growing fraction of this diversity accessible to molecular
investigation. At least in principle the full protein repertoires of organisms
all over the tree of life are readily available. As a consequence, there are
two major reasons why asking how protein function evolves is a timely
question.
On one hand, this development generates an immediate necessity to
study functional evolution: due to the ever-growing throughput of se-
quencing technologies, the bottleneck shifted from data gathering to its
functional annotation [5]. The predominant strategy for functional annota-
tion is transfer of existing annotations applying the “guilt by association”
principle [6, 7]. However, this is becoming insufficient because by defini-
tion ‘transfer’ cannot predict functional novelty [8, p. 164f]. As a result
the fraction of uncharacterised genes grows [9]. A deeper understanding
of how function evolves has the potential to assist and guide functional
genomic efforts.
On the other hand, the amount of freely accessible data presents an
opportunity as it greatly facilitates comparative analysis at previously
unimaginable scale. Together with other methodological innovations (see
Subsection 1.1.3), this has lead to a renewed interest in integrative func-
tional and evolutionary research on proteins [10, 11], with potential to
unveil general principles where previously only case-studies had been pos-
sible.
Here, we review some of the work that asked or is relevant to the
question how protein function evolves. As is true for any biological phe-
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nomenon, a satisfactory answer has to incorporate many different levels.
What is the genetic and genomic basis of mutations generating protein
sequence variation? What are the functional consequences, i.e. biochem-
ical, cellular and organismal, of these mutations? And finally, what are
the evolutionary mechanisms sieving or favouring a functional variant?
The next sections are devoted to these three aspects of the evolution of
protein function, i.e. genetics, function, and evolution, although a strict
separation of the different levels is not always possible. We begin with
the biochemistry of evolving protein function, however, before we briefly
define what we refer to as the function of a protein, when we consider it
to have evolved, and summarise the approaches and tools to study this
process. Finally, prior to the conclusion of this chapter, we introduce the
Rab family of small GTPases analysed in the remainder of this thesis, and
argue why Rabs are a promising model system to study the evolution of
protein function.
1.1.1 What is the function of a protein?
Asking when and how protein function has changed throughout evolution
first and foremost requires a clear definition of what is considered the
function of a protein. Here, we simply consider every effect a protein has
as its overall function2, leaving many philosophical problems of defining
biological function aside. However, what these functional effects are de-
pends on the particular biological level that is considered [14, p. 50]. For
example, the biochemical function of insulin is to bind the insulin receptor,
at the cellular level one of its many effects is the translocation of glucose
transporters to the plasma membrane, whereas an organismic function of
insulin is the removal of excess glucose from the blood to prevent toxic
effects. In the following, we predominantly focus on the lowest, biochem-
2More precisely, every effect that does not occur when the protein is experimentally
inactivated, the so-called causal role definition of function [12, 13].
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ical level of protein function which we simply refer to as ‘the function’
of a protein. Although any classification remains subjective to a certain
degree, we follow reference [14] and distinguish four major functions of a
protein: binding, catalysis, switching and as structural elements [15, p. 2].
These functions are not exclusive: the most fundamental one is binding,
and is required for all the others [14, p. 50]. Moreover, molecular switches
such as small GTPases depend on both binding and catalysis.
1.1.2 When does protein function evolve?
The definition and distinction of basic protein functions provides the
means to delineate when protein function is different between two ho-
mologs and has therefore evolved. At the biochemical level, we wish
to distinguish qualitative (which we further consider) from quantitative
changes (which we do not further consider). For interactions, any change
in binding specificity, i.e. the ability of a protein to bind to a ligand, is
considered functional evolution, but not so adjustments in binding affini-
ties defined as the strength of binding. Similar for catalysis, modulation
of enzyme kinetics is considered a quantitative change and in principle of
no matter here, unlike changes in product outcome or in the biochemistry
of a reaction (Box 1.1 introduces EC numbers as a system to systematise
biochemical reactions).
This relatively straight-forward distinction between qualitative and
quantitative gets blurred as soon as functions at higher levels are con-
sidered. For example, a transcription factor (TF) may bind to a newly
formed transcription factor binding site affecting the regulation of a cellu-
lar process. Although the TF itself has not altered its biochemical function,
i.e. the binding to a specific DNA sequence motif, it may now nonetheless
have a different function at the cellular or organismal level. The same
reasoning holds for protein-protein and any other type of protein interac-
tion. Another complication arises from evolutionary change for example
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in protein biophysical properties: parameters like length, flexibility and
stability are continuous, and can therefore not change qualitatively. Yet,
alteration of any of these properties can have functional implications at
the cellular and organismic level even without affecting the biochemical
functions of proteins like binding and catalysis.
The question when protein function evolves can also be raised from
an evolutionary standpoint: we exclude cases of adaptation of proteins
without functional innovation, i.e. to maintain an existing function. For
instance, the authors of reference [16] describe selection for protein stabil-
ity in Myoglobins that does not affect protein function. Rather, stability is
likely to minimise the higher burden inflicted by misfolded proteins result-
ing from increased expression levels. Other examples are proteins adapting
to preserve their function in the face of extreme temperatures or pressures
(reviewed in reference [17]). In contrast to adaptation, the related concept
of exaptation by definition implies evolution of function [18]: exaptation
in proteins designates the co-option of a protein to perform a function
different from the one it originated for. It is most readily inferred when
phylogenetic analysis suggests that the protein is older than the process
it is involved in today, which has for example been found for prominent
families such as p53 [19] or various families essential for multicellularity
[20–22]. However, exaptation does not necessarily imply this new function
to be at the biochemical level (see e.g. reference [23]).
Box 1.1: EC numbers
The Enzyme Commission (EC) number is a hierarchical classification
scheme assigning numbers serving as identifiers for chemical reactions
catalysed by enzymes. Hence, enzymes with the same EC number
catalyse the same reaction, but not necessarily by the same structural
mechanism, nor are the enzymes necessarily orthologous.
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EC reaction examples
EC1 Oxireductases
Dehydrogenase,
Oxidase
EC2 Transferases
Transferase,
Kinase
EC3 Hydrolases
Lipase, Amy-
lase, Peptidase
EC4 Lysases Decarboxylase
EC5 Isomerases
Isomerase,
Mutase
EC6 Ligases Synthetase
An EC number has
four levels. The first
level broadly assigns a re-
action into one of the
six categories shown in
the table. The second
and third level specify
the (sub-)subclass, usu-
ally containing informa-
tion about the type of
compound or group in-
volved and detailing the
type of reaction. The
fourth digits represent
the substrate specificity
or a simple serial number
identifying individual enzymes in a sub-subclass [24].
For example, small GTPases have the EC number 3.6.5.2, classi-
fying them as Hydrolases (EC 3), acting on acid anhydrides (EC 3.6),
specifically on GTP (EC 3.6.5), and lastly identifying them as small
monomeric GTPases (EC 3.6.5.2).
1.1.3 Studying evolution of protein function
In the following, we briefly describe the recurrent conceptual, computa-
tional and experimental tools and techniques used to study the evolution
of protein function.
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Conceptually
Two related conceptual tools are particularly useful to understand the
evolutionary trajectory between homologous proteins. The challenge is
twofold: first, represent the steps of this trajectory at the three relevant
levels, i.e. genotype, phenotype (here restricted to some readout of func-
tion) and fitness, and secondly, relate or map these steps across the three
levels.
Representing the mutational steps at sequence level is most easily done
in protein sequence space [25]. In its most common form, amino acids at
positions differing between two proteins are treated as binary alternatives,
and the hypercube representing all combinatorially possible intermediates
becomes the protein sequence space (see e.g. Box 3 in reference [11]). Due
to its high-dimensional nature, a meaningful graphical representation is
only possible for up to four or five amino acid positions. Adding an addi-
tional dimension representing a phenotypic variable generates an explicit
map between genotype and phenotype. How proteins ‘move’, i.e. evolve,
through this space can for example reveal accessible mutational paths.
These indicate constraints on the process of protein evolution for instance
resulting from epistasis (see Subsection 1.2.1).
The second related concept is that of a fitness landscape, which we
employ here to designate the map between phenotype and organismal
fitness3. Much has been written as to whether the metaphor of a landscape
is more harm- than useful [27], however, it remains in frequent use and
allows to connect phenotypic variants and the evolutionary forces acting
on an organism carrying them. Fitness differences is one of the crucial
ingredients for evolutionary change by natural selection [28].
3This is not the original definition [26], neither the frequently encountered broader
definition as genotype-fitness map. However, it is complementary to the genotype-
phenotype map captured in the protein sequence space concept introduced above, and
therefore a useful interpretation in the context of proteins.
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Computationally
The computational analysis of protein evolution is based on what has been
coined the typical ‘phylogenetic pipeline’ [29].
Starting from a protein sequence of interest, the fist step is to find
homologs in other species. This is usually done based on pairwise struc-
ture or sequence comparisons, where similarity above a given threshold is
interpreted as evidence for homology. The most fundamental step is then
to multiply align the sequences, which is critical because all subsequent
analyses directly or indirectly depends on it. Unlike pairwise sequence
alignment, which is merely a measure of similarity, a multiple sequence
alignment (MSA) represents an evolutionary hypothesis of homology be-
tween sites of a protein. MSAs can already be exploited for comparative
analysis (see e.g. reference [30]), although failure to account for phylo-
genetic relationships amongst proteins is bad practice and may bias the
results of statistical significance tests [31].
The next step is to derive a phylogenic tree often interpreted as a his-
torical hypothesis of the relationship between the sequences. A proper
phylogeny can for example serve to detect sites that convergently evolved
and may therefore be functionally important (see e.g. reference [32]). If
independent information on the species phylogeny is available, it can be
used in an additional reconciliation step. Usually, reconciliation looks for
the most probable tree that additionally minimises the number of gene du-
plication and loss events needed to inscribe the gene tree into the species
tree (briefly explained in Box 1.2). Reconciliation is required for two rea-
sons. First, reconciliation labels the branching points in a tree as either
speciations or duplications, which is the only way to establish the nature
of homology relationships between sequences, i.e. orthology or paralogy.
If independent estimates of species divergence times are available, these
can serve for instance to relate duplications to known ecological events
[33]. Second, a common use of gene phylogenies is the reconstruction of
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ancestral protein sequences. These do obviously only make sense for se-
quences at branching points that have a historical equivalent. Ancestral
sequence reconstructions are an important tool to study the evolution
of function, especially when followed by actual experimental resurrection
discussed below.
Box 1.2: Gene tree/species tree reconciliation
A gene phylogeny relates a set of sequences by a tree. The tree
is commonly inferred to maximise the likelihood of observing the
sequences given a model of how proteins are thought to evolve. The
resulting tree is then assumed to reflect the historical relationships
between the genes.
In order to get the homology relationships between the sequen-
ces, a reconciliation with the species tree is necessary, that labels
the internal nodes in tree as either speciation or duplication (figures
adapted from reference [34]). Orthologs and paralogs are all pairs of
sequences whose least common ancestor is labeled as a speciation or
duplication respectively. Reconciliation can be thought of as inscrib-
ing the gene tree into the species tree [35] (see figure below).
gene tree reconciled tree
gene tree
species tree
Speciation
Duplication
reconciliation
species tree
One of the
oldest applica-
tions of gene
trees is the infe-
rence of species
phylogenies,
assuming that
the branching
patterns of the genes and species are the same. This is not always the
case: different events like gene duplications, gene loss, recombination
and other more complicated phenomena like incomplete lineage
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sorting can result in incongruence between gene and species tree. If
independent information on the species tree is available, the criterion
for reconciliation is usually to minimise the number of duplication
and loss events that have to be assumed to reconcile the trees [36].
Speciation
Duplication
reconciliation
† Gene loss
gene tree reconciled tree
† † †
species tree
A differ-
ent interpre-
tation of rec-
onciliation is
not to ac-
cept the gene
tree as given,
but to con-
sider the rec-
onciliation distance (i.e. the number of duplication and loss events
that have to be assumed) as part of the likelihood of the gene tree (see
e.g. reference [37]). In the last figure for example, a better gene tree
is obtained by inverting the two left leaves resulting in a tree match-
ing the species tree. A possible scenario leading to this incongruence
may be accelerated evolution in the orange sequence, provoking the
well known long-branch attraction bias.
Another analysis requiring a gene tree is the mapping of sites that show
statistical signs of positive selection. Sites inferred to have experienced
positive selection are often indicative of functional evolution, and may
therefore inspire a functional hypothesis.
Experimentally
In conjunction with computational methods, a mixture of old, repurposed
and new experimental techniques forms the methodological basis for the
evolutionary analysis of protein function. Two major classes of exper-
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imental strategies exist, by analogy comparable to forward and reverse
genetics.
Similar to reverse genetics, the first class starts with a protein of in-
terest and manipulates its sequence. The difference is that the mutations
are specific and most often introduced by site-directed mutagenesis [38],
although comprehensive library-based approaches were recently developed
[39, 40]. Therefore, this strategy allows to examine the functional impor-
tance and consequences of particular sites. A more sophisticated version
of this approach is specifically designed to study mutational trajectories
between natural protein homologs. In ancestral protein reconstruction,
computationally inferred ancestral proteins are synthesised and function-
ally characterised [41]. The great advantage of this technique is that the
effect of mutations is considered in the correct historical background, for
example allowing to account for and study epistatic interactions.
The second type of experimental strategy takes a ‘forward’ approach:
starting with a function of interest, directed evolution of proteins pro-
ceeds through repeated rounds of random mutations followed by filtering
via selection for the function of interest [42]. The characterisation of in-
termediates then allows to dissect the process of functional evolution.
These conceptual, computational and experimental techniques and ap-
proaches described above have been used to interrogate how protein func-
tion evolves, reviewed in the next sections.
1.2 The biochemistry of evolving protein
function
This section summarises some of the work that has elucidated the biochem-
ical basis of how protein function evolves. The overwhelming amount of
research on many diverse aspects of the topic precludes an exhaustive re-
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view. Instead, we focus on some aspects important to start understanding
the phenotypic or functional space of proteins, i.e. the conceptual space in
which protein function evolves. In particular, we highlight some themes
that are relevant for the rest of this thesis. In this section, we distin-
guish three alternative possibilities or modes to evolve protein function:
changes in binding, in catalysis and in biophysical properties. Following
the distinction of basic protein functions introduced in Subsection 1.1.1,
these modes are relevant for all proteins, for all enzymes, and for struc-
tural and some non-enzymatic proteins respectively. The discussion is
focussed around the biochemical function of proteins, however, higher-
level functional evolution is briefly discussed in the context of biophysical
properties. Lastly, aspects specific to protein switches are considered later
in Section 1.5 when the Rab protein family of small GTPases is introduced
as a promising model system to study the evolution of function.
1.2.1 Binding
Binding is the most fundamental function of proteins, all proteins bind
other molecules [43, p. 52]. Binding partners or ligands can be other pro-
teins, DNA, or molecules like carbohydrates, lipids, ions, or even nascent
ice crystals. About 55% of gene products have no annotated enzymatic ac-
tivity [44], and may therefore be expected to functionally evolve commonly
by changing their set of ligands (with exception of changes in biophysi-
cal properties and switching). For enzymes, an alternative possibility is
to alter the biochemistry of the reaction. However, a recent large scale
analysis of over 2 million enzymes classified into 276 structurally defined
superfamilies found ∼1500 changes in substrate specificity as measured
by different EC numbers at the fourth level (see Box 1.1), in contrast to
∼1000 at higher EC classification levels [45]. Therefore, altering the set
of ligands is most likely the predominant form of functional evolution in
proteins.
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How many mutations to alter interactions?
The question how many mutations are needed in a protein, i.e. few or
many, to alter its specificity and in particular form an interaction has
been addressed and reviewed mostly as part of the broader question about
evolutionary step size (see e.g. [10]). Clearly, if mutations only have small
effect, one expects that shifts in specificities require many mutations.
Two systems allowing to address this issue have been particularly well
studied. One example is the engineered change of coenzyme specificity in
decarboxylating dehydrogenases. Two members of this family, isopropyl-
malate dehydrogenase (IMDH), which exclusively uses nicotinamide ade-
nine dinucleotide NAD+ as coenzyme, and isocitrate dehydrogenase (IDH),
which uses both NAD+ and nicotinamide adenine dinucleotide phosphate
(NADP+), were altered by site-directed mutagenesis. In the first case,
seven mutations in E. coli IDH caused a total switch from NADP+ to
NAD+ and generated an enzyme kinetically comparable to natural IDHs
using NAD+ [46], although two replacements outside the active site are
not related with specificity [33]. In the opposite direction, six replace-
ments switched the E. coli IMDH coenzyme specificity to NADP+ [47].
Hence, although IMDH and IDH are ancient paralogs and share only 25%
sequence identity [46], as few as five or six targeted mutations are enough
to switch binding specificity in both backgrounds.
A second gene family extensively studied in a series of papers are nu-
clear receptors for steroid hormones, which function as ligand-activated
TFs. Vertebrates have two major clades of steroid receptors, one acti-
vated by estrogens and another clade containing several paralogous groups
bound for example by glucocorticoids and mineralocorticoids. The two
clades are derived by duplication from an ancestor that functioned as an
estrogen receptor [48]. Using phylogenetic and structural analysis, the au-
thors could identify and later confirm by ancestral protein reconstruction
that two amino acid replacements cause the shift in specificity towards
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nonaromatised steroids that include glucocorticoids and mineralocorti-
coids [49]. Notably, unlike the mutations in the decarboxylating dehydro-
genases mentioned above, these mutations were not located in the ligand
cavity, but in side chains albeit in contact with the ligand.
Hence, these two examples and others [50–56] suggest that few mu-
tations, both engineered and naturally occurring, can be enough to alter
binding specificities, both in proteins without catalytic activity and in en-
zymes. Moreover, these mutations are not necessarily restricted to the
binding interface, although these are probably more common [57].
How to lose interactions
An alternative way protein function can evolve is by selective loss of in-
teractions. It is clear that for instance in the engineered cases referenced
above, the number of mutations needed to selectively lose an interaction
is at most the number that was needed to gain it. Interactions may be
disrupted with fewer mutations in case epistatic interactions require the
co-occurrence of several residues. Most often interactions are critical as-
pects of protein function, and as such the interface residues are protected
from accumulating mutations by purifying selection. This has for example
been demonstrated in ubiquitin, where comprehensively quantifying the
fitness effects of mutating each position into every possible residue has
revealed that binding is the dominant cause behind purifying selection in
ubiquitin [40]. Yet, there are different scenarios in which the loss of an
interaction is the crucial step to evolve protein function.
On one hand, there is the loss of interactions previously shaped by
selection, which may be lost for several reasons. For instance, after the
duplication giving rise to the two clades of steroid receptors already in-
troduced, the estrogen receptor in the Branchiostoma floridae lineage lost
its ability to interact with ligands by virtue of two replacements, although
each of them separately is enough to disrupt the interaction [58]. However,
18
the duplicate kept the ability to bind DNA. As a result, it competes for
the binding sites with the original copy and in this way functions as a
repressor. The new repressor function is thus a type of exaptation, i.e.
the co-option for a new use of a protein previously shaped by selection
[18]. An example not for exaptation but for adaptation involving loss of
interactions in the evolution of two-component signalling pathways after
duplication in α- and β-proteobacteria. These pathways typically consist
of sensor histidine kinases which often very specifically phosphorylate a
specific response regulator that in turn modulates gene expression. In
α- and β-proteobacteria, the duplication of kinase-regulator pair led to
crosstalk between the new response regulator NtrX and the conserved
kinase PhoR, with negative effects on fitness in phosphate-limited condi-
tions. The two lineages followed a different path to eliminate the cross-talk
and insulate the signalling pathways: in α-proteobacteria two mutations
in the kinase PhoR restored specificity to the co-evolving response regula-
tor PhoB, whereas β-proteobacteria achieved specificity by four mutations
in NtrX [59].
On the other hand, there is the loss of promiscuous, i.e. selectively
neutral interactions that exist because of a lack of purifying selection.
Specificity may often become important for function, large-scale studies
for example found that residues surrounding the interfaces involved in
transient interactions often contribute to prevent non-native interactions
and maximise specificity [60]. A well studied example is the evolution of
mineralocorticoid and the cortisol-specific glucocorticoid receptor from a
mineralocorticoid-like, promiscuous ancestor. In the glucocorticoid lin-
eage, two mutations largely recapitulate the loss of sensitivity to ligands
other than the native ligand cortisol [61], although six additional muta-
tions are needed to evolve the fully cortisol-specific enzyme [62]. It has
been argued more generally that a principle of minimal specificity well de-
scribes the evolution steroid receptors: as long as promiscuity has no cost
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and the receptor works sufficiently well, for instance because the cell will
not encounter the promiscuously binding ligand, structural mechanisms
leading to higher specificity do not evolve [63]. Note that promiscuity may
not always be due to lack of purifying selection, but can reflect a biochem-
ical constraint inherent to the structure and biochemistry of the protein.
In this case, the interaction could not be lost without also losing the native
function coupled to it, as for example observed in Rubisco that sometimes
confuses its substrate CO2 with its product O2 [64].
In conclusion, the selective loss of interactions can be important for
the evolution of protein function, and can much like gains of interaction
be achieved with few mutations. The number of mutations needed is most
likely independent of the type of interaction, i.e. of promiscuous origin or
selected for.
Mutational paths to alter interactions
The question how many mutations are needed to evolve protein function
can be elaborated. Commonly, the order of the mutations matters as
a mutational path becomes mostly inaccessible if it does not monotoni-
cally increase fitness [25]. Therefore, rather than how many mutations, the
question becomes how many mutational paths exist. Besides theoretical
studies on abstract fitness landscapes models [65], the problem has be-
gun to be addressed experimentally [66]. The pertinent questions are how
many of the paths between two functional variants are accessible, what
the mechanisms to block the others are, and whether there are processes
biasing the choice of which path a protein is actually going to take. Before
addressing these questions looking at three scenarios of how mutational
paths can behave, we briefly comment on how mutational paths can be
studied. It is clear that in naturally diverging proteins, the denser the
phylogenetic sampling, i.e. the more species are analysed and the closer
they are related, the better the order of mutations can be established.
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However, in many cases proteins may substantially diverge in time peri-
ods between speciations, for instance after duplications. In these cases,
hypotheses about the order of mutations can only be generated using ex-
perimental techniques like for example site-directed mutagenesis.
All mutational paths are accessible—When considering two functional
proteins and the mutational path between them, the simplest way muta-
tions can behave is having additive functional effects, i.e. effectively being
independent. This has been shown for instance for the engineered switch
in coenzyme use from NAD+ to NADP+ in E. coli IMDH [47]. Every muta-
tion creates a functional, intermediate protein on the path between NAD+
and NADP+ specificity and consequently every mutational path is accessi-
ble, at least in principle. The reservation stems from the fact that absence
of epistasis at the phenotypic level does not imply that there is none at
the level of fitness. In the example above, the system follows a logic of
diminishing returns [67], that is the same absolute increase in coenzyme
specificity in an already specific enzyme contributes less to organismal
fitness than it would in an inefficient enzyme [47]. Hence, the resulting
composite genotype-fitness map is a concave function, in this case there-
fore not changing the accessibility of mutational paths.
Some mutational paths are blocked—The above situation becomes more
complicated in the presence of epistasis, i.e. the dependence of mutational
effects on other mutations. Two different structural mechanisms for epis-
tasis have been described which are particularly important for functional
evolution.
First, the structural repositioning of a residue by another mutation
alters the mutational effect of the former, a situation which has been
coined conformational epistasis [62]. An example is the loss of specificity
for hormones other than cortisol in the evolution of the glucocorticoid re-
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ceptor from a promiscuous ancestor already mentioned above. While one
mutation in isolation has a deleterious effect by destabilising the binding
interface, it repositions another residue into contact distance with the lig-
and. A mutation in this latter residue then allows it to form a new bond
specifically with cortisol, which would have had no effect in its old locali-
sation. Hence, in this case a deleterious and a neutral mutation together
have a beneficial fitness effect [62], but the mutational path in which the
deleterious mutation comes first is blocked or at least its accessibility re-
duced.
A second epistatic mechanism with equal consequences for the acces-
sibility of mutational paths is the increase in protein stability. Stability
often results from functionally neutral mutations, that later become es-
sential to buffer the destabilising effects of mutations altering specificity.
The glucocorticoid receptor again serves as an example: a neutral mu-
tation that occurred millions of years before the actual switch in ligand
specificity stabilises crucial parts of the protein and becomes necessary
to tolerate any of the following mutations that actually modulate binding
specificity [62]. This type of “new-function-stability tradeoff” [68] is a com-
mon phenomenon: a large analysis of 548 mutations observed in directed
evolution experiments of 22 enzymes showed that mutations that affect en-
zyme specificity destabilise the protein more than other surface mutations
on average [69]. At the same time, many functionally neutral mutations
in these experiments had stabilising effects. One possible structural ex-
planation for the destabilising effect of mutations altering specificity has
been found when analysing the natural and in vitro evolution of TEM-1
β-lactamases that gained activity against cephalosporin antibiotics [70].
To accommodate a larger substrate, the binding site has to be enlarged
at the expense of internal interactions that stabilise protein structure. As
most proteins—including the β-lactamases—are only marginally stable,
small effects on stability may have drastic effects on function and there-
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with fitness. Thus, the consequence of epistasis is again that mutational
paths to altered specificities are blocked unless compensatory mutations
have occurred. This form of epistasis provides a good example for the
connection between function and basic biophysical properties of a protein.
Finally, an interesting consequence of epistasis is that it can block the
reverse mutational path that would undo functional changes in a protein
(as for instance reported in reference [53]). Such an “epistatic ratchet” [71]
has been described in the glucocorticoid receptor. Five mutations that
mildly optimise cortisol specificity in the glucocorticoid receptor desta-
bilise structures needed for the function of the ancestral protein, and as
a result reversing the two mutations that are mainly responsible for the
switch in specificity yields a non-functional protein. Hence, unless the
five mutations are reversed, which have no effect on the ancestral function
and would therefore have to be accumulated against purifying selection
for cortisol specificity, the reverse path is inaccessible [71].
In conclusion, epistasis provides a mechanism to constrain accessible
mutational paths (or depending on the perspective, opening them). How
many paths are blocked depends on the strengths of purifying selection
that determines the tolerance against mildly deleterious intermediates,
and may vary from protein to protein: for some there is no restriction,
as for example discussed for E. coli IMDH [47], in other cases most paths
may be blocked, as has been shown experimentally for instance in TEM
β-lactamases [50]. In general, epistasis is a common phenomenon [72, 73]
and can therefore be expected to often influence the evolutionary path of
proteins [74]. Note that regardless of epistasis, there are mechanisms that
enable proteins to evolve via less fit or even non-functional intermediates:
redundancy resulting from gene duplication for example has been intro-
duced by Ohno as a solution to precisely this problem [75].
Some mutational paths are more likely than others—An entirely dif-
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ferent perspective on mutational paths is not to focus on how many are
accessible or blocked, but to ask if mechanisms exist that may bias the
actual path taken in the functional evolution of a protein. Of major im-
portance in this context are mostly neutral mutations that contribute to
promiscuous enzyme functions different from the native function under pu-
rifying selection, but that do not affect the latter [76]. The ability of neu-
tral mutations to affect promiscuous interactions has been demonstrated
by experimental evolution for instance in cytochrome P450 [77]. These
promiscuous binding activities may poise proteins for future functional
evolution, as new specificities can emerge simply by amplifying already ex-
isting affinities to an alternative substrate via shorter and therefore more
likely mutational paths in sequence space [78]. For example, protein res-
urrection showed that ancestral enzymes in the SABATH lineage of plant
methyltransferases in Solanaceae have promiscuous activity on nicotinic
acid (NA), a secondary activity still present in most extant members the
family. After a gene duplication within Nicotiana, amplification of this
promiscuous activity gave rise to a nicotinic acid carboxyl methyltrans-
ferase whose preferred substrate is NA [53]. In conclusion, promiscuity is
a widespread phenomenon [79] particularly important for the evolution of
function because it provides a set of functions that can immediately be
tinkered with circumventing the need to evolve them from scratch.
Different mechanisms to alter interactions
So far, we exclusively discussed the effect of point mutations on bind-
ing specificities. However, diverse other mechanisms exist to alter protein
interactions that can therefore play an important role in functional evolu-
tion.
Binding partners can be altered by loss and gain of longer strips of
DNA, for example linear motifs, disordered regions or interaction domains.
Short linear motifs, or SLiMs, are regions between three and ten amino
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acids frequently found outside protein domains, which function as modules
mediating weak and transient protein interactions [80]. Since they are short
and unlike domains not constrained by the necessity to properly fold, they
can be readily gained and lost and are therefore very dynamic throughout
evolution. This is best illustrated by the frequent mimicry of SLiMs that
convergently evolved for instance in viruses to hijack the host cellular ma-
chinery [81]. An important example for a protein that functionally evolved
by altering its set of binding partners through gain and loss of SLiMs is the
Drosophila ftz TF. ftz has homeotic functions conserved in most arthro-
pods, mediated by a homeodomain binding DNA and a [FY]PWM motif for
co-factor binding. The ancestor of beetles and Drosophila gained a LxxLL
motif, allowing it to interact with nuclear hormone receptors, which re-
sulted in ftz assuming an additional function in segmentation. However,
in Drosophila the [FY]PWM motif was lost, therefore the ability to interact
with the certain co-factors and as a result the ancestral homeotic function
[82]. Interestingly, the importance of functional evolution of the TF itself
through altered protein-protein interactions rather than evolution of cis-
regulatory elements has recently been emphasised as a mode of evolution
of gene regulation and developmental evolution in general [83, 84]. An-
other important mediator of interactions with very similar properties and
consequences for functional evolution are intrinsically disordered (ID) re-
gions, which are commonly defined as regions that do not adopt a regular
three-dimensional structure. The large-scale analysis of protein-protein
interaction networks has shown that interactions mediated by ID regions
are more abundant than their ordered counterparts [85], which may be
explained by their usually high binding promiscuity [86]. Hence, acquiring
and altering ID regions may is an important evolutionary route for mas-
ter regulators or hub proteins in general. Yet another possibility is the
loss or gain of entire domains that mediate interactions. Interaction do-
mains are independently folding modules usually between 35-150 residues
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in length that can easily be inserted into loops or terminal regions [87,
p. 88f]. Domains with varying specificities are known, some of the most
frequent for example being WD40, the Armadillo repeat or SH3 that specif-
ically binds proline-rich sequences [88]. An important protein family that
has evolved by combination of domains bringing together distinct activ-
ities is Hedgehog. The hog domain, which in itself is already composed
of an autoproteolytic and a cholesterol binding domain [89], fused with
the receptor-binding Hedge domain at the base of Eumetazoa [90]. The
composite is secreted into extracellular space and functions as a diffusible
ligand in one of the fundamental signal transduction pathways in animal
development.
A fundamentally different mechanism from the intrinsic determinants
of binding specificities discussed so far, i.e. those found in the protein it-
self, are extrinsic factors, most importantly the cellular context. Many
proteins are not localised in a diffuse manner all over the cell, but specifi-
cally targeted and localised to specific compartments or structures within
the cell. A good illustration for the fact that localisation is a mechanism
providing specificity are kinases. There are many more proteins targeted
by kinases than kinases themselves, necessarily requiring them to phos-
phorylate several substrates. To nonetheless ensure specificity, kinases are
targeted to the right localisation effectively preventing interaction with un-
desired targets [87, p. 90]. An example suggesting a role for relocalisation
in the evolution of protein function is the hominoid-specific CDC14Breto
gene. After duplication from a microtubule-localised phosphatase, muta-
tions in the termini relocalised the protein to the Endoplasmic Reticulum.
While sequence analysis suggest it maintained its phosphatase activity, it
is very likely that the protein changed its substrates at its new localisation
[91]. However, the cause-effect relationship between localisation and pro-
tein interactions goes both ways: the Drosophila gene Umbrea altered its
localisation as a result of a mutations in a binding motif entirely changing
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its interaction partners [55].
1.2.2 Catalysis
Virtually all chemical reactions in the cell are catalysed [15, p. 2], which
speeds them up sometimes more than a billion fold and allows for spa-
tiotemporal control [14, p. 63]. Both speed and control are essential for
life to exist. Although some RNAs also have catalytic functions, most cat-
alysts are proteins with 45% of all proteins having an annotated enzyme
function [45]. As already discussed in Subsection 1.2.1, changing binding
specificities is the most common mode of functional evolution in proteins,
including enzymes. Yet, within enzyme superfamilies the evolution of
product outcome and biochemistry are frequent and account for roughly
two fifth of the recorded events of functional evolution in a survey of over 2
million enzymes [45]. Importantly, functional evolution is not constrained
to transformations within enzymes or non-enzymes: loss of enzymatic ac-
tivity is frequent [92] and discussed later, but also the reverse case, i.e. the
evolution of an enzyme from a non-enzymatic ancestor, has been found to
occur [93, 94].
How many mutations to alter biochemistry?
We begin by asking the same question as above for binding. Clearly,
the fact that evolution of enzyme biochemistry is still relatively frequent
compared to alterations of binding specificities suggests that the number
of mutations needed may be in the same order of magnitude.
One possibility for enzyme function to evolve is to alter the enzyme
product. An example of a single amino acid changing the product has
been described in the kaurene synthase-like (KSL) gene family of rice.
Whereas a particular member of the KSL family in the subspecies indica
catalyses ent-copalyl diphosphate specifically to ent-isokaur-15-ene, the
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ortholog in subspecies japonica produces ent-pimara-8(14),15-diene. Us-
ing site-directed mutagenesis, the authors could show that only one of
three differences in the active site of the enzymes is sufficient to convert
the product outcome between the two proteins [95]. That this is a com-
mon phenomenon at least in terpene cyclases has been demonstrated by
generating and analysing all mutational intermediates between tobacco
5-epi-aristolochene and henbane premnaspirodieme synthase. These en-
zymes act on the same substrate but have distinct product outputs and
can be reciprocally interconverted by mutations in nine amino acids [96].
While most mutations have moderate, additive effects on outcome profiles,
punctuated changes as a result of a single amino acid were not rare [97]. In-
terestingly, much like substrate promiscuity discussed in Subsection 1.2.1
mutational paths proceed through catalitically promiscuous intermediates
with equivalent conclusions for the evolution of new enzyme functions [98].
Another, more drastic possibility for the evolution of enzyme function
is altering the catalytic activity. A remarkable example of two closely
related but functionally distinct enzymes differing by only nine amino
acids can be found in bacteria. Melamine deaminase from Pseudomonas
sp. strain NRRl B-12227 and atrazine chlorohydrolase from Pseudomonas
sp. strain ADP catalyse different reactions on different substrates, with
no detectable activity on the respective other substrate [99]. A greedy
strategy illuminating the most likely evolutionary paths between these
two enzymes found evidence for many of the phenomena described above
in the context of binding: epistatic interactions blocking certain paths,
amongst others the direct reversal of the most likely mutational paths
from one to tother emzyme, promiscuous intermediates, and a trade-off
between enzymatic activity and stability [100].
In conclusion, these few examples suggest no qualitative differences
between the evolution of binding specificities and enzymatic product out-
come or reaction biochemistry, at least in terms of number of mutations
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required. This agrees with previous findings that evolution of new chem-
istry can also be achieved by small local changes, that is not necessarily
requires evolution of entirely new protein structures [45].
How to lose catalytic activity
Perhaps more surprising than in the case of binding, enzymes have also
been found to functionally evolve by losing their enzymatic activity. There
are several possibilities how this can happen. In a rather straightforward
manner comparable to the case of the steroid receptor in the Branchios-
toma floridae lineage described above, a multidomain protein may lose its
enzymatic domain but keep other domains, for example binding domains.
An example for such a case has been found in the family of mammalian
polo-like kinases (Plks), master regulators of cell division that also have
functions outside the cell cycle. A recently described member, Plk5, has
lost its kinase activity by inactivating mutations, and the human sequence
even lost the domain altogether due to the creation of a premature stop
codon [101]. Yet, these proteins kept their substrate-binding domains and
have assumed a new function in the brain, likely as anti-proliferative sig-
nals [102].
An interesting example, different in the sense that loss of enzymatic
activity and gain of a new function happen within a single domain, has
been found in the guanylate kinase (GK) enzyme which catalyses phos-
photransfer from ATP to GMP. A single mutation is capable of disrupting
the enzymatic activity, and at the same time confers the ability to bind
an interaction partner that ultimately allows the new protein domain to
function in spindle-orientation. Remarkably, the structural mechanism by
which the functional transition is achieved does not depend on a specific
mutation, rather other mutations preventing the GMP-induced conforma-
tional change in the GK enzyme also achieve the same effect and lead
to a protein functioning in spindle-orientation. Hence, in this particular
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example the evolution from an enzyme to a binding protein as a result
of a single mutation is not an oddity but can be achieved via multiple
mutational paths [103].
These two examples demonstrate that loss of enzymatic activity is
not a death-sentence for genes inevitably leading to pseudogenisation, al-
though this is the most likely outcome as it is generally the case for gene
duplicates. How widespread this phenomenon really is has been assessed
by several large-scale studies scanning the public protein sequence and
structure databases for enzyme homologs with substitutions in their ac-
tive sites [92, 93]. The surprising result is that inactive enzyme-homologs
are the rule, not the exception: 10% of the enzyme domains in humans and
even higher percentages in flies and C. elegans are predicted to have lost
their enzymatic activity, with some superfamilies like RAS small GTPases
reaching almost 50% likely inactive members [92]. As has been pointed
out [104], these fractions are likely to be overestimates because of atypical
enzyme mechanisms (see for instance [105]), nevertheless, the numbers are
likely to remain substantial. Many of these inactive enzymes are under
purifying selection and have therefore acquired a new beneficial function,
which has been hypothesised to mainly be regulatory [92]. This is indeed
an attractive and experimentally supported possibility, as the inactive en-
zymes can exploit their ability to bind substrates and co-factors of their
enzymatic counterparts and often retain their tissue-specificity and sub-
cellular localisation [104]. In summary, loss of enzymatic activity emerges
as a powerful mechanism for regulatory evolution as well as functional
evolution in general.
The degeneracy of the protein sequence-function map
The evolution of enzymes inspires to ask general questions about the rela-
tion between sequence and function in proteins. Of particular interest for
the evolution of protein function is the degeneracy of this map, or in other
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words: can different sequences perform the same specific function, and
vice versa, can different functions be performed by the same sequence?
In the case of binding the answer is trivial. A short glance at a protein
interaction network confirms the degeneracy of the map as proteins can
be bound by many other evolutionarily unrelated ones, and a protein may
bind many proteins. In the case of enzymes the answer is less immediate.
The question if different, i.e. non-homologous, enzymes can perform
the same function has recently been addressed by at least two studies
[106, 107]. The authors differ by the stringency of their criteria: in one
case, equal EC numbers indicate the same enzyme function and differ-
ent structural folds are used to ensure non-homology [107], in the other
case the authors additionally consider enzymes that only share the first
three digits of the EC hierarchy but constrain non-homologs only to those
cases that convergently evolved the same active sites [106]. Either way,
in both cases the conclusion is that for more than 4% of the EC num-
bers non-homologous enzymes evolved. Hence, there is degeneracy in the
map from enzyme sequence to function, meaning that different sequences
evolutionary converged on the same enzymatic function.
The other direction is arguably more spectacular, that is a single se-
quence with different functions. Again, it turns out to be more common
than one may expect: a series of multifunctional proteins from all over tree
of life have been described coined moonlighting proteins. By definition,
they perform autonomous functions not partitioned between different pro-
tein domains [108]. Strikingly, only in one of these cases a protein has two
different enzymatic functions: an albaflavenone monooxygenase of the soil
bacterium Streptomyces coelicolor has additional terpene synthase activity
[109]. Most other cases consist of enzymes that have additional structural
or regulatory functions.
In conclusion, the relationship between sequence and function is de-
generate. The consequences for the understanding of the evolution of
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function are abstract but fundamental: the fact that a single sequence
provides a solution to several functional challenges and that a particular
functional challenge can be met by different sequences makes functional
evolution overall more probable. Using a popular analogy, not only are
several needles in the haystack (several sequences for one function), but
different people are looking for them simultaneously (several functions for
one sequence).
1.2.3 Biophysical properties
A third possibility how the function of a protein can evolve is via change
of biophysical properties. Biophysics has already been mentioned several
times in the preceding subsections, for example in the context of new-
function-stability tradeoffs [68] frequent in the evolution of new binding
specificities or the loss of conformational flexibility as a mechanism to lose
catalytic function in the guanylate kinase [103]. However, in these cases the
change in a biophysical property like stability or flexibility only indirectly
leads to functional change, i.e. merely represents a mechanism that affects
binding or catalysis which in turn underlie the evolution of function. Yet,
properties like length, stability and flexibility can also directly cause the
evolution of protein function and examples from each of these categories
are discussed below. In comparison to protein binding and catalysis, this
mode of functional evolution is probably rare and relatively little is known
about it. Rather than from dedicated studies the following examples are
inferred from functional and evolutionary analyses conducted mostly for
different purposes.
As already argued in Subsection 1.1.2, the continuous nature of bio-
physical parameters make them incompatible with our definition of func-
tional evolution that requires qualitative differences (see Subsection 1.1.2).
In the following, we therefore depart from the strictly biochemical defi-
nition of protein function applied so far and consider higher level, i.e.
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cellular and organismal functional consequences. Higher order functional
consequences stemming from quantitative changes are not restricted to
biophysical properties, changes in binding affinity or catalytic efficiency
can also have important qualitative phenotypic effects. For example, re-
duction of binding affinity of the garter snake voltage-gated sodium chan-
nel to tetrodotoxin, a neurotoxin toxin produced by some of these snakes’
preys, confers actual physiological resistance to the toxin [110]. Similarly,
the venoms of some shrews and lizards achieve toxicity via a serine pro-
tease paralog with enhanced catalytic efficiency. This enzyme releases a
catalytic byproduct into the circulatory system which effectively becomes
toxic due to its sheer amount [32].
Length
A clear case for the importance of protein length comes from molecu-
lar rulers. These molecules function in length control of specific cellular
structures, which are synthesised to match the length of the molecular
ruler [111].
An example can be found in certain pathogenic bacteria with a type-
III secretion system, which consists of secreted effectors and proteins that
form the injectisome, a stiff needle-like structure that is thought to func-
tion as a conduit for the secreted proteins. The needle length of the
injectisome is controlled by a molecular ruler [112], and has been shown
by manipulations to be essential for proper translocation of the effectors
through the host cell plasma membrane [113]. In Yersinia enterocolitica,
the protein acting as a ruler has internal repeats that contain stretches
forming α-helices which have been shown to be the critical structural el-
ements for length control [114]. Hence, internal repeats or mutations af-
fecting the formation of helices are able to modulate protein length, which
likely evolved to match specific distance requirements between the bac-
terium and its eukaryotic host cell [113]. As a consequence, changing the
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length of this protein can evolve its cellular function in the control of an
organismic phenotype, the pathogenicity of the bacterium.
Stability
A fascinating functional co-option of protein folding stability is found in
bacterial protein thermosensors. Bacteria have evolved different mecha-
nisms to sense temperature that are built around the central principle to
exploit physico-chemical change of macromolecules that occur in response
to temperature, for example in DNA, RNA, and most relevantly here pro-
teins [115].
Pathogens of the genus Yersinia for example need to rapidly adapt
their physiology after entering their warm-blooded hosts, often coincid-
ing with the expression of virulence-associated genes. On the other hand,
genes important for the initial stages of the infection like surface pro-
teins that mediate binding to host cells are of little use in later stages
or may even render the bacterium more susceptible to host immune re-
sponses [116]. Different Yersinia species do indeed downregulate expres-
sion of these genes upon entering the host using a direct temperature-
sensing mechanism: the TF RovA reacts to the body-temperature of the
host by reversible partial unfolding, which reduces its DNA binding affinity
resulting in release from operator-sites and downregulation of transcrip-
tion [117]. Most interestingly, substitution at three positions in RovA to
match the amino acids found in a close homolog of RovA in Salmonella
that remains stable and active at body temperature result in complete loss
of thermosensitivity [118]. Hence, minor sequence changes causing loss of
protein stability and resulting in a marginally stable protein domain pro-
vide the mean to evolve a new protein function.
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Flexibility
Protein flexibility is another example of a biophysical property that can
have direct functional consequences and is therefore relevant for the evo-
lution of protein function. Probably the most intuitive class of proteins
for which flexibility (or complementarily rigidity) is expected to be im-
portant are structural proteins, as for example cytoskeletal components.
An intriguing possibility is therefore to hypothesise that different paralogs
of cytoskeleton genes, for instance the highly similar actin isoforms, have
different flexibilities which could underlie functional differences and ulti-
mately their maintenance by purifying selection. Yet, while measurements
of viscoelastic properties of distinct actin isoforms indeed found differences
[119], the physiological importance of these differences remains unclear.
Rather, the mechanical properties of actin networks are a consequence
of varying dynamics [120] and structures [121] of actin-binding proteins
(ABP) cross-linking the filaments. The slightly divergent regions of actin
isoforms likely contribute to different binding affinities to ABP [122], and
actin may therefore represent an interesting case where evolution of bind-
ing leads to functional evolution via altered biophysical properties.
A group of proteins for which flexibility itself has been suggested to
be the key to functional evolution are pathogen effectors. The realisation
that intrinsically disordered regions are overrepresented in secreted effec-
tors of plant pathogens has led to the hypothesis that the conformational
flexibility of disordered regions is a key structural feature of effectors. It
could allow the effectors to be translocated through the type-III secre-
tion system, to avoid recognition by the plant innate immune system, and
mimic eukaryotic proteins [123]. Whereas in the latter two cases function
is affected by flexibility only indirectly by altering the binding properties
of the effectors, the requirement of flexibility for translocation can mod-
ulate if the protein reaches the eukaryotic cell altogether. Thus, in this
case changing protein flexibility is an evolutionary degree of freedom with
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drastic consequences for protein function.
1.3 The genetic basis of evolving protein
function
In the following, we change the focus from biochemical aspects of func-
tional evolution to its genetic basis. One of the fundamental prerequisites
for evolution is the existence of phenotypic variation [28], serving as the
raw material that evolutionary forces act upon. This variation has its root
in genotypic variation which exists as the result of mutations in DNA, and
is translated into phenotypes by physiology and development. In the fol-
lowing, we briefly summarise three different types of mutations leading to
variation in protein function: modifications, duplications and rearrange-
ments. In particular, we specify their rate whenever available and highlight
consequences, biases and constraints of different types of mutations for the
evolution of protein function.
1.3.1 Modification
Although point mutations affect only the minimum of one ‘quantum’ of
genetic information, the functional consequences of a single point mutation
can already be striking as discussed in Section 1.2. In particular, drastic
effects are expected when mutations affect gene structure, for instance by
causing gain (for example [101]) or loss (for example [124]) of stop codons.
Note that even synonymous mutations may have functional consequences
[125], yet effects are usually regulatory and therefore most likely affect
higher functional levels. Synonymous mutations can reveal mutational
biases deriving from genomic fluctuations in GC-content, as for instance
reported in reference [126], implying a potential for the genomic location
to influence the functional evolution of a gene.
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While point mutations conserve protein length (with exception of those
affecting stop codons), indels have the potential to alter it. Most indels are
short (smaller than 5 residues [127, 128]), and indels are less common than
substitutions: analyses found around 1 indel per 40 substitutions in coding
sequence for both primates and bacteria [129]. Although less common,
their accumulation has clear effects, as exemplified by the analysis of over
350 structural domain superfamilies, 60% of which showed at least 5%
length variation from their typical size [127].
1.3.2 Duplication
Duplication of DNA is fundamentally important for the evolution of func-
tion as it introduces redundancy which can free the duplicated segment
from purifying selective pressure [75]. Thus, duplication is a constant
source of new and potentially functioning DNA material that can be tin-
kered with. The easiest way to discuss duplications is by order of how
much DNA is affected. In general, there is a negative relationship between
the length of the duplication and its frequency, i.e. small duplications are
observed much more often than long ones [130].
Repeats are the smallest duplications, Microsatellites for example con-
sist of repeating units of less than 10 nucleotides. Duplications altering
the number of repeats may cause variation in repeat number in between
12% and 22% of all yeast genes [131] and can have important functional
consequences. For instance, strength of cell adherence has been shown to
scale with the number of repeats in the yeast cell surface adhesin FLO1
[132], likely mediated by an increased hydrophobic surface [133].
Larger internal duplications of gene segments are also frequent and
have been found in between 8% and 16% of genes from six diverse eukary-
otes [134]. They frequently lead to creation of novel introns and splice sites
[134], therewith contributing to the functional diversification of proteins.
The duplication of segments containing an entire gene is of particular
37
interest, as unlike repeats and most internal segments the new stretch of
DNA codes for an independent functional unit. Gene duplications are sur-
prisingly frequent and have been found to occur at the same rate as point
mutations [135]. They are probably the best studied duplication scenario,
and evolutionary models of sequence divergence and functional dynamics
are discussed in the next Section 1.4.2. Although all gene duplications
by definition result in two copies of the original gene, the actual genetic
mechanism of duplication influences the further evolution of the copies. A
basic difference arises from genomic context: tandem duplications creating
adjacent gene copies may be expected to preserve the regulatory context
of a gene, whereas relocating one copy for example onto a new chromo-
some may not. A special case is retrotransposition: not only can the gene
be inserted into a new regulatory landscape, but it is also cleared from
all introns which often contain regulatory elements. The altered genomic
context may therefore bias the evolutionary trajectory and predispose the
gene for regulatory and functional evolution [136].
The most extreme cases of gene duplication are changes in ploidy, for
instance whole genome duplication events. Whole genome duplications
are interesting from a functional perspective because unlike duplication of
a single gene, all interaction partners of a gene are also duplicated and
therefore their relative dosage conserved. This may prevent immediate
deleterious effects arising from changed post-duplication stoichiometry and
give duplicated genes time to functionally evolve.
1.3.3 Rearrangements
A third class of mutations relevant for the evolution of protein function
is genomic rearrangements. Basically, changing the mere localisation and
context of a gene on the chromosome can influence its evolution, e.g. by
fluctuations in GC-content already mentioned in Subsection 1.3.1. Another
example are subtelomeric regions, which have been shown to be particu-
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larly dynamic with elevated rates of duplication and recombination [137].
Recombination, i.e. the exchange of genetic information between two
DNA molecules, is an important evolutionary force, as it breaks the asso-
ciations imposed by the linear structure of the DNA strand. For example,
intergenic recombination in the context of pralogous gene families has been
observed to increase the diversity of alleles and functional variants by gen-
erating new genes carrying combinations of the mutations that separately
arose in the different copies [138]. Because each individual mutation has
been subject to purifying selection before, the recombined variants may
be expected to be less often deleterious, as shown for instance using engi-
neered β-lactamase chimera [139]. Recombination thus provides a mecha-
nism to increase the probability of finding and fixing positively epistatic
mutations. In directed evolution experiments, recombination has been
found to be able to generate both new ligand specificities [140] and more
stable proteins [141, 142].
Gene fusions are another outcome of rearrangements. Fused genes are
frequent, an early study for example found around 5% of E. coli genes
to have been involved in fusion events [143]. An interesting example in
eukaryotes are three independent fusions of the adh gene in Drosophila,
which were hypothesised to subsequently have followed convergent path
of functional evolution [144]. The impressive potential of fusion to couple
functionally unrelated genes has been demonstrated using a directed evolu-
tion strategy. The fusion of an E. coli maltose binding protein and TEM1
β-lactamase generated a β-lactamase with switch like catalytic activity
dependent on the presence of maltose [145]. Thus, gene fusions emerge as
a powerful mutational mechanism to generate new complex functions.
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1.4 Evolution and protein function
So far, this chapter discussed the biochemical basis of how protein function
evolves, and what mechanisms generate the necessary genetic variation
serving as raw material for this process. Here, we consider the forces
that sieve the pool of random mutations by guiding the path of functional
change. In other words, we discuss evolution.
How protein function evolves has been studied in molecular evolu-
tion for a long time, however, usually implicitly by following a ‘statistical
paradigm’ focussed around the origin and maintenance of genetic variation
[10]. The strength of this approach is the generality of its results which
avoid the reference to any function in particular. This is achieved by relat-
ing sequence variation to fitness directly and leaving the phenotypic level
out altogether, or by considering abstract phenotypic spaces for the study
of adaptation as for example in Fisher’s geometric model [146]. The price
of this generality is that mechanistic explanations for fitness differences are
impossible, as those can only be derived from an explicit representation
of a concrete phenotypic space. In particular, protein function evolves in
phenotypic space, and can therefore only be studied indirectly when this
level is omitted. In order to complement the classical statistical approach
and study phenomena as for instance the evolution of protein function,
alternative paradigms have been out forth which stress the benefits of in-
tegrating the three levels genotype, phenotype, and fitness [11, 147, 148].
They can be seen as part of a larger ‘functional synthesis’ subsuming most
of what has been discussed in this chapter [10]. Yet, also as part of this
synthesis the comparative analysis of sequences in search of statistical pat-
terns left by evolution remains fruitful for functional analysis, in particular
as more and more genomes become available. In the following, we detail
aspects of gene sequence and -family evolution that are relevant for the
study of protein function.
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1.4.1 Gene sequence evolution
The evolutionary fate of a mutation is tightly linked to its effect on organ-
ismal fitness. Although fitness effects are continuous, one can qualitatively
distinguish three categories: beneficial, neutral and deleterious mutations.
The proportions of mutations falling into each of these categories and in
particular the functional form of mutational effects are old, important
yet mostly unsolved problems in evolution [149]. At least in experimental
evolution studies, typically 30− 50% of point mutations are strongly dele-
terious, 50− 70% can be considered neutral and roughly 0.5− 0.01% are
beneficial [51]. The type of selective pressure a mutation will be exposed
to, if any, critically depends on which category it belongs to: beneficial
mutations are swept to fixation by positive selection, neutral mutations are
invisible to selection but may be fixed as a result of drift, and sufficiently
deleterious mutations are purged from the population due to purifying
selection.
The value of positive selection for studying the evolution of protein
function mostly lies in the following reasoning: if a statistical footprint left
by positive selection can be detected, one can infer that the site in question
is functionally important and its alteration contributed to the beneficial
consequences. Therefore, inferring selection can serve to guide further
functional investigation (see e.g. [150] and references therein). However,
the concrete functional consequences of a positively selected site are by no
means obvious, in particular they do not need to be at the biochemical
level. For example, selection for protein stability already mentioned in
Subsection 1.1.2 does not necessarily alter the biochemical function of a
protein itself, yet, at the cellular level the function may be overall physi-
ological robustness.
In the case of neutral mutations, the importance for the evolution of
function may be less obvious: as neutrality by definition implies no ef-
fect on fitness, neutral mutations may be expected to be irrelevant for
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functional evolution. However, this turns out not to be the case. Two
examples were already mentioned in Subsection 1.2.1 [51]: first, epistatic
interactions frequently alter the fitness effect of mutation that are neu-
tral in isolation. These can for instance stabilise protein structures and
therewith open evolutionary paths to new substrate specificities otherwise
blocked due to biophysical constraints resulting from marginal protein sta-
bility. Second, they may contribute to binding promiscuity, which in turn
can facilitate for example the evolution of new specificities to previously
low-affinity binding partners.
Lastly, there is purifying selection, which is a conservational force pre-
venting the accumulation of mutational changes and therefore the loss of
protein function. The hallmark of purifying selection, conservation of se-
quence beyond neutral expectation, is an important statistical footprint for
function and at the base of most genomic screens for functional elements
[151]. Conceptually, these methods follow the basic comparative reasoning
mentioned in the introduction and applied since the early 1950s, however,
in addition they properly account for the phylogenetic relationships which
underlie the evolutionary process [31].
1.4.2 Gene family evolution
Besides protein sequence itself, another level of evolution is crucial for in-
novation in protein function and functional change in general: the evolu-
tion of gene families. Without the occurrence of gene duplications, a gene
family consists of at most one ortholog per species as the only family-level
event is gene loss. Thus, in this case the only dynamics important for
functional evolution is sequence divergence at the level of genes, governed
by the processes described above. In contrast, gene duplications lead to
more intricate pattens, and various models for gene duplication have been
developed. Note however that despite its importance duplication is not
a prerequisite for functional evolution, as orthologs may also diverge in
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function [59, 152–154].
The most basic models merely describe the patterns of gene family
evolution. They distinguish two basic scenarios for the divergence within
and between orthologs and paralogs: divergent- and concerted evolution.
Divergent evolution was the first pattern observed in the 1960s for example
in hemoglobins, and is characterised by higher sequence divergence after
duplication than after speciation, leading to multiple clades of orthologs
in the gene phylogeny. Concerted evolution is the opposite case, i.e. lower
sequence divergence after duplication, resulting in clades of paralogs in the
phylogeny. Concerted evolution can be caused by frequent gene conversion
[155], and is the mode of evolution for instance of rRNA genes. Another
scenario stresses the effect of different rates of duplication and loss, mod-
elling gene family evolution as a birth death process [156]. These basic
evolutionary patterns can already be correlated with functional patterns:
the vertebrate cytochrome P450 family for example can be partitioned into
a stable part evolving by divergent evolution and having core functions,
and an unstable one better modelled by a birth-death process and having
accessory functions [134].
Gene duplication has also been studied specifically in the context of
functional evolution. The importance of gene duplication as a source of
new genetic material for functional evolution has been hypothesised since
the 1930s [157]. However, the link with innovation is mostly mentioned
in connection with Susumu Ohno, who boldly advocated the importance
of duplication: “natural selection merely modified, while redundancy cre-
ated” [75]. In the following, we summarise three scenarios for gene du-
plication. Ohno initially formulated two models connecting evolutionary
patterns and functional consequences, and a third possibility only requir-
ing neutral processes has been proposed later. While one of these scenarios
often well describes actual events, they are not exclusive and may overlap
or co-occur in the evolution of a gene family (see e.g. [54]).
43
Neofunctionalisation
Ohno presented redundancy as a solution to the problem of how a mu-
tational path could proceed through non-functional intermediates that
would otherwise be purged. In other words, redundancy functions a mech-
anism to defy purifying selection. The neofunctionalisation model applies
this idea to the evolution of duplicate genes: after gene duplication, the
copies are functionally redundant, therefore effectively freeing one gene
copy from the conservative force of purifying selection and allowing it to
explore the sequence neighbourhood independently of deleterious effects
of mutations on the original function. If this path encounters a protein
sequence able to perform a new beneficial function, it is picked up by pos-
itive selection and fixed in the population, forming a new gene with a new
function that is in turn protected from accumulating deleterious muta-
tions by purifying selection [75]. Hence, neofunctionalisation is a general
model for the innovation of function, satisfying the requirements of the
selected effects definition of function [3] (i.e. past positive selection, cur-
rent purifying selection [4]). It is general in the sense that it follows the
statistical paradigm of molecular evolution ignoring the phenotypic level.
Most relevantly, it does not specify how mutations can bring about a new
function (discussed in Section 1.2).
Dosage
A second possibility presented by Ohno is retention of a gene duplicate
due to beneficial effects of higher dosage. In this case, both copies are
conserved by purifying selection, leading to pattern of concerted gene fam-
ily evolution. This model does not lead to functional innovation at the
biochemical level, and is therefore less interesting in the context of this
chapter.
However, dosage can nonetheless play an important role in functional
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evolution as part of more complex gene duplication models. For instance,
poxviruses transiently increase the copy number of genes that counteract
host defence in order to make up for the initially low efficacy of these genes
in a species they are maladapted for [158]. The greater number of genes
and their protection from deleterious mutations by purifying selection in-
creases the probability of mutations optimising at least one of the copies
[159]. This mechanism does not necessarily imply evolution of protein func-
tion beyond quantitative adjustments of efficacy or affinity, however, the
same principle also works in conjunction with neofunctionalisation [160].
In what has been called the Innovation-Amplification-Divergence (IAD)
model [161], promiscuous side-functions which may not be efficient are
the cause for purifying selection initially maintaing the multiple copies.
One copy subsequently neofunctionalises by the action of positive selec-
tion turning one of these promiscuous side-activities for example into the
main substrate of an enzyme [53].
Subfunctionalisation
Subfunctionalisation offers an alternative explanation for gene duplicate
retention. In the tradition of the critique of adaptionism [162], it demon-
strates the important possibility that nonadaptive processes alone, i.e.
without requiring the action of positive selection, can lead to increased
genomic complexity [163]. After duplication, the initially redundant gene
copies accumulate deleterious or neutral mutations that partially disrupt
complementary parts of the function. This renders both copies necessary
to perform the original function, and both are conserved by purifying se-
lection. Complementarity can for instance be achieved by splitting the set
of tissues a gene is active in [164], a reduction in individual performance
requiring two copies to attain the original activity level, or by partitioning
any type of discrete function like interactions [163]. Unlike neofunctionali-
sation, subfunctionalisation is therefore a model in which function evolves
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by loss or reduction.
An interesting variation of subfunctionalisation is the EAC-model (Es-
cape from Adaptive Conflict), in which a constraint of any sort prevents
the independent optimisation of any of (at least) two functions of an undu-
plicated protein, creating an adaptive conflict. After duplication, parti-
tioning the functions between the copies alleviates the conflict and positive
selection is free to optimise the functions separately (see e.g. [165, 166]).
Finally, more complicated scenarios can result by introducing func-
tional coupling, for example when distinct protein domains interact to
perform the protein’s function or if the protein homodimerises. A sce-
nario of this kind has been described for duplications of steroid hormone
receptors, ligand-activated TFs that consist of a DNA and ligand binding
domain. Degenerative mutations in either of these two domains can re-
sult in a partially inactive protein that competes for either DNA binding
sites or the ligand and therefore functions as a repressor [58]. Thus, a new
protein function emerges, yet solely by virtue of degenerative mutations
which increases the probability of this scenario and therefore of functional
innovation. However, the evolution of a new function is not a necessary
outcome. This scenario may simply lead to an increase in the number of
molecular components and therefore complexity of molecular assemblies
without change in function[167, 168].
1.5 Rab GTPases: the evolution of function in
protein switches
In the present section, we argue that protein switches represent a rele-
vant and interesting class of proteins to explore the evolution of function.
Furthermore, we introduce the Rab family of small GTPases analysed in
the remainder of this thesis as a promising model gene family for protein
switches.
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Switching, i.e. the conformational change of a protein in response to
a signal or event, can be considered one of the fundamental biochemical
function of proteins (see Subsection 1.1.1). The nature of the of the trigger
leading to switching can be very diverse: conformational changes result
from hydrolysis of GTP or ATP, binding of ions like for example calcium,
posttranslational modifications, change in PH or even from light.
The biochemical function of protein switches can evolve in unique ways.
For example, the transcription factor CEBPB is essential in placental mam-
mals and initiates transcription after being activated via conformational
switching in response to phosphorylation. Using ancestral sequence recon-
struction, it could be shown that three mutations introduced and removed
phosphorylation sites that lead to an inversion of CEBPB behaviour: rather
than being repressed, phosphorylation activates the transcription factor
[169]. Hence, in this case very few mutations are capable of altering the
switching mechanism representing a mode of functional evolution exclu-
sive to protein switches. While this is a striking example of a direct effect
of switching on function, it is likely that evolution of switching leads to
different functions mostly indirectly via alteration of binding specificities.
An illustration for this mechanism is the calcium-binding C2-domain. It
has been shown that skipping an exon of only nine amino acids by al-
ternative splicing abrogates the conformational change needed to activate
the ability to bind calcium, generating an isoform able to permanently
bind calcium [170]. Hence, in this case small changes are enough to alter
switching and indirectly affect protein function via binding.
As already mentioned in Subsection 1.2.1, this latter mode of func-
tional evolution by tinkering with binding specificities is the most com-
mon form of evolution of function, and therefore of upmost importance.
Protein switches are most relevant models to study this phenomenon as
they are a critical class of proteins, involved in the regulation of key bi-
ological processes and intimately linked to central organisational features
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of the cell like compartmentalisation. They are compelling models as they
are subject to a unique set of constraints that is interesting to consider in
the context of functional evolution: maintenance of enough flexibility to
switch conformations, yet without resulting in unstable proteins; multi-
specificity to often to a large number of interaction partners; and enzyme
function in case of switching triggered by nucleotide hydrolysis. With this
argument in mind, we introduce a particular family of protein switches in
more detail—the Rab family of small GTPases—that serves as a model to
inquire into the evolution of function in the remainder of this thesis.
1.5.1 The Rab family of small GTPases
Rabs are GTPase enzymes belonging to the Ras superfamily, which is also
referred to as small GTPases. Structurally, the Ras superfamily is a repre-
sentative of the P-loop NTPases, one of the chain folds found in proteins
that bind and hydrolyse nucleoside triphosphates including ATP and GTP.
P-loop NTPases are the most populous protein fold in many cellular or-
ganisms, comprising 10 − 18% of all gene products [171]. GTPases are a
monophyletic superclass within P-loop NTPases, that can be—based on
sequence and structure—further divided into two large classes and have
been coined SIMIBI (after its three biggest subgroups, the Signal recog-
nition GTPases, the MinD superfamily and the BioD superfamily) and
TRAFAC (for translation factor-related). The latter includes the extended
Ras-like superfamily, and other important GTPases like heterotrimeric G
proteins that are activated by G-protein coupled receptors [171].
Ras-like proteins are found in all three superkingdoms of life, however,
in prokaryotes the only member is the MglA family. In the bacterium
Myxococcus xanthus, MglA functions in motility, sporulation, and morpho-
genesis. Interestingly, a MglA gene deletion leads to sporulation defects
which can be rescued by a yeast small GTPase [172]. This emphasises that
not only the overall structure but also fundamental aspects of the func-
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tional mechanism are conserved across the superkingdoms. In eukaryotes,
small GTPases have massively expanded as early as in the last eukaryotic
common ancestor, laying the foundation for the extraordinary diversity
of Ras-like families and proteins observed in extant eukaryotes [171]. For
example, the human Ras superfamily comprises over 150 genes [173], and
excavate genomes with over 320 small GTPases have been sequenced [174].
The Ras superfamily owes its name to its founding members, genes that
were identified in rats as the targets of transformation by rat-derived Har-
vey and Kirsten murine sarcoma retroviruses and therefore named Ras
(from ‘rat sarcoma’) [175]. Ras have signalling functions and remain the
most extensively studied family within the superfamily because of their
critical role in human oncogenesis [176].
Among the members of the Ras superfamily, Rabs are the largest fam-
ily, for instance accounting for over 60 of 150 Ras superfamily genes present
in the human genome. Rabs were originally described in yeast due to their
similarity with Ras [177], and suggested to function in microtubule organ-
isation [178]. Shortly after, another member of the the yeast Rab family
was implicated in secretion [179], and its functional mechanism began to
be worked out [180]. In the meantime, Rabs were shown to be widespread
in eukaryotes and conserved in sequence [181, 182] and function [183]. The
name is derived from the origin of the library they were identified in, ‘Ras
genes from rat brain’ [182].
Sequence and structure
Rabs are relatively short proteins of length around 220 amino acids. They
can be partitioned roughly into a central conserved region that contains
various GTPase and Rab-specific motifs and that is flanked by two more
divergent so-called hypervariable termini (see Figure 1.1).
The conserved region harbours six different types of motifs hierarchi-
cally defining the sequence as a Rab. First, the catalytic triad, i.e. three
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amino acids shared by certain hydrolase and transferase enzymes. Sec-
ond, two motifs that define P-loop NTPases, the N-terminal Walker A
(GxxxGK[ST]) motif or P-loop that binds phosphate and the distal Walker
B motif (DxxG) that binds a Mg ion. Third, besides having a specific
form of the Walker B motif, GTPases have an additional distal [NT]KxD
motif conferring specificity to GTP and thus not found in other P-loop
NTPases [171]. Fourth, small GTPases share four further motifs, two sin-
gle conserved [FY] and T residues, the latter located in the second loop
also known as the effector loop, and two conserved strips with consensus
DTAGQ and SAK respectively. These residues participate in the inter-
actions with guanine, phosphate and Mg. Fifth, bioinformatic analysis
determined five Rab family motifs distinguishing them from other fam-
ilies of the Ras superfamily [185]. These regions are important for the
interaction with Rab-specific regulators discussed later. Finally, Rab sub-
family motifs recapitulate the partitioning of the family into subfamilies
based on overall sequence similarity, with the first and last motif extend-
ing into the hypervariable termini [185, 186]. The regions corresponding
to the subfamily motifs have been proposed to confer specificity to the
distinct sets of effectors of Rab subfamilies.
Rabs are protein switches belonging to the structural class of α/β
proteins, with an antiparallel sheet opposite to the strand with the Walker
B motif distinctive of GTPases of the TRAFAC class [171]. A diagram of
the relative order of the six β-sheets and five α-helices common to small
GTPases is shown in Figure 1.2. The region before the antiparallel β-
sheet β2 and the one after the adjacent β-sheet β3 constitute the switch
1 and 2 respectively. The switch region as a whole including the inter-
switch region is the primary structural determinant of nucleotide-state
dependent function, undergoing major conformational change between the
GTP- and GDP-bound state. In the inactive GDP-bound conformation the
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Figure 1.2: Rab structural topology—The organisation of Rab secondary
structure elements represented as a 2D topology diagram (generated with
Pro-origami [189] and manually recoloured). The sheets and helices are num-
bered β1− 6 and α1− 5 respectively corresponding to the sequences shown
in Figure 1.1. The switch region changing conformation upon nucleotide-
binding is highlighted (blue) (see main text). For clarity, overlapping con-
nections between secondary structure elements are drawn in a different colour
(violet) [189].
switch region tends to be unstructured, whereas a structured conformation
defines the active state and is involved in conferring specificity to the
binding of effectors [187, 188]. The full spatial organisation of Rab proteins
and in particular the switch region is exemplified by Figure 1.3.
Function
Rabs function as molecular switches cycling between a GTP-bound ac-
tive and GDP-bound inactive state, primarily defined by the conforma-
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Figure 1.3: Ypt1 (yeast Rab1 ortholog) crystal structure—Crystal structure
of Ypt1, the yeast Rab1 ortholog, in active conformation bound to a GTP
analog (not shown) [190]. Regions corresponding to the different Rab motifs
shown in Figure 1.1 are coloured equivalently (green: Rab G1−3 and PM1−3
motifs, red: RabF motifs [185], yellow: RabSF motifs [186, 191]). The switch
region (see main text) covers β-sheets β2 (labelled) and the immediately
adjacent β3 and is located in front in the upper view, on the back in the
rotated view.
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tion of the switch region that changes depending on the nucleotide. The
conformation of the active state is recognised by effector proteins that
preferentially bind the GTP-bound form, although proteins specific to the
GDP-bound form are also known [192]. The recruited effectors perform
the functions regulated by Rabs in their respective pathways, which are
discussed below.
Besides the switching between active and inactive states, Rabs spa-
tially cycle between a cytosolic and membrane-bound form. The full Rab
cycle is summarised in Figure 1.4. After translation, a GDP-bound Rab
associates with a Rab escort protein (REP) that presents it to a Rab ger-
anylgeranyl transferase (RabGGT) which posttranslationally modifies a
C-terminal prenylation motif. The modified Rab is delivered to the target
membrane, where its now hydrophilic tail allows membrane insertion that
may be assisted by a GDP dissociation inhibitor (GDI) dissociation factor
(GDF). In the membrane-inserted state (‘In’), the Rab is activated (‘On’)
by the aid of a guanine exchange factor (GEF) that catalyses exchange
of GDP for GTP. It is now that effector-binding occurs. The low intrin-
sic GTP-hydrolysis is accelerated by a GTPase-activating protein (GAP)
that promotes the formation of the inactive GDP-bound state (‘Off’). Fi-
nally, the spatial cycle between the membrane-bound and cytoplasmic pool
(‘Out’) of Rabs is closed by GDIs, that extract Rabs from the membrane
and deliver them back to GDFs for reinsertion (see [173, 188] for reviews).
In the cellular context, Rabs function as master regulators of mem-
brane traffic. The active forms are localised in the membrane of a variety
of compartments where the recruited effectors mediate different steps of
vesicular trafficking. Figure 1.5 summarises the known intracellular local-
isation of most vertebrate Rab subfamilies (adapted from reference [188]).
The mechanisms targeting Rabs to their respective compartment are not
fully understood, but the hypervariable C-terminus [193, 194] and cer-
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Figure 1.4: Rab cycle—The full Rab cycle consisting of Rab activation and
two cycles switching between the membrane-inserted ‘In’ and cytosolic ‘Out’
state, and the GTP-bound ‘On’ and GDP-bound ‘Off’ state (see main text).
Abbreviations: Rab escort protein (REP), Rab geranylgeranyl transferase
(RabGGT), GDP dissociation inhibitor (GDI), GDI dissociation factor (GDF),
guanine exchange factor (GEF), GTPase-activating protein (GAP),
tain RabF and RabSF regions [195] have been experimentally implicated.
The functions performed by effectors that Rabs regulate can be associated
to distinct steps of vesicular trafficking. First, cargo is selected for coated
vesicle trafficking and enclosed in a forming bud. Afterwards, the matured
vesicle is transported by molecular motors and cytoskeletal filaments to
the acceptor membrane. After uncoating, tethering factors ensure that
the vesicle is then fused with the right membrane. Effectors involved in
each of these steps have been found to be regulated by specific Rabs (see
[188, 196] for reviews).
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Figure 1.5: Intracellular localisation of vertebrate Rab subfamilies—Rab
subfamilies found in vertebrates are shown at their intracellular localisation
together with the associated trafficking pathways (adapted from reference
[188]). The boxed subfamilies are found in most eukaryotes, and the names
of the orthologs in vertebrates (black), fungi (blue) and plants (green) are
given.
1.6 Conclusion
Biological phenomena occur on many levels. Here, we consider the fas-
cinating question how protein function evolves, and identify three levels
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essential to a complete answer and relevant for the rest of this thesis: bio-
chemistry, genetics and evolution. This list could be further extended:
an obvious perspective missing for a complete understanding is ecology,
which is concerned for example with the agents of selection, i.e. the causes
for natural selection [197].
The main conclusions from reviewing work on the structure of the
protein genotype-phenotype map and the protein phenotype or function
space itself are twofold. First, the evolution of protein function is incred-
ibly dynamic. Probably the most powerful examples come from proteins
that evolve across functional categories: enzymes evolve from non-enzymes
[93, 94] and vice-versa [92]. We find that regardless of the type of protein
the mutational paths to new functions can be short, frequently even single
amino acid changes have dramatic effects. This implies that mutations of
large effect not only exist, but also occur in the evolution of protein func-
tion. Yet, this does not contradict the fact that functions can be conserved
even in very divergent proteins, also a consequence of the unintuitive na-
ture of the high-dimensional sequence space. Even if mutational paths
are short, they are not straight. There is ample evidence for epistasis in
the evolution of protein function, which leads to rugged landscapes and
complicates the prediction of mutational effects. Second, the evolution of
protein function is not unlikely. This is a common criticism of evolutionary
theory in general, where apparent unlikeliness is perverted to justify the
existence of higher powers. In proteins, the argument of unlikeliness has
been most prominently addressed by Maynard-Smith [25], but research
since then adds a few nuances. Besides the dynamic nature of functional
evolution discussed above, this is most relevantly the degeneracy of the
protein genotype-phenotype map. A protein can serve many functions,
and a function can be carried out by different proteins, which increases
the likelihood that particular pairs of protein and function evolve.
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1.6.1 Rabs to study the evolution of function
In Section 1.5, we argue that protein switches are interesting yet under-
studied models for the evolution of protein function, and introduce Rabs as
the model family for the rest of this thesis. What makes Rabs well-suited
for the study of functional evolution?
First of all, Rabs can be seen (and are even used in experimental prac-
tice) as markers for certain compartments and trafficking pathways, due
to their essential functions in vesicle transport and organelle identity [198].
Their evolution is therefore relevant for the function and evolution of the
entire endomembrane system, that fundamentally shapes intracellular or-
ganisation and defines eukaryotes. As protein switches, they are subject
to various constraints already mentioned above, e.g. flexibility, stability,
multispecificity and enzyme function, providing the opportunity to study
the influence of these factors on the evolution of function. With publica-
tion of the first complete genomes, it became clear that the Rab family
greatly expanded in animal evolution, which suggests that despite multiple
constraints Rab proteins easily evolve new functions. This counterintu-
itive observation stimulates interesting questions about the mechanisms of
functional evolution. Not only in animals, but throughout the eukaryotic
tree of life the Rab family displays the interesting pattern of a conserved
core of subfamilies complemented by lineage-specific evolutionary events,
resulting in many independent cases of functional evolution that can be
studied. The annotation of eukaryotic Rabs and the resulting patterns of
Rab subfamily-level evolution are subject of Chapter 2 within this thesis.
In more practical terms, Rabs are a good model proteins because a rich
body of work established publicly accessible data on sequence, structure
and function, including expression, localisation and interactions. Some
isolated cases of functional evolution have already been studied. For in-
stance, the duplication of a Rab6 by retrotransposition in the ancestor
of apes and humans lead to paralogous gene copy that lost its ability to
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bind GTP and therefore catalytic activity. In lieu of localisation to the
Golgi like other Rab6, the new isoform localises to the centrosome where
it functions in cell cycle progression [124]. Hence, cases do exist in which
Rab function evolved in non-trivial ways underscoring the interest in Rabs
as a model. Chapter 4 asks how Rab function in general evolves after du-
plication, and in particular analyses the Rab11 duplication that gave rise
to Rab25.
On the other hand, testing hypotheses about the evolution of function
in Rabs also poses technical challenges. Most importantly, Rabs carry lit-
tle phylogenetic information due to their size and mixture of highly con-
served and highly divergent sequence regions. This complicates obtaining
phylogenetic trees, which form the basis of for all further computational
analysis of Rab sequences. This particular challenge is addressed later in
Chapter 3.
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In: NOÛS 28.3 (Apr. 1994), pp. 344–362.
[4] W Ford Doolittle. “Is junk DNA bunk? A critique of ENCODE”.
In: Proceedings of the National Academy of Sciences of the United
States of America 110.14 (Apr. 2013), pp. 5294–5300.
[5] Crysten E Blaby-Haas and Valérie de Crécy-Lagard. “Mining high-
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[81] Norman E Davey, Gilles Travé, and Toby J Gibson. “How viruses
hijack cell regulation”. In: Trends in Biochemical Sciences 36.3
(Mar. 2011), pp. 159–169.
68
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Chapter 2
Evolutionary patterns of the Rab
family of small GTPases
“[. . . ] the study of pattern must be divorced as much as
possible from the study of process, to provide an unbiased
baseline for the evaluation of alternative hypotheses about
process.” [1, p. 4f]
—Eldredge, Cracraft, 1980
Abstract Chapter 2
Rab proteins are small GTPases that act as essential regulators of
vesicular trafficking. 44 subfamilies are known in humans, perform-
ing specific sets of functions at distinct subcellular localisations and
tissues. Rab function is conserved even amongst distant orthologs.
Hence, the annotation of Rabs yields functional predictions about
the cell biology of trafficking. So far, annotating Rabs has been a
laborious manual task not feasible for the genomic output of deep
sequencing technologies. We developed, validated and benchmarked
the Rabifier, an automated bioinformatic pipeline for the identifica-
tion and classification of Rabs, which achieves up to 90% accuracy.
We cataloged ∼8000 Rabs from 247 genomes covering the entire eu-
karyotic tree. The full Rab database and a web tool implementing
the pipeline are publicly available at www.RabDB.org. For the first
time, we describe and analyse the evolution of Rabs over the whole
eukaryotic phylogeny. We found a highly dynamic family under-
going frequent taxon-specific expansions and losses. We dated the
origin of human subfamilies using phylogenetic profiling, which en-
larged the Rab repertoire of the eukaryotic ancestor with Rab14,
32 and L4. A detailed analysis of the Choanoflagellate M. brevi-
collis Rab family pinpointed the changes that accompanied animal
multicellularity, mainly an expansion and specialisation of the secre-
tory pathway. Lastly, we experimentally establish tissue specificity
of mouse Rabs and suggest that neo-functionalisation best explains
the emergence of new Rab subfamilies. The Rabifier and RabDB
allow non-bioinformaticians to integrate thousands of Rabs in their
analyses. They are designed for the cell biology community to keep
pace with the increasing number of genomes and change the scale at
which we perform comparative analysis in cell biology.
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2.1 Introduction
I ntracellular compartmentalisation is found in all cellular lifeforms,yet eukaryotes have evolved extensive membranous compartments u-
nique to this domain of life. Protein trafficking pathways accomplish the
movement of cellular components like proteins and lipids between the cel-
lular compartments. These essential pathways play house-keeping roles,
such as transport of proteins destined for secretion to the plasma mem-
brane via the secretory pathway, or recycling of membrane receptors via
the endocytic pathway. In addition, they play a variety of specialised
roles, such as bone resorption in osteoclasts, pigmentation in melanocytes
and antigen presentation in immune cells. Malfunction of protein traffick-
ing components leads to a large number of human diseases, ranging from
hemorrhagic disorders and immunodeficiencies to mental retardation and
blindness [2–5], as well as cancer [6–9]. Furthermore, protein trafficking
pathways are frequently exploited by human pathogens to gain entry and
survive within host cells [10–13].
The endomembrane system accounts for a large fraction of the pro-
tein coding sequences in eukaryotic genomes [14], and a plethora of data
on molecules and interactions in different model organisms is available.
However, it is unclear how these data map across organisms, and how
general the mechanisms characterised in single species are. To answer
these question we need to understand the evolution of the protein traf-
ficking pathways and organelles. An evolutionary framework for protein
trafficking is particularly important given the overwhelming accumula-
tion of genomes, many from pathogenic organisms. Their comparative
analysis can distinguish conserved from taxon-specific machineries, with
clear practical applications. For example, conservation of genes led to
the discovery of novel components and mechanisms in ciliogenesis [15],
whereas the presence of taxon-specific pathways allowed the identifica-
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tion of Fosmidomycin as a potential antimalarial drug [16]. Studying the
evolution of protein trafficking is essential to understand the origins of eu-
karyotes. Comparative genomics and phylogenetics have established that
the Last Eukaryotic Common Ancestor (LECA) already had a complex
membrane trafficking system [17] including most types of extant molecu-
lar components [18]. These are believed to have expanded by duplication
and specialisation giving rise to the full diversity of organelles and traf-
ficking pathways observed today (see [17] for a detailed description of this
evolutionary scenario).
Rabs are central regulators of protein trafficking. They are small
GTPases that work as molecular switches to regulate vesicle budding,
motility, tethering and fusion steps in vesicular transport [19]. Most re-
cently the authors of [20] also linked Rabs to membrane fission. They
recruit molecular motors to organelles and transport-vesicles, coordinate
intracellular signalling with membrane trafficking, organise distinct sub-
domains within membranous organelles and play a critical role in the def-
inition of organelle identity (recently reviewed in reference [21]). Rab
subfamilies localise to distinct cellular locations, and regulate trafficking
in a pathway-, organelle- and tissue-specific manner. This makes them
ideal markers for the majority of trafficking-processes and compartments.
Among trafficking-associated proteins, the Rab family expanded most in
evolution [17, 22], suggesting that it provided the primary diversification
element in the evolution of trafficking [22]. An important feature of the
Rab family is that Rab orthologs tend to perform similar functions even in
divergent taxa. For example, the mouse Rab1 has been shown to be able
to functionally replace its ortholog YPT1 in yeast [23]. Hence assigning
a Rab to a known and functionally described subfamily, e.g. Rab1, is a
strong functional prediction, i.e. functioning in the early secretory path-
way in the case of Rab1. Together with the ability to classify them into
subfamilies based on sequence alone, this allows to establish the presence
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or loss of pathways and organelles solely based on the annotation of the
Rab repertoire—a procedure we subsequently refer to as Rab profiling.
Previously, we defined criteria to identify and classify Rab proteins
[24], which have been used as a basis for detailed manual analysis of the
Rab families in a variety of organisms [24–32]. However, manual identifica-
tion of Rab repertoires is tedious and time-consuming and not compatible
with the deluge of fully sequenced eukaryotic genomes that new sequenc-
ing technologies are generating. We thus need to develop methods that
enable the automated annotation of Rab proteins. Several characteristics
of the Rab family make this a challenging bioinformatics problem. First,
there is a strong non-specific signal from GTPase motifs spread throughout
the protein sequence [33], which makes it hard to distinguish Rabs from
other small GTPases. Second, the Rab family is large due to extensive
duplication in several branches of the eukaryotic tree (e.g. [27, 28]). To-
gether with high sequence similarity amongst Rabs this causes difficulties
to correctly classify Rabs into subfamilies and to further discern yet unseen
subfamilies. Lastly, any automated scheme has to respect and perpetuate
as much as possible the current naming conventions, despite any inconsis-
tencies stemming from the decentralised nature of scientific discovery and
the huge bias of existing annotations towards Opisthokonts. This requires
a flexible, learning scheme both able to cope with the contingency of the
field and to easily incorporate new naming consensuses.
Here, we overcame these problems and developed an automated bioin-
formatic pipeline for the identification and classification of Rabs. We
termed our pipeline the ‘Rabifier’, which we describe, validate and bench-
mark. Using our tool, we cataloged nearly 8.000 Rabs from 247 genomes
covering the major taxa of the eukaryotic tree, which we make available
along with our pipeline at www.RabDB.org.
Based on this comprehensive dataset of Rab proteins, we describe and
analyse the evolution of Rabs. We found a highly dynamic family under-
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going frequent taxon-specific expansions and losses. We extend the Rab
repertoire previously reported to have been present in the LECA, identify
the changes in the Rab family that accompanied the emergence of multi-
cellularity and show that neofunctionalisation best explains the emergence
of new human Rab subfamilies.
2.2 Results / Discussion
2.2.1 The Rabifier
We implemented a bioinformatics pipeline to identify and classify Rab
GTPases in any set of protein sequences independently of taxonomical
information, which we term ‘Rabifier’. The Rabifier proceeds in two major
phases, which are schematised in Figure 2.1. First, it decides whether a
protein sequence belongs to the Rab family, i.e. that it is not a Ras, a Rho,
etc., and in the second phase it classifies the predicted Rab sequence into
a Rab subfamily (e.g. Rab1). We describe the rationale for this procedure
below—technical details are given in Sections 2.4 and 2.A.
Phase 1 (Figure 2.1A), which classifies protein sequences to the Rab
family, proceeds in three stages. First, we check that the protein has a G-
protein family domain. As the presence of such a domain can be decided
with near certainty, this step drastically reduces the number of candidate
Rabs while not excluding any real Rab. In order to do so, we align the se-
quence against a profile Hidden Markov Model (HMMs) [38] describing the
known GTPase structures, as provided by the Superfamily database [39].
Secondly, we search for local sequence similarity by performing a BLASTp
[35] query against an internal reference set of manually curated GTPases
and discard the protein if it is most similar to a GTPase other than a
Rab. At this stage of the workflow, the majority of non-Rab sequences
has already been rejected (see Figure 2.1C, where the number of sequences
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Figure 2.1: Flowchart of the Rabifier—(A) Identification- and (B)
classification-procedure implemented by the Rabifier, see Section 2.2 for de-
tails on the two phases. Panel (C) shows descriptive statistics from the
application of the Rabifier to 247 genomes in the Superfamily database [34],
and details about M. brevicollis. Abbreviations: best BLAST hit (BH) [35],
Rab family motif (RabF) [36], reverse Ψ-BLAST (RPS-BLAST) [37], subfamily
(sf.), Rab not classified to any subfamily within our internal reference set
(RabX)
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that transition between these phases is shown for M. brevicollis and for
a database of 247 genomes described below). However, small GTPases
are so similar to each other that a residual amount of false positives still
remains undetected. We remove them in the third stage, where we scan
the sequence for the presence of at least one of five characteristic RabF
motifs defined in reference [36]. If no motif is found, it is concluded that
the protein cannot be a Rab and rejected. Remaining sequences are all
assigned to the Rab family at an individual confidence level computed for
each Rab. The confidence score is derived from the combination of the in-
dividual statistics generated by the three stages according to a procedure
described in Text S1.
The second phase (Figure 2.1B) proposes a classification into one of the
Rab subfamilies present in our internal reference set, or suggests no simi-
larity to any of those. It proceeds in two stages. First, we test whether the
Rab respects a 40% identity cut-off to its BH that prevents assignment of
too disparate sequences to any of the pre-defined subfamilies. If the cut-off
is met, a classification is proposed, if not, the Rab is classified as belong-
ing to the undetermined subfamily RabX. The use of a 40% threshold is
supported in Figure 2.13, and has previously been employed for example
in reference [29]. The actual subfamily classification is based on the com-
putation of a likelihood score for each of the subfamilies in our reference
set. Intuitively, the protein is classified as belonging to the highest scoring
subfamily, however, all scores are kept and thus provide an estimate of the
relative uncertainty associated with each call. Like the Rab family score
generated in the first phase of the Rabifier, the computation integrates
output statistics from different tools, namely from local alignments via
BLAST and from alignments using reverse Ψ-BLAST (RPS-BLAST [37]).
Similar to HMMs, RPS-BLAST compares a sequence against a summary of
a set of sequences, in our case summaries of all sequences in our reference
set belonging to a single Rab subfamily, and measures how likely the in-
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put belongs to any the subfamilies. This way we take information from
all sequences in the internal reference set into account. For details on the
procedure check Section 2.4 and Supplementary Methods Text S1.
2.2.2 Validation of the Rabifier classifications and design
Any new methodology has to be validated. Ideally this is based on a
test data set fulfilling three requirements: the test data is correctly and
comprehensively annotated with those features the tool automatically de-
tects, it is large enough to provide robust statistics, and it covers the
entire range of possible inputs the tool might encounter in its real-world
application, at best even respecting the expected proportions of worst-
to best-case inputs. In our case, no dataset is available which fulfils the
three requirements simultaneously: Rab repertoires are only available for
a limited number of organisms which are not evenly distributed across
eukaryotic phylogeny, and whose annotation was manually performed by
different groups, hence may be inconsistent or even incorrect (in some
cases a ‘correct’, i.e. consensual, classification might not even exist).
In the absence of a suitable validation dataset, we opted to validate
the Rabifier against the manually curated Rab families of three organisms
representing distinct worst case scenarios for the Rabifier (Figure 2.2A-C,
see Table S1 for a list of all sequences used). This ensures that the vali-
dation is meaningful, as it provides a strict lower bound on the expected
performance in every day use. First, we chose the Excavate Trypanosoma
brucei [31], which is one of the most distantly related organism to our
reference sequences, which are dominated by Opisthokonts (an unranked
scientific classification sometimes also called ‘Fungi/Metazoa group’). The
second is Entamoeba histolytica [29], a Unikont from the phylum of Amoe-
bozoa that is thus marginally closer to the sequences that dominate our
reference database, but has a heavily expanded and diverse Rab repertoire
which makes it challenging to assign Rab subfamilies. The third organism,
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Monosiga brevicollis from the class of Choanoflagellates, was chosen as a
representative of a phylum (Choanozoa) for which no information on the
Rab family is available yet. In this third case, we compare the automated
predictions against a manual analysis we performed in this study (Figure
2.2E), and which we will discuss below.
The first aspect we assessed is the ability of the Rabifier to distinguish
Rabs from other GTPases (summarised in Figure 2.2A). We present the
Rabifier with the set of GTPases from the above organisms and count how
often we miss a Rab (false negative—FN), and how often we incorrectly
classify a non-Rab as a Rab (false positive—FP). For T. brucei, we cor-
rectly classified 101 out of 102 GTPases as being a Rab or not, 292 out of
295 in E. histolytica and finally all 125 GTPases in M. brevicollis. Alto-
gether, we have no FP and 4 FN, which means that for this particular set
of genomes we make correct decisions about whether a protein is a Rab in
99.2% of the cases with no differences amongst the organisms. In order to
understand the sources of the misannotations at family level, we inspected
the false negatives individually. The Rabifier disagrees with the manual
curation of [31] in T. brucei for TbRabX3, a RabL2-like protein, that is
counted as a false negative. We explicitly added RabL2 sequences to our
negative data set as we do not consider these proteins as members of the
Rab family (see section 2.4). The remaining disagreements between the
Rabifier and the manual annotations are three false negative proteins in
E. histolytica in which we cannot find any detectable RabF motif, and one
protein which has no similarity to any member of our reference dataset of
small GTPases. We conclude that these proteins are likely misclassified in
reference [29], and hence that the above failures of the Rabifier to identify
Rabs are artificially introduced by our validation procedure.
Secondly, we established the accuracy by which a given Rab sequence is
assigned to the right subfamily (summarised in Figure 2.2A). Concretely,
for those sequences which were correctly identified as Rabs, we checked
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whether the proposed subfamily agreed either with the public annotation
or our own one for M. brevicollis. We distinguished between two operating
modes of the Rabifier: a normal one which does not consider the confidence
levels the Rabifier attributes to its classifications, and a high-confidence
mode which accepts only the high-confidence annotations above a certain
confidence threshold, whereas those below are classified as belonging to
the undetermined subfamily RabX. Ignoring the information provided by
the classification confidence, we correctly called 16 out of 17 Rabs for
T. brucei, 59 out of 91 in E. histolytica and 20 out of 25 for M. brevi-
Figure 2.2 (preceding page): Validation and benchmarking of the Rabi-
fier—(A) summarises the validation in normal mode, i.e. without taking the
subfamily score produced by Rabifier into account, against the Rab families
of Trypanosoma brucei [31], Entamoeba histolytica [29] and Monosiga bre-
vicollis, which we annotated in (E). Three quantities needed to judge the
performance of the Rabifier are shown for Rabs belonging to human and
other subfamilies separately: sequences erroneously classified as not being a
Rab by the Rabifier (red), sequences correctly identified as Rabs, however,
wrongly classified at subfamily level (light green), and those which were
entirely correct (dark green). (B) displays the distribution of confidence
scores associated to each subfamily call, respecting the same colour code as
above. The blue line indicates the threshold which we propose on default,
and below which subfamily classification may be rejected and treated as a
undefined RabX. That choice is based on the ROC-curve [40] analysis shown
in (C), which plots the true positive rate against the false positive rate for
each possible confidence threshold [40] and provides a combined measure of
the accuracy of a classifier (Area under the curve, AUC [41]). The effect of
choosing an 0.4 confidence threshold (blue circle) on the classification ac-
curacy, i.e. running the Rabifier in high confidence mode, is shown in the
inlay. (D) plots the improvement in terms of the three quantities discussed
above the Rabifier achieves compared to an alternative strategy (see Results
and Discussion for details on its implementation). (E) Phylogenetic tree of
the human and M. brevicollis Rab family on which the manual classification
of the latter Rab family was based (bootstrap support above 70% shown).
Colours indicate the results of the corresponding automated annotation for
that specific sequence. Abbreviations: subfamily (sf.), annotation (annot.)
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collis, leading to an overall fraction of 71.4% correct decisions (79.7% on
average per organism). However, if one defines a threshold below which
a classification is systematically considered as belonging to the undefined
subfamily RabX, the accuracy can be substantially improved. To illus-
trate this, Figure 2.2B displays the distribution of scores associated to
correct and wrong calls, which shows that wrong calls clearly have lower
confidence scores on average. In order to test for all possible thresholds
exploiting this difference, we performed a ROC curve analysis presented
in Figure 2.2C. This machine learning technique allows to summarise and
quantify the classification performance for all thresholds (Area Under the
Curve (AUC) [41], here 0.94), and enables to objectively choose a threshold
providing an optimal TP/FP-tradeoff. Here, we opted for 0.4, which we
propose as a default choice for the interpretation of the Rabifier’s results.
Yet, the use of this threshold is not fixed as it may vary depending on the
dataset, and can be freely modified by users of the Rabifier. The conse-
quences of applying a cutoff on the classification accuracy are quantified
by the inlay in Figure 2.2C: only trusting calls with confidence higher or
equal to 0.4 greatly reduces the amount of misclassified Rabs from non-
human subfamilies and improves the overall accuracy to 90% (92.01% on
average per organism).
In summary, we conclude that our workflow is able to correctly dis-
cern Rabs from other GTPases. Furthermore, calls both at family and
subfamily level have an associated confidence score which correctly cap-
tures uncertainty in the decision. Relying on the information provided by
the confidence level, the Rabifier suggests correct subfamilies around 90%
of the time even in difficult and phylogenetically isolated cases.
2.2.3 Benchmarking the Rabifier
After having established the correctness of our procedure, we wished to
assess the improvement it represents over possible alternative large-scale
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approaches in an objective manner. This excludes benchmarking against
methods for example based on phylogenetic trees, as reasoning over them
is difficult to automate and not feasible for thousands of sequences.
We chose to compare the Rabifier to the Conserved Domain Database
at the NCBI [42], the only resource we are aware of that specifically scores
for RabF motifs. To this end, we implemented an alternative decision
scheme which given a protein retrieves the protein name and CDD domain
annotation of its BH in the NCBI protein database. Note that if the pro-
tein is in the NCBI database, the BH retrieves the protein itself. As for the
choice of genome, the Rabifier has to be benchmarked against an organ-
ism whose Rab family has not been manually curated, as our alternative
procedure would simply retrieve that annotation. Moreover, an organism
from a taxon which is both close to Metazoa and for which no information
on the Rab family exists best ensures an unbiased measurement. These
requirements are met by the Choanoflagellate M. brevicollis, which we
analysed ourselves and is thus an ideal candidate for a direct comparison.
The results of this experiment are detailed in Figure 2.2D (see also
Table S1). As above, we distinguished between the ability to discern Rabs
from other GTPases and to actually propose the correct subfamily for a
given Rab. First, while the Rabifier achieved 100% accuracy in separat-
ing Rabs from other GTPases in M. brevicollis, the alternative strategy—
although not introducing false positives—misses 8 of 25 Rabs leading to
an overall drop in sensitivity. On top of these eight sequences, the Rabifier
correctly suggests subfamilies for four further proteins wrongly classified
by the alternative strategy, leading to an overall difference of 12 sequences
correctly classified only by the Rabifier.
Thus, our annotation pipeline represents a significant improvement
over currently available large scale approaches, both in terms of sensitive
identification of Rabs and especially with regards to the difficult automatic
classification of Rabs into subfamilies.
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2.2.4 Availability of the Rabifier and its predictions
In order to make our pipeline useful to the cell biology community inter-
ested in Rabs, we provide access to the Rabifier in form of a web tool
(Figure 2.3A). Via the graphical interface users can submit up to five pro-
tein sequences at a time, and the classifications generated by our workflow
are returned together with their associated degree of confidence. We en-
visage users who want to quickly generate hypotheses about one or a few
candidate proteins. Users wishing to classify more sequences are encour-
aged to contact us. We emphasise that the Rabifier works without need
for phylogenetic information about the input, hence any set of protein se-
quences can be submitted. In addition, we generated a database of nearly
8,000 classified Rab sequences in 247 eukaryotic genomes, which we make
publicly available at www.RabDB.org (Figure 2.3A) together with basic
browsing and visualisation tools. Our database is built on top of the Su-
perfamily database [34] (September 2009 release), which allows us to follow
its release cycle and include predictions for all newly sequenced genomes
contained therein. Figure 2.3B details the phylogenetic distribution of
genomes in RabDB and the number of Rabs we predict in each of those
eukaryotic branches. The correctness of the content in www.RabDB.org is
not manually confirmed systematically. However, we constantly inspect
and manually curate the generated predictions and update our internal ref-
erence database accordingly. Furthermore, we provide users the possibility
to notify us of a potential mis-annotation found in the database such that
we can correct the classification of the Rab in question. These measures
further enhance the expected quality of future releases of www.RabDB.org.
2.2.5 New hypothetical subfamilies
As can be noticed from Figure 2.3B, the Rabifier detected a large number
of Rabs not belonging to any subfamily represented in our reference set,
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Figure 2.3: Resources we make available—(A) Snapshots of the database
www.RabDB.org which provides public access to the results of the Rabifier
applied to the Superfamily database [34] and the online version of the Ra-
bifier. (B) Statistics of the current content of www.RabDB.org in terms of
number of genomes (left), absolute number of Rabs either belonging to a
subfamily also present in humans or not (middle), and the relative fraction
of the two types of Rabs for a given branch (right). The cladogram (i.e. the
branch length are arbitrary, see [43]) of the eukaryotic taxa is derived from
[44].
i.e. most subfamilies which have been described before. By definition these
sequences show no similarity to any functionally characterised Rab, hence
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a bioinformatic annotation is not possible. However, in order to structure
the space of new sequences and provide a starting point to study this
yet unexplored diversity, we clustered these Rabs with respect to their
sequence identity and propose several hypothetical Rab subfamilies (see
Section 2.4 for details). The result of this procedure is shown in Figure
2.4, which details the amount of hypothetical subfamilies according to
the breadth of their occurrence (see Figure 2.16 for an overview of the
amount of Rabs falling into each of these classes). We integrated these
new subfamilies both in our database, where they can be browsed with
help of the visualisation tools we provide, and in the online version of the
Rabifier. Note that in addition to these new hypothetical subfamilies we
still find hundreds of Rabs that we cannot group with others. Those may
result from erroneous gene models in less well curated genomes, represent
cases where our simple clustering procedure failed, or indeed be bona fide
singletons. A detailed phylogenetic analysis may be required to resolve
these cases which is out of the scope of this study.
2.2.6 Global Dynamics of the Rab sequence space
A dataset of 8,000 Rabs allows us to take a global view of the Rab se-
quence space, and to address previously inaccessible questions. Here, we
investigate the patterns of Rab repertoire expansion in the eukaryotic tree
(Figure 2.5). Expansion of certain protein families has been found to cor-
relate with organismal complexity [45]. The anecdotal evidence of Rab
profiles in different organisms suggests at least three possible scenarios:
a conserved core of Rabs present in all organisms; tinkering with a core
of subfamilies by taxon- or species-specific expansions of existing subfami-
lies; a major variation of the Rab machinery with taxon- or species-specific
Rab repertoires. We asked whether any such scenario is apparent for the
Rab family across the eukaryotic tree, or if different ones predominate in
different branches.
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Figure 2.4: Rab subfamilies in our dataset—Number of different Rab sub-
families found in our dataset. Human sf. are shown in blue, and other
known sf. in orange. The last four categories are hypothetical subfamilies
we propose in the context of this paper (see Section 2.4 for details on the pro-
cedure): subfamilies whose members span more than one taxon (red), those
spanning more than on genome (green), subfamilies with several members
yet only present in one organism (brown) and finally singletons (grey) which
are not similar to any other known Rab. All members and subfamilies can
be browsed in our website at www.RabDB.org. Abbreviations: hypothetical
(hypo.), subfamily (sf.)
We observe a tremendous heterogeneity in the sizes of Rab repertoires,
ranging from five to several hundreds of Rabs in Encephalitozoon cuniculi
and Trichomonas vaginalis respectively. Genomic analyses have shown
a general trend for more and larger families in bigger genomes [46, 47].
In the case of Rabs, linear regression over all taxa reveals that genome
size explains roughly 60% of the observed variance in numbers of Rabs
in an organism (Figure 2.14). However, due to the current bias in fully
sequenced genomes towards Opisthokonts (compare Figure 2.3B), it is
unclear whether these numbers will remain as such in the future. We
find that closely related organisms tend to have similar Rab repertoires
in size, but at the level of phyla we encounter marked differences indi-
cating taxon-specific adaptations. For example, although Ciliophora and
Apicomplexa belong to the same superphylum (Alveolata), these sister
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phyla show very different repertoires, highly expanded in the first case,
and streamlined in the second. The smaller Rab repertoires in Apicom-
plexan genomes, mostly dominated by intracellular parasites, may be due
to secondary gene loss, similar to that reported in bacterial intracellular
parasites and endosymbionts [48] and in the obligate intracellular para-
sitic Microsporidia [48]. Another example of reduction of Rab repertoires
is observed in the fungal branch, as we reported previously [24] and now
confirm based on an extended set of 103 genomes. It is noteworthy that
Fungi are Unikonts, a taxon which comprises Metazoa and Amoebozoa,
i.e. branches that appeared to have suffered independent expansions of
their Rab repertoires [29, 36]. We observe large expansions in Diplomona-
didaTrichomonadida, Ciliophora and Amoebozoa. Much of these expan-
sions are accounted for by species-specific subfamilies (see Figure 2.4).
This demonstrates that there is frequent invention of new Rabs, perhaps
in a taxon-specific manner—a hypothesis that will have to await broader
sampling of the genomes space to be tested in most taxa. On the other
hand, inspection of Figure 2.5 reveals that for those Rabs that can be clas-
Figure 2.5 (preceding page): Rab subfamily expansions relative to Metazoa
in a dataset of 247 genomes—For each of the eukaryotic taxa (as derived
from [44]), (A) displays the relative size compared to Metazoa of each hu-
man Rab subfamily on average per genome. The dashed line represents the
average in Metazoan genomes, i.e. any circle lying on that line represents
a human subfamily that has the same amount of members on average per
genome than on average in Metazoa. Similarly, any circle to the left rep-
resents a subfamily that is smaller compared to Metazoa, finally, all on the
right are expanded compared to the Metazoan average. Note that the axis
are in logarithmic scale. In addition to the numbers indicating the human
Rab subfamily, a colour code to distinguish subfamilies is shown below, where
similar colours indicate proximity in the phylogenetic tree of human Rabs.
The same plot for all other Rabs is shown in (B), again on a logarithmic
scale. All sequences used are accessible at www.RabDB.org. Abbreviations:
subfamily (sf.)
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sified, different subfamilies expanded in each branch of the tree. For exam-
ple, Rab7 forms the largest subfamily in Diplomonadida/Trichomonadida
and Amoebozoa, whereas Ciliophora’s most expanded subfamily is Rab2.
This suggests that these are independent expansions, which has already
been observed for example within the Rab5 subfamily [24, 49]. Note that
we repeated these analyses for different confidence cutoffs and observed
no significant consequences on the broad picture.
In summary, the global evolution of Rab repertoires is highly dynamic
with frequent taxon-specific subfamily expansions, gain of new Rabs and
losses. Hence, we observe a scenario where a core set of Rabs tends to be
universally conserved, and can coexist in different taxa with subfamily ex-
pansions and/or taxon- or species-specific Rabs. It is clear that no unique
path to cellular complexity and specialisation exists, implying that any
conclusion about the evolution of Rabs in a given taxon is not necessarily
true for other eukaryotic taxa.
2.2.7 Dating the origin of Rabs and expanding the LECA
The systematic identification and classification of Rab repertoires in mul-
tiple branches of the eukaryotic tree of life allows the establishment of a
phylogenetic profile for each Rab subfamily. As Metazoa and Fungi are
the most extensively sampled and best annotated groups, we profiled hu-
man subfamilies (Figure 2.6) and determined their likely time of origin
(Figure 2.7). For a detailed analysis of fungal Rabs see [24]. We further
established the direction of duplication, i.e. from which Rab subfamily
another emerged by duplication and subsequent divergence, by crossing
their likely time of origin with a phylogenetic tree of the human Rab fam-
ily. We reasoned that for two closely related Rabs, the one that is present
in more taxa is likely the ancestral one. Since all Rabs are by definition
paralogs and especially the deeper evolutionary relationships are unclear,
we restricted the inference of direction of duplication to well supported
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branches. Here, we define well supported branches as those with boot-
strap support higher than 58% in a tree of human Rabs, which is chosen
to include the branch between Rab5 and Rab22 as their association is
commonly accepted [50–54]. As further support, we note that all branches
selected according to this criterion are also present in the tree of mouse
Rabs we present below, however, in general 58% is not a strong branch
support and should not be used indiscriminately on trees of other Rabs.
Based on a 58% cutoff, one obtains directed duplication scenarios for a
number of subfamilies as summarised in Figure 2.7. We term subfamilies
with a clear origin as ‘derived’.
This analysis suggests new candidates for ancestral Rabs. Previously
Rab1, 2, 4, 5, 6, 7, 8 and Rab11 [17], Rab18 [30, 59], Rab21 [29, 60]
as well as Rab23 and 28 [31] could be mapped to more than one ma-
jor branch of the eukaryotic tree, making them likely candidates to be
present in the LECA. Our results support these assignments and reveal a
new set of proteins that can be found in two or more basal eukaryotic taxa,
namely Rab14, 32 and RabL4. Applying the same parsimony argument
as previous studies suggests that these Rabs were part of the ancestral
set of Rab in the LECA. Are these putative ancestral Rabs an artefact
due to incorrect assignments or convergent evolution? We validated the
automated subfamily classification by phylogenetic trees, and could not
disprove their annotation (Figures S4 A-C from reference [61]). The pos-
sibility of convergent evolution is however harder to rule out. Regardless,
an organism with 15 Rabs is not surprising and comparable with some
unicellular eukaryotes [31, 32], and free living fungi frequently have less
[24]. It is remarkable that with every new analysis the LECA appears to
become increasingly more complex [62]. On functional grounds, mapping
these Rabs to the LECA is plausible. RabL4, also known as IFT27, plays
a role in ciliogenesis as part of the Intra Flagella Transport (IFT) ma-
chinery [63]. Flagella are believed to be ancestral characters, present in
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the LECA [64, 65]. Rab32 regulates transport to the pigmentedsecretory
granules [66], an animal-specific function, but it has also been claimed
to have a mitochondria-related function [67, 68]. The known function of
Rab14 in phagosome maturation and a recycling step at the TGN [69, 70]
is less clearly ancestral, but it may lend support for a phagotrophic LECA
as previously proposed [71].
In summary, our results support the claim that the LECA had a highly
complex endomembrane system, and that secondary Rab losses have been
dominant in the evolution of the major eukaryotic taxa [17].
2.2.8 The Rab family in Monosiga brevicollis and the ori-
gin of animals
The emergence of multicellularity is one of the major transitions in evo-
lution [72], which happened independently multiple times (see [73] for a
recent review). There are several critical features necessary for the evolu-
tion of multicellular organisms, for example mechanisms for cell adhesion,
cell polarity and inter-cellular communication. Little is known about how
protein trafficking has evolved during this transition. We take advantage
of our extensive annotation of the Rab family to derive the Rab comple-
ment prior to and after the emergence of multicellularity in Metazoa.
Monosiga brevicollis belongs to the Choanozoa, the closest unicellu-
lar relatives of Metazoa. The genome of this organism was only recently
Figure 2.6 (preceding page): Phylogenetic profiles of human Rab subfami-
lies in selected organisms—A black dot reads as presence of the correspond-
ing subfamily in the respective species. Rab subfamilies are ordered accord-
ing to the top phylogenetic tree generated as explained in Materials and
Methods. Branches with bootstrap support above 58 are coloured in red.
The tree on the left represents the species’ branching order and is derived
from [44, 55–57] together with the naming of the partially nested mono-
phyletic groups on the right.
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Figure 2.7: Summary of evolutionary age and duplication origin of human
subfamilies—Each level represents a nested evolutionary stage from the LECA
to humans (derived from [44, 58]) with one circle per human subfamily.
Those subfamilies for which we could establish a clear origin, that is which
subfamily it was derived from by duplication, are right from the dotted line
with the subfamily it was derived from attached at the bottom right.
sequenced [74], and in the context of the validation of the Rabifier we
conducted a detailed analysis of its Rab family. The phylogenetic tree
in Figure 2.2E reveals a relatively large Rab family with nearly no sub-
family expansions (see also Figure 2.5), i.e. mostly with a single member
per subfamily (only Rab32 has two members). This is also observed in
simpler animals like D. melanogaster and C. elegans [59], suggesting that
larger subfamilies observed in mammals represent taxon-specific dupli-
cations. Secondly, we observe several organism-specific Rabs, which we
labeled MbRabX. Consistent with results from the last section, the “in-
vention” of new Rabs is a recurrent feature in multiple branches of the
tree of life (e.g. [27, 29, 31, 59]). We observed the emergence of three
novel sub-families, Rab9, 22, 29, none playing ‘animal-specific’ roles. The
function of Rab29 is unknown, but Rab9 and Rab22 both appear to be
involved in late endocytic traffic [52, 53, 75, 76]. Surprisingly, the genome
of M. brevicollis codes for proteins previously believed to be specific to
multicellular organisms, for example Cadherins [74, 77]. In animals, traf-
ficking of the cell adhesion molecules Integrins and Cadherins is regulated
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by Rab4, 5, 11, 21 and 25 [78–81], and Rab5 and 7 [82, 83], respectively.
Interestingly, these Rabs are also found in M. brevicollis, and—with the
exception of Rab25—are all likely ancestral proteins. That highlights that
complex new functions, as are for example the regulation of Cadherin and
Integrin and ultimately cell adhesion, can be gained without inventing new
subfamilies.
Our analysis revealed 14 Rab subfamilies that emerged at the base of
Metazoa (Figure 2.7). Surveying the currently known functions of these
animal-specific subfamilies suggests roles mainly in regulated secretion
(Rab3 [84–87], Rab26 [88], Rab27 [87, 89–91], Rab33 [87], Rab37 [87, 92],
Rab39 [93]), trafficking from (Rab10 [94]) and to the Golgi (Rab43 [95])
and more generally localisation at the Golgi (Rab30 [96–98], Rab33 [99],
Rab34 [100], Rab43 [101]). Hence, our analysis suggests that the appear-
ance of animals cooccurred with an important expansion and specialisation
of the secretory pathway.
2.2.9 A model for Rab subfamily innovation
Gene duplication is a frequent mode of gene gain in eukaryotes. This
is well illustrated by the expansion of the Rab family in emergence and
evolution of Metazoa. Following gene duplication, the most common fate
for one of the duplicates is accumulation of mutations up to the point of
pseudogenisation. In the alternative case, the retention of both duplicates
has been explained by different theoretical scenarios, recently surveyed in
reference [102]. Most prominently, either divergence results in gain of a
beneficial new function (neo-functionalisation) by one of the duplicates,
or disruption of complementary parts of the function in each of the genes
leaves both paralogs indispensable to perform the original function (sub-
functionalisation). As discussed in reference [102], those models predict
distinct types and strengths of selective forces acting on the two dupli-
cates allowing to test and distinguish amongst putative scenarios. Namely,
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while in both neo- and subfunctionalisation the new copy indistinguish-
ably evolves neutrally, detecting purifying selection acting on the original
copy is an indication of neofunctionalisation, whereas relaxed purifying
selection or neutral evolution is suggestive for subfunctionalisation. In
the case of Rabs, Figure 2.6 shows that the original copy is conserved
and keeps its identity as the original subfamily, whereas the new copy
initiates a distinct subfamily defined by a discernible level of sequence di-
vergence. We interpret this pattern as evidence that the mode by which
the Metazoan Rab family expands is most probably neofunctionalisation
rather than subfunctionalisation.
To gain further insights into the nature of the gain of function, we asked
whether the derived Rab subfamilies show differences in tissue-specificity
that could hint at the type of newly evolved functions. To this end, we
investigated tissue-specificity in expression of Rabs in mouse tissues and
cell lines (Figure 2.8) by means of PCR (see Section 2.4). We also analysed
publicly available microarrays (Figures 2.15 and S5 from reference [61])
which overall corroborate the trends described in the following.
First, we observed that all ancestral Rabs are widely expressed (i.e. in
all tested tissues), most probably performing general functions required in
all tissues. Similarly, Rabs that predate the advent of multicellularity are
also broadly expressed, a general phenomenon that has been described
for genes which emerged prior to multicellularity [103]. Second, for the
derived subfamilies in which a clear directionality of duplication could
be established (see Figure 2.7), we detected a trend for an increase in
tissue specificity, i.e. a reduction in number of tissues in which the Rab
is expressed relative to its progenitor subfamily. For example, Rab34 is
expressed in all tissues investigated but the liver, whereas the derived
Rab36 is only expressed in lung and brain. Thirdly, at no time we observe
complementary expression, i.e. a pair of subfamilies which have opposite
tissue specificities.
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Overall, these observations are strong indications that derived sub-
families are retained for a new tissue-specific functions, different from or
at least complementing the progenitor ones. Thus, our results support
a neo-functionalisation model explaining the retention of novel Rab sub-
families in Metazoa. This model makes several predictions about expres-
sion patterns of Metazoan Rabs for which we could not derive expression
data. Concretely, Rab41 which we only find in primates and dolphin is
expected to show a restricted tissue expression, as its origin from Rab6
is statistically well supported. Rab29 is expected to be ubiquitously ex-
pressed despite its clear origin from Rab32 as it predates the evolution of
multicellularity, a prediction at least supported by our microarray-based
analysis (Figure S5 in reference [61]). One notable observation is that
the tested mouse tissues express an unexpectedly high number of distinct
Rabs. This is also observed in individual cell lines, which indicates that
it is not an artefact from multiple cell types mixed in the tissue. While
it is clear that Rabs are expressed at different levels [104] (see also Figure
2.15), our results from a more sensitive method than microarrays reveal
that the tissue-specific Rabs may be more widely expressed than previ-
ously anticipated. It remains to be investigated whether the low levels of
expression we can detect by PCR are functionally significant.
2.3 Conclusions
We developed the ‘Rabifier’, a bioinformatics tool to identify and clas-
sify Rabs from any set of protein sequences with no need for additional
phylogenetic information, which we make available as a web tool for the
community. We deployed the Rabifier on 247 proteomes predicted from
complete genome sequences, generating the first comprehensive view of
the Rab sequence space, which we also make available in form of a brows-
able database of Rab proteins. We envisage that cell biologists interested
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in specific organisms may use RabDB and the Rabifier as a first descrip-
tion of the family, at accuracy levels we showed to be very high. In fact,
our predictions are well suited to be the first step towards high quality
manual annotations. Furthermore, we introduced unified and objective
criteria for the annotation of Rabs which is especially important for large-
scale comparative studies, which can now be grounded on a coherent body
of data.
The classification of Rab repertoires in hundreds of genomes gives us
the first global view of the Rab family in evolution, revealing that this
family followed different routes in each branch of the tree. Massive expan-
sions co-exist with extensive losses. These expansions can vary from taxon
to taxon, suggesting that care must be taken when transferring informa-
tion amongst different branches of the tree of life. In this respect, future
work may focus on understanding the detailed evolutionary patterns in
eukaryotic taxa other than Metazoa, which we analysed here. It appears
that plants are ideal candidates for such a study as multiple genomes have
been sequenced covering both unicellular and multicellular organisms.
One of the perhaps most surprising observations we made was the ex-
tension of RabXs, i.e. Rabs that cannot be assigned to any previously
characterised subfamily. Hence, a major bioinformatic and cell biologi-
cal challenge now is to identify how many Rab subfamilies exist overall,
and to establish their conservation or taxon-specificity. Here, we started
this classification by proposing new Rab subfamilies derived from clus-
tering of RabXs with respect to their sequence similarity. We hope to
stimulate further research which may allow the refinement of our crite-
ria and ultimately the definition of a Rab subfamily. The notion of Rab
subfamily is supposed to reflect both evolutionary history and functional
information, but has historically been mixed with less clear criteria. In
the absence of functional information for all Rabs, phylogenetic analysis
becomes particularly important, especially for functional prediction. In
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this context, it is all the more serious that we found a notorious frailty
of Rab trees. Factors such as choice of sequences, outgroups, alignment
program, probabilistic model and program implementing it contribute to
very different trees (compare for example [59, 105, 106] and Figures S4A-
C in reference [61]). We thus need to derive objective criteria that define
a Rab subfamily which go beyond the clearly outdated yet still useful
sequence identity cutoff [36]. Possibilities are for example to introduce
soft thresholds depending on background divergence levels within a given
taxon, or to restrain the area considered to measure sequence divergence
to the functionally relevant regions.
We focused on the evolutionary path from the LECA to mammals in
order to gain insight into the mechanism of functional innovation within
the Rab family. Based on objective and re-usable criteria we were able
to map directionality to duplications clarifying the origin of some human
subfamilies. Crossing these relations with data on tissue-expression pat-
terns of Rab genes, we proposed that neo-functionalisation best explains
the emergence of new subfamilies. More recent subfamilies are most likely
retained for newly evolved tissue-specific functions and coexist with older
ones in a subset of tissues. It remains to be determined whether the same
happens within a subfamily, i.e. whether a RabXa and a RabXb represent
cases of neo- or sub-functionalisation [107]. This is particularly relevant
to conceptually tell apart isoforms and distinct subfamilies. As we re-
stricted our analysis to subfamilies present in humans, it is important
now to test whether the same neo-functionalisation scenario is observed in
other branches of the tree of life. As mentioned before, plants appear to
be ideal candidates to extend this analysis. Finally, while we studied the
fate of new subfamilies in the context of tissue-specific expression, it will
be important to understand the contribution of subcellular re-localisation
to neo-functionalisation [108, 109].
New generations of sequencing methods promise to change that scale
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at which we perform comparative analysis in cell biology. But for this
change to reach the cell biology community, we need the appropriate tools
that allow the non-bioinformatician to take advantage of all the emerging
data. The Rabifier is one such tool, tailored to enable the cell biologist to
analyse protein repertoires in hundreds of genomes.
2.4 Materials and Methods
2.4.1 Ethics Statement
C57BL/6 mice were bred and housed in the pathogen-free facilities of the
Instituto de Gulbenkian de Ciência (IGC). Mouse experimental protocols
were approved by the Institutional Ethical Committee and the Portuguese
Veterinary General Division.
2.4.2 The set of human Rabs
Before we devised a workflow able to identify and classify Rabs, we decided
which protein subfamilies we considered being human Rab subfamilies.
Since the early genomic analyses of the human Rab repertoire reporting
subfamilies 1 to 40 (with exception of 16) [36], five subfamilies have been
newly discovered (41 to 45/RasEF) [110]. Besides those clear cases, the
distinction remained less obvious for those which are termed ‘Ran’ and
‘Rab-like’, each of which we briefly discuss in the following.
Rans control nucleocytoplasmic shuttling [111], and are frequently con-
sidered to be members of the Rab family [105, 110]. This view is supported
by our own phylogenetic analysis (see tree in Figure S3 in reference [61]),
although without strong bootstrap support. Due to the distinct function
and localisation [111] partly within the nucleus we do not further consider
Rans in our dataset. However, Rans have recently been linked to ciliary
entry of certain kinesins [112], and they may be included in the future.
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RabL2 proteins were already mentioned in reference [36] where it is
concluded that they are not Rabs, amongst others due to non-conforming
RabF motifs. In reference [105], RabL2s are said to cluster together with
Rans, which we do not include in our analysis. The tree of human GTPases
shown in reference [106] suggests that RabL2 proteins branch of Rhos at
an early stage. Finally, our own tree of human GTPases (Figure S3 in ref-
erence [61]) positions RabL2s at the periphery of the Rab branch, yet with
little bootstrap support. Altogether, we do not see enough evidence for
RabL2 proteins to be considered Rabs. The situation is similar for RabL3
and RabL5. Colicelli clusters them together with Rans [105], whereas in
reference [106] both reside on a branch with Arfs though classified as be-
longing to none of the classes Rab, Ras, Arf, Rho or Ran. Our tree of
human GTPases suggests that RabL5 and Arfs have a common ancestor,
equally so RabL3 and RabL2, hence we ignored both in our further anal-
ysis. Rab7L1 is nearly identical to Rab29 and represents a simple case of
naming ambiguity, as has already been pointed out in reference [36].
The last case is RabL4, which all [105, 106, 110] consider being a
Rab. We confirmed that interpretation by detecting and validating four
RabF motifs, as well as by our phylogenetic tree, which places RabL4
within Rabs. However, we only group RabL4 together with Rab28 as
suggested in reference [105, 110] when no GTPase other than the human
Rab subfamilies 1 to 45 are included (see trees in Figure S3 and Figures
S4 A-B both in reference [61]). In mouse, RabL4 is not classified as being
monophyletic with Rab28 (see Figure S4 C in reference [61]).
2.4.3 The Rabifier
We give some technical details about the implementation of the Rabifier
which for the sake of brevity have been omitted above. For information
on the computation of the confidence scores see Text S1.
In the first phase (Figure 2.1A), the profile HMMs representing the
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G-protein family domain are either run manually using Perl scripts (as
of June 2010) provided by Superfamily [39] and HMMER 2.3.2 [38], or in
the case the sequences have been retrieved from the Superfamily database
[34] the domain structure is taken directly from Superfamily. Note that
Superfamily is a pure protein resource that contains proteomes predicted
from genome sequences. It does not provide information about the un-
derlying genes systematically, hence counts of how many Rab genes are
present in a specific genome can generally not be derived from Super-
family. BLASTp [35] queries are performed with soft masking (parame-
ters -F m S) and considered up to an e-value threshold of 10−10. Our
reference set of sequences not being Rabs is provided as Dataset S1,
whereas the reference database of Rabs are the sequences accessible at
www.RabDB.org with redundancy removed using CDHit (at a 90% sequence
identity threshold) [113]. Our reference data set of Rabs covers more than
just the human subfamilies, namely previously published and function-
ally described subfamilies from Arabidopsis thaliana (AtRabA1, AtRabA3-
AtRabA6, AtRabC2, AtRabD1, AtRabF1, AtRabG1) [30], yeast (yptA,
ypt10, ypt11), Drosophila melanogaster (DmRabX1-X6, DmRab9D, Dm-
Rab9F) and C. elegans (CeRabY6) [59]. Furthermore, as detailed in the
main text we proposed a set of hypothetical subfamilies which we inte-
grated into our reference set. The members and phylogenetic distribution
of these hypothetical subfamilies can browsed directly on our web site
www.RabDB.org. The last stage of the first phase is performed using the
Motif Alignment & Search Tool (MAST) (motif finding threshold 0.0005)
[114] from the MEME-suite [115], with probabilistic representations of the
motifs ‘IGVDF’, ‘KLQIW’, ‘RFxxxT’, ‘YYRGA’, ‘LVYDIT’ [36] as input gen-
erated on our reference database of Rabs beforehand using MEME.
In the second phase (Figure 2.1B), RPS-BLAST queries [37] are per-
formed with standard parameters and an e-value threshold of 10−5, with
position-specific scoring matrices (PSSM) previously generated by Ψ-BLAST
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on all members of each of the Rab subfamilies present in our reference
database.
2.4.4 Hypothetical subfamilies
The hypothetical subfamilies result from two distinct clustering steps.
First, we clustered sequences classified as RabX by the Rabifier and be-
longing to the same genome at a sequence identity threshold of 70% [36].
In order to resolve the potential conflicts caused by sequences that be-
long to several clusters at the same time, we applied MCL [116] (inflation
parameter 2.0), which resulted in a clean partition, i.e. non-overlapping
clustering, of the sequences. In a second step, we merged the resulting
clusters across genomes if at least one pair of sequences across clusters
shared a sequence identity over 70%. We chose this threshold as it is the
lowest which ensures meaningful clusters, that is clusters which in their
majority respect taxa boundaries.
2.4.5 Phylogenetic trees
All phylogenetic trees of Rabs and GTPases presented in this article have
been generated with PhyML [117], which implements a Maximum Likeli-
hood probabilistic model, using standard parameters and 100 bootstraps.
Alignments were performed with MAFFT [118], and manually edited to
remove sites with deletions using Jalview [119]. The human trees have
been generated using human kRas as an outgroup, the mouse trees us-
ing mouse kRas as outgroup, and the mixed tree of human and Monosiga
brevicollis Rabs uses both human and M. brevicollis kRas as outgroups.
Sequence accessions of all sequences can be taken from Table S2. Tree vi-
sualisations have been generated with Figtree1. The tree of human Rabs
not displaying isoforms (see Figure 2.5, Figure 2.6) has been generated by
1http://tree.bio.ed.ac.uk/software/figtree/
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removing isoforms and keeping the longest branch as representative of the
corresponding subfamily.
2.4.6 Rab PCR of mouse organs and cells
Cell lines and primary cells
We decided to use both cell lines and primary cells. Cell lines are popula-
tions of cells that grow and replicate continuously, i.e. that have undergone
genetic transformations which result in indefinite growth potential. They
are prone to genotypic and phenotypic drifting, and can both lose tissue-
specific functions and acquire a molecular phenotype quite different from
primary cells. In contrast to that, primary cells have a finite lifespan
but reflect the in vivo situation, despite their added complexity. In the
following, we list the protocols we followed to obtain our cell material.
Mouse hepatoma Hepa 1-6 cells were cultured in DMEM supplemented
with 10% FCS, 100 U/ml penicillin and 100 µg/ml streptomycin, main-
tained at 37◦C in 10% CO2 until the cells were 80% confluent and then
used to extract RNA. The melanocyte cell line melan-ink was cultured
in RPMI 1640 with glutamax and hepes, supplemented with 10% FCS,
0.1 mM 2-mercaptoethanol, 200 nM phorbol 12-myristate 13-acetate, 100
Uml penicillin and 100 µg/ml streptomycin at 37◦C with 5% CO2. We
extracted RNA when the cells were 80% confluent. Primary dendritic
cells (DC) were isolated from the bone marrow of C57BL6 mice. Femurs
and tibia were removed, both ends of the bones cut and the bone mar-
row flushed using a syringe. Cells were cultured in plates (2-4x106 cells
per plate) with 10 ml of Iscove’s medium with glutamax and hepes, sup-
plemented with 10% FCS, 100 Uml of penicillin, 100 µgml streptomycin,
5x10-5 M 2-mercaptoethanol, 0.5 mM sodium pyruvate, containing 2%
of culture supernatant from X630 myeloma cells transfected with mouse
GM-CSF cDNA. After 3 days of culture, new medium with GM-CSF was
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added to each plate. After 7 days of culture, the non-adherent cells were
collected and processed for purification with magnetic beads on MACS
columns (Miltenyi Biotec). Cells were incubated with CD11c+ magnetic
beads and passed through the column. The positively selected cells were
pelleted by centrifugation for RNA extraction. Typically more than 90% of
the positive cell population expressed the dendritic cell marker CD11c+ as
determined by flow cytometry. Primary macrophages were isolated from
the bone marrow of C57BL6 mice using the same procedure as for the DC
and matured in M-CSF-containing media. Cells were cultured in plates
(4x106 cells per plate) with 10 ml of Iscove’s medium containing 30% of
L929 cell-conditioned media as a source of M-CSF. After 4 days of culture,
additional media with M-CSF was added. Macrophages were used after
8 days in culture for RNA extraction after removing non-adherent cells.
Typically more than 90% of the cell population expressed the macrophage
marker CD11b (Mac-1) as determined by flow cytometry. Primary hepato-
cytes were obtained from C57BL6 mice as previously described in reference
[120] and used to extract RNA.
RNA isolation and cDNA synthesis
Tissue samples (Spleen, Liver, Kidney, Brain, Heart and Lung) were
rapidly dissected and immediately homogenised in Trizol reagent. To-
tal RNA was purified from the cells or tissues using a RNeasy Mini Kit
(Qiagen) following the manufacturer’s instructions. For cDNA synthesis
500ng of total RNA was reverse transcribed using the “First-Strand cDNA
synthesis kit” (Roche) following the manufacturer’s instructions.
PCR and DNA analysis of Rab GTPase expression profiles
PCR was performed on the cDNA product to assess the expression of Rab
GTPases. The primers used for amplification can be taken from Table S3.
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The PCR amplification was performed in a reaction mixture containing 1x
green Go Taq buffer (Promega), 1 mM MgCl2, 0.2 mM of dNTP mix, 2.5 U
of Taq polymerase (Promega) and specific primers at a final concentration
of 0.5 µM, followed by a denaturation step of 3 min at 94◦C and a 32-cycle
program consisting of 94◦C for 40 s, 58◦C for 40 s and 72◦C for 1 min. The
final amplification mixture was separated in 1.2% agarose gel containing
ethidium bromide and photographed under UV illumination.
2.A Supplementary text / figures
Files, missing supplementary figures and tables can be obtained from the
author upon request.
This supplementary text describes the computation of the statistical
confidence scores generated with each call in phase one and two of the
Rabifier (see Figure 2.1). Generally, the procedure implements a naive
Bayesian classifier [121]. This well studied probabilistic machine learning
approach is one of the simplest yet most performant classifiers in a super-
vised setting.
The basis for our score is a feature vector computed for a given input.
In our case, the input is a sequence to be classified, and the features
are the output of different tools we feed with the input sequence (see
workflow in Figure 2.1). In the following, we describe the two distinct
steps necessary to perform the classification. As a prerequisite, we first
establish distributions from our reference data or training set, and second,
we evaluate them and combine the results to produce a single value per
input sequence. This result represents the actual confidence score. The
procedure is equivalent for both Rab family and Rab subfamily scores,
with the difference that the Rab family score is binary and only generates
two values for the classes ‘Rab’ and ‘non-Rab’, whereas the subfamily score
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produces one per subfamily in our reference set. For the sake of simplicity,
we describe the procedure for the binary case, however, all descriptions
equivalently apply to the subfamily score.
2.A.1 Step 1
The purpose of this phase is to establish how likely certain feature values
are under the assumption that the input is a Rab and that it is not. The
tools we use to obtain features or measure properties of the input are
BLAST [35] and MAST [114] from the MEME-suite [115] to get the sequence
identity, similarity and e-value of the alignment to the best hit in our
reference set, and the number and alignment e-value of the RabF motifs
[36] respectively. We used the same manually compiled reference set of
Rabs and sequences which are not Rabs to measure the values described
above, however, to ensure we did not bias the distributions by aligning
sequences against themselves we excluded this case for each sequence.
The result are two times (both for Rabs and non-Rabs) five histograms
(sequence identity, similarity and e-value of the alignment to the best hit in
our reference set plus number and alignment e-value of the RabF motifs).
For illustration purposes Figures 2.9 and 2.10 show two such histograms.
Note that we did not fit any distribution to obtain true densities, but used
the empirical distributions as they are shown in the Figures.
2.A.2 Step 2
Given these ten histograms, five per possible outcome (Rab or non-Rab),
the computation of the confidence score given an input sequence is straight-
forward. Once the sequence in question has been BLASTed against the
internal reference set of the Rabifier and MAST has detected the motifs
and their e-value, the obtained values are evaluated under both possible
outcomes with help of the density functions defined by the histograms.
122
Figure 2.9: Cumulative distribution of the negative logarithm of the BLAST
[35] alignment e-value of our reference set of Rabs against itself —Self hits
are excluded.
Figure 2.10: Cumulative distribution of number of RabF motifs detected
by MAST [114] in the reference set of non-Rabs.
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The final score is then obtained by applying Bayes formula:
P (C|~F ) = P (
~F |C)
P (~F |C = Rab)× P (~F |C = non-Rab)
where ~F is the feature vector with five individual components being
the sequence identity, similarity and e-value, as well as the motif count and
e-value, and C are the possible outcomes or classes, i.e. Rab or non-Rab.
Figure 2.11 shows the distribution of scores we obtained from the appli-
cation of the Rabifier to 247 genomes taken from the Superfamily database
as described in the main manuscript. Note that in a true classification set-
ting, any score below 0.5 would lead to consider a sequence as not being a
Rab and vice versa. However, as presented in Figure 2.1 and unlike in the
second phase, the family score does directly influence the decision of call-
ing a sequence a Rab or not, and is to be understood as a pure confidence
level. In fact, the Rabs with scores lower than 0.5 are mostly accounted
for by exceptions as for example very short sequences or those with long
strips of masked residues, where motif detection and alignments generally
tend to fail.
Figure 2.12 summarises the result for phase 2 of the Rabifier.
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Figure 2.11 (preceding page): Rab family scores obtained for all G-protein
family domain containing proteins from the 247 genomes described in the
main text—Black bars capture sequences the Rabifier classified as Rabs and
are browsable at our public website www.RabDB.org, in red are those we
classified as not being Rabs. The lower histogram shown the same quantities
in log-scale. Sensitivity and specificity refer to the threshold at 0.5 marked
by the red dashed line.
Figure 2.12: Distribution of subfamily scores of the highest scoring sub-
family for all Rabs in our database—Database accessible at www.RabDB.org.
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Figure 2.13: Sequence identity to best hit within same subfamily—
Histogram of sequence identity of all sequences in our reference database
to their respective best hit within the same subfamily (itself excluded). Sub-
families can contain sequences from organisms anywhere in the eukaryotic
tree. The threshold is the minimal required identity for a sequence to be
attributed to the subfamily of its best hit (see Figure 2.1). It is chosen to
minimise the number of times a sequence is annotated as belonging to the
unspecified subfamily RabX although it is a member of the same subfamily
as its best hit.
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Figure 2.14: Linear regression of number of Rabs against genome size—
Data consists of the 247 genomes profiled by the Rabifier. The taxa are
shown in different colours.
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Figure 2.15 (preceding page): Microarrays of Rabs in mouse tissues—The
average expression across the mouse tissues (cell lines not included) in the
same data as shown in Figure S5 in reference [61].
Figure 2.16: Distribution of Rabs belonging to non-human subfamilies—
The histogram details for each taxon how we classified those Rabs not be-
longing to human subfamilies. Subfamilies falling into the orange category
have been previously described in the literature, whereas all other subfami-
lies result from clustering of the sequences as described in Section 2.4. See
Figure 2.4 for an overview of the number of subfamilies in each category.
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Chapter 3
Phylogeny and the inference of
episodic positive selection
“Detecting selection needs comparative data” [1]
—Nielsen, Hubisz, 2005
“Comparative biological analysis can be carried
out only in the context of a phylogeny.” [2]
—Thornton, DeSalle, 2000
Abstract Chapter 3
The Branch-Site Test of Positive Selection is a standard approach to
detect past episodic positive selection in a priori specified branches
of a gene phylogeny. Here, we ask if errors in the topology of the
gene tree have any influence on its ability to infer positively selected
sites. Using simulated sequences, we compare the results obtained for
the true and erroneous topologies, and find a strong linear effect on
the ability to predict sites if an erroneous tree topology changes how
long sequences are inferred to have experienced selection. Moreover,
reanalysing a previously published data set we show that the choice
of gene tree also alters the results obtained for real-world sequences.
This is the first time a clear effect of the gene tree topology on the
inference of positive selection is demonstrated. We conclude that
the gene tree is an important factor for the branch-site analysis of
positive selection so far unrecognised.
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3.1 Introduction
T he branch-site test of positive selection (BSPS) [3, 4] is a standard ap-proach to detect sites that evolved under episodic positive selection,
i.e. in a subset of branches in a phylogeny. It is based on a codon model
of sequence evolution [5] with an explicit parameter ω representing the
nonsynonymous to synonymous substitution rate ratio (dN/dS), which is
commonly interpreted as evidence for positive selection when above one.
Given a multiple sequence alignment (MSA), a gene tree relating these
sequences, and a partition of the branches into so called ‘foreground’ and
‘background’, a likelihood ratio test (LRT) determines if a codon model
with ω greater one for some sites in the foreground branches fits the data
significantly better than a null model with no site above one. If this is
the case, the actual sites most likely evolving under positive selection in
the foreground branches can be determined in a second step by a Bayes
Empirical Bayes (BEB) procedure [6]. For each site, BEB outputs the prob-
ability that it evolved under selection in the foreground, with values above
0.95 generally considered as significant.
The performance of the BSPS, usually defined by the type I and type
II errors of the LRT, has been assessed mostly using simulations, as in
general the true history of selection pressures cannot be known.
The most common scheme is to generate different sets of sequences
under a varying simulation parameter and compare the performance of
the BSPS on each of those data sets. Examples of variables that have
been examined are sequence length, strength of positive selection, pro-
portion of sites under positive selection [7], indels and alignment errors
[8], synonymous substitution saturation and variations in GC-content [9].
In contrast, to the best of our knowledge the effect of the gene tree on
BSPS performance has not been systematically quantified. At least for
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site models, the gene tree does not seem to be of great concern as long
as it is “reasonably good” [10], i.e. inferred from the data for example by
Maximum Likelihood (ML).
Here, we ask if and how the gene tree topology impacts on the perfor-
mance of the BSPS. Note that we define performance here as the ability
to retrieve the actual sites under positive selection by BEB and not as the
errors committed by the LRT. Except for a short paragraph in reference
[8], BEB performance has so far only been measured in the context of site
models [6, 11–13]. However, although statistically “[i]dentifying amino acid
residues under positive selection along the lineages of interest is clearly
much more difficult than testing for the presence of such sites” [3], the
actual sites are often most useful to molecular biologists (see for example
[14] and the references therein). Therefore, our performance metric is rel-
evant in practice and novel in the context of the BSPS.
3.2 Results / Discussion
First, we measured the performance of BEB on simulated sequences given
the true topology. This establishes the baseline against which the results
on erroneous topologies can be compared.
We simulated sequences along the Ensembl Compara [15] species tree
for selected mammals and chicken shown in Figure 3.1 in order to ensure
a realistic tree topology. We generated eight independent replica for 21
different foreground branches (each contiguous subset of labeled branches
in Figure 3.1, i.e. {fg1}, . . . , {fg6}, {fg1, fg2}, . . . , {fg5, fg6}, . . . , {fg1,
fg2, fg3, fg4, fg5, fg6}), resulting in 168 sets of 32 sequences in total. Each
time, the foreground was simulated with 30% of the sites at a dN/dS
above one. Although shown to be of critical importance for the BSPS [8],
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we did not simulate insertions or deletions (indels) as we did not want to
confound the effect of tree topology alone. More details on the simulation
procedure are given in the Materials and Methods Section 3.4. For each
of the sets of sequences we determined the sites inferred to be under pos-
itive selection in the foreground branch by BEB (at site-specific posterior
probability > 0.95) [6] using PAML [16]. We compared those to the true
simulated sites and summarised the elements of the confusion matrix by
computing sensitivity, specificity and Matthew’s Correlation Coefficient
(MCC) (definitions given in Section 3.4). By default, we average deriva-
tions of the confusion matrix over the eight replica to mask the variation
across replica.
The overall distribution of sensitivity, specificity and MCC values is
shown in Figure 3.2. It is obvious that specificity is generally high, i.e.
very few sites are erroneously inferred to have evolved under selection in
the foreground branches. Hence, in the following we focus on sensitivity
as a measure of BEB performance, which has the advantage of being easier
to interpret (analogous to the power of a statistical test, or verbally: of
all sites under selection, what fraction has been correctly found) than
for example MCC. Interestingly, at least for the more lenient simulation
scenario without indels followed here, we attain higher power than the
previous report of less than 1% [8].
In Figure 3.3, we detail the sensitivity for each of the 21 different fore-
ground branches to visualise potential differences in performance depend-
ing on the foreground. Indeed, we find marked differences, with almost
no sites inferred for foreground branch six and one (referring to the labels
from Figure 3.1), and highest power for foregrounds stretching (nearly)
the entire path from root to leaf.
These performance differences can be explained in terms of properties
of the foreground branch. For the power of the LRT, two aspects have
previously been shown to be important: the foreground branch length,
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and to a lesser extent its age, loosely formalised as the distance to the root
[8, 9]. We confirm the major influence of the length of the foreground also
on the sensitivity of the BEB procedure (simple linear regression r2 = 0.85,
p = 1.95×10−9). Moreover, adding the age of the foreground (see Section
3.4 for the definition used here) as a second explanatory variable leads to
a better model fit (multiple linear regression r2 = 0.90, p = 5.26× 10−10,
the resulting regression plane is shown in Figure 3.4). Although the gain is
modest, it is favoured by model selection (Bayesian Information Criterion
(BIC), ∆BIC=−6.1).
Hence, we show for the first time that the foreground branch length
is a major factor for the performance of the BEB also in the context of
the BSPS, as well as the age of the foreground to a lesser extent. In our
simulations, these factors together account for roughly 90% of the ob-
served variation in mean sensitivity. In the following, we use the obtained
sensitivities as reference values for comparison, allowing to assess the ef-
fect of erroneous tree topologies on the performance of the BEB procedure.
Next, we turned to our principal question and asked if errors in the
Figure 3.1 (preceding page): Gene tree underlying sequence simulations—
The gene tree along which the sequences were simulated using INDELible
[17]. The tree represents a subset of the Ensembl Compara [15] species tree,
however, the species names and the corresponding NCBI taxon IDs are only
given for orientation purposes as the simulations start from a random se-
quence and are therefore not related to any of the species’ sequences. Every
contiguous subset of branches labeled as foreground and highlighted in red,
i.e. {fg1}, . . . , {fg6}, {fg1, fg2}, . . . , {fg5, fg6}, . . . , {fg1, fg2, fg3, fg4, fg5,
fg6}, is simulated under a foreground selection scheme described in Section
3.4, with the remaining branches simulated using a background selection
scheme, leading to 21 different foregrounds for which eight replica each have
been generated. Most basal branches serving as outgroups are shown in blue.
Dashed lines are solely for clarity and labelling of sets of leaves for reference
in the main text. Abbreviations: foreground (fg.), branch length (bl.)
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Figure 3.2: Overall distribution of derivations from the confusion ma-
trix—The boxplots show the distributions of mean sensitivity, specificity
and (MCC) across eight replica for all foreground branches. Abbreviations:
Matthew’s Correlation Coefficient (MCC)
topology of the gene tree have any influence on the performance of BEB.
Our approach is to manually introduce topological errors (the trees
analysed in the following are listed in Table 3.2), pass these trees as input
to PAML, and quantify the effect on the BEB procedure. Hence, the trees
are not inferred from the simulated sequences for example by ML, allowing
to freely manipulate the topology independently of its likelihood on the
MSA of the simulated sequences.
First, we established that erroneous trees had an effect at all. The
distribution of effects on sensitivity is shown in Figure 3.5, indicating that
sensitivity can drop by over 0.15 in the most extreme cases, which we
recall represents over 50% of the maximal observed sensitivity (see Figure
3.3). This is the first time a clear effect of the gene tree topology on the
inference of positive selection is demonstrated.
Second, we sought to explain this effect as a function of the tree and
foreground. We hypothesised that the most drastic effects on the results
occur when the altered topology affects how long sequences are inferred to
have experienced selection. To quantify this phenomenon, Figure 3.6 in-
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sensitivity (P
(ω
>
1)>
0.95)
Figure 3.3: Sensiticity of the BEB procedure on the true gene tree—For
every foreground branch, specified here by the pair of distances from the
root to the start- and end-point of the branch on the tree, the mean sensi-
tivity across the eight replica is shown. Green and blue lines are standard
deviations. Abbreviations: Bayes Empirical Bayes (BEB)
troduces the “conflicting branch length” of a sequence, which we define as
the difference in branch length that a sequence is inferred to have evolved
under positive selection in the true and in a topologically perturbed tree.
Note that conflicting branch length depends both on the gene tree and
the position and lengths of the foreground branch simulated to be under
selection, meaning that the same tree can result in different conflicting
branch lengths.
In the major finding of this chapter, we validate our hypothesis by
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sensitivity (P
(ω
>
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0.95)
r =0.92
Figure 3.4: Performance of the BEB procedure on the true gene tree—
Multiple linear regression of BEB performance inferring the sites simulated
under positive selection in the foreground given the true tree. Performance
is measured as MCC and averaged over the eight replica. The explanatory
variables are foreground branch length and age (see Section 3.4 for the defi-
nition of age employed here). Abbreviations: Bayes Empirical Bayes (BEB),
Matthew’s Correlation Coefficient (MCC)
demonstrating a linear relationship between the loss in sensitivity of the
BEB procedure and conflicting branch length (simple linear regression r2 =
0.87, p < 2.2×10−16, Figure 3.6). Note that we also observe a small (here
below 0.02) yet significant increase of specificity with conflicting branch
length (simple linear regression r2 = 0.45, p < 2.2 × 10−16, data not
shown), resulting in two opposite effects of conflicting branch length on
the overall accuracy.
155
difference in sensitivity
fr
eq
ue
nc
y
−0.15 −0.10 −0.05 0.00
0
50
10
0
15
0
20
0
Figure 3.5: Differences in sensitivity observed with erroneous topologies—
Histogram of mean differences in sensitivity across the eight replica observed
for each of the erroneous topologies (listed in Table 3.2) and each of the
foreground branches.
To further understand this phenomenon, we asked if the likelihood
that a site evolves with ω > 1 in the foreground, i.e. the numerical result
of the BEB procedure per site, is also dependent on conflicting branch
length. Surprisingly, Figure 3.7 shows that the likelihood of a site which
was inferred to have evolved with ω > 1 given the true topology, but
not so given the erroneous topology , is reduced largely independently of
conflicting branch length. In other words, higher conflicting branch length
causes more sites to be inferred not to have evolved under selection in the
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foreground, but the strength of the effect on a single site remains the same.
Interestingly, this is also true for trees that introduce no conflicting branch
length.
In summary, model violations introduced by erroneous tree topologies
can have a strong detrimental effects in the context of the BSPS. We define
and single out one parameter—conflicting branch length—as an explana-
tory variable for a strong linear loss in sensitivity. Furthermore, it appears
that the overall tree quality, which has previously been suggested to be
important for site models, is only indirectly related to the loss of sensi-
tivity observed here (see inlay in Figure 3.6), as it has less explanatory
power (simple linear regression r2 = 0.50, p < 2.2× 10−16). We conclude
that the effect we describe is important whenever the branch-site analysis
is performed and competing gene tree topologies exist. This may even
Figure 3.6 (preceding page): Conflicting branch length explains the loss
in sensitivity of the BEB procedure—Panel A illustrates the definition of
“conflicting branch length” as the difference in branch length that a sequence
is inferred to have evolved under positive selection in the true and in an
altered tree. In the middle panel, moving leaf A to another part of the
tree causes it to seemingly never have experienced positive selection, i.e. the
set of sequences {A, B, C} which were inferred to have experienced positive
selection in upper panel is changed to {B, C}. Changing the tree as seen in
the lower panel does not create such an error. The definition of conflicting
branch length is naturally extended to an entire tree as the sum of the
conflicting branch lengths of all of its sequences. Note that the definition
does not distinguish the direction of change, meaning that changing the set
of sequences which are inferred to have experienced positive selection for
example to {A, B, C, D} also leads to a conflicting branch length of one. In
Panel B, each data point in the simple linear regression gives the change
in sensitivity averaged over the eight replica corresponding to a manually
altered topology (all listed in Table 3.2) and a specific foreground branch.
The inlay depicts the same quantity, however, against the difference in the
log-likelihood of the codon models fitted by PAML [16] on the true versus the
erroneous topology. The line is a non-parametric local regression (LOESS).
Abbreviations: Bayes Empirical Bayes (BEB)
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Figure 3.7: Individual sites behave the same qualitatively independent of
conflicting branch length—For ten equally sized partitions of simulations by
conflicting branch length (varying interval lengths suggested by the x-axis
labels are caused by rounding), the distribution of losses in the likelihood
that a site has evolved under selection (i.e. with ω > 1) in the foreground is
shown. Only sites that were inferred to have evolved under selection given
the true topology, but not not so given the erroneous topology are included.
hold if the position of the foreground prevents alternative topologies to
introduce conflicting branch lengths, as single sites (even if few) can still
substantially lose likelihood to evolve under selection in the foreground.
We address this last point in the following paragraph.
Lastly, we ask if the choice of gene tree also affects the results in real
sequences. Real sequences usually evolve in more complex manners than
it is possible and desirable to simulate, in particular compared to the
rudimentary scheme without indels used here. Hence, although we loose
the certainty about the right tree topology and selective regimes, only
these conditions can show if the effect we described remains detectable, or
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Table 3.1: Results of the Branch Site Test of positive Selection on data from
[18] obtained with original and reconciled gene tree—Branch names refer to
the labels given in Figure 3.8.
branch tree H0 H1 LRT p-value
A original -25007.8 -24994.3 27 < 0.0005reconciled -25130.1 -25116.0 28.1 < 0.0005
B original -25026.7 -25024.4 4.4 < 0.025reconciled -25147.1 -25144.9 4.3 < 0.025
C original -25018.3 -25005.3 26 < 0.0005reconciled -25139.1 -25125.8 26.6 < 0.0005
if it is minor and therefore without consequence for real sequences.
To answer this question, we reanalysed a data set of fungal glucosidase
genes that have been studied by the authors with respect to their func-
tional specialisation after gene duplication [18]. We chose this data set as
it exemplifies a situation in which alternative tree topologies commonly
arise, namely when the gene tree of orthologs and the species tree are in-
congruent, or alternatively when a gene tree / species tree reconciliation
(see Box 1.2) yields a competing gene tree in the presence of paralogs.
There seems to be no consensus on which tree to use (see [19] and [20] for
examples of a gene- and a reconciled gene tree respectively) which suggests
that both generally represent plausible choices.
The authors of [18] analysed the sequences using a gene tree inferred
by MrBayes [21] testing for sites under positive selection in three different
foreground branches. Based on the author’s species tree of yeasts, manual
gene tree / species tree reconciliation alters the subtree under each of these
foreground branches. When comparing the BEB results obtained with the
original tree and our reconciled tree, we observe that all three lists of sites
changed as summarised in Figure 3.8 (see Table 3.1 for the results of the
LRT).
This demonstrates that the gene tree influences the results also on
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real sequences, including alignments containing indels. Yet, the experi-
mental setting does not allow to tell if one inference of sites and tree or
the other are better, because outside simulations the truth is generally
unknown. Interestingly, these incongruences are obtained without intro-
ducing conflicting branch length. However, with exception of an outlier,
the difference in likelihood at single sites are small and in the range of
the values we predominantly observed in our simulations (see Figure 3.7).
Hence, on this small scale where the result consists only of a few sites,
the comparably small fluctuations in likelihood per site resulting from al-
ternative tree topologies that we also report in simulations are enough to
affect the output. This means that also in this case the gene tree matters,
and it does so beyond the sole effect of conflicting branch length shown in
Figure 3.6.
3.3 Conclusion
For the first time, we assessed the performance of the Bayes Empirical
Bayes procedure in the context of branch-site models. We have shown
Figure 3.8 (preceding page): Different gene trees can lead to different BEB
results on real sequences—The upper left panel represents the gene tree pub-
lished as Figure 4 in reference [18], with the analysed foreground branches
highlighted in red and basal branches in blue. The three boxed areas corre-
spond to the subtrees which we manually reconciled in the middle column
using the species tree from Figure 1 in reference [18]. The results of infer-
ring sites under positive selection with the two different trees (original and
reconciled) are compared by Venn diagrams in the right column. Note that
we were not able to reproduce the original results (here indicated by stars
after the common sites) despite using the same sequences, alignments, trees
and program version. None of the differences we report change the author’s
conclusions. Additionally, the lower left panel details the difference in likeli-
hood for each of the sites reported by BEB. Red dots correspond to the sites
differently classified using the original and reconciled tree. Abbreviations:
Bayes Empirical Bayes (BEB)
162
that the length and age of the foreground not only determine the power of
the LRT as reported before, but also that of the BEB procedure. Most im-
portantly, we found evidence for an effect of the gene tree on the inference
of selection in both simulated and real-word sequences. In simulations,
we are able to explain this effect by virtue of a single parameter we coin
conflicting branch length.
We conclude that the gene tree is an important factor for the branch-
site analysis of positive selection so far unrecognised. Further investiga-
tions are needed to understand the precise effects and interplay with other
known factors, and most relevantly develop guidelines for the choice of the
gene tree in the analysis of real data sets.
3.4 Materials and Methods
Genes consisting of 522 codons were simulated along the tree depicted in
Figure 3.1 starting from a random sequence at the root using INDELible
(version 1.03) [17]. Simulation parameters were the transition/transversion
ratio κ=2.1, chosen to match the average reported for the human genome
(see for example [22]), a background selection scheme [1, 1, 0.8, 0.8, 0.5,
0.5, 0.2, 0.2, 0, 0] with every class making up 10% of the sites (the same
as background scheme X from reference [8]), and a foreground selection
scheme [0.5, 1, 4, 0.8, 4, 0.5, 4, 0.2, 0.8, 0.5]. We did not simulate indels.
The simulated sequences were analysed with PAML (version 4.6) [16],
labelling the branches as foreground which were simulated as such. Branch
lengths are estimated by PAML. The sites under selection in the foreground
branches were obtained by BEB, but only in case the LRT was significant
(here > 2.71, i.e. p < 0.05). Note that we did not correct for multiple
testing, as every foreground branch and replicate is based on an indepen-
dent simulation and we therefore never interrogate the same data twice.
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We defined the age a of a foreground branch delimited by nodes n1 and
nm and—in case of foregrounds spanning several individual branches—
with additional internal nodes n2, . . . , nm−1 as
a := 1
m
·
m∑
i=1
d(ni, nhuman),
where d(k, l) represents the distance between node k and l on the tree
and nhuman designates the node corresponding to human, i.e. the leaf at
then end of fg6 in Figure 3.1.
We summarised the elements of the confusion matrix (i.e. true posi-
tives (TP), false positives (FP), true negatives (TN), and false negatives
(FN)) computing sensitivity, specificity and MCC according to their stan-
dard definitions T PT P +F N ,
T N
F P +T N ,
T P ·T N−F P ·F N√
P ·N ·P ′·N ′ respectively. Although
the numerical values are hard to interpret, MCC provides an attractive
measure as it summarises all values of the confusion matrix, while cor-
recting for unequal amounts of positives (here selected sites, 30%) and
negatives (other sites, 70%).
Tree manipulations were done in Python using Biopython [23] and the
ETE library [24].
The DNA MSA for the reanalysis of the sequences from [18] were gener-
ated by using Pal2Nal (version 14) [25] on amino-acid alignment provided
in the Supplementary material of reference [18]. The original tree was re-
produced and reconciled manually, with branch length of the constrained
topologies shown in Figure 3.8 computed by PhyML (version 3.1) [26].
All sequences, alignments and trees used to generate Figure 3.8 can be
obtained from the author upon request. In order to exclude potential
differences in our results stemming from different versions of PAML, we
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performed the computations with PAML version 4.4 used by the authors
in reference [18].
3.A Supplementary tables
Table 3.2: List of perturbed topologies tested for their effect on the perfor-
mance of the Bayes Empirical Bayes procedure.—The leaf names refer to the
NCBI taxon IDs also listed in the species tree in Figure 3.1.
name operations
within set 1 swap leaves 13616, 9315
within set 2 swap leaves 9371, 9361
within set 3a swap leaves 42254, 9615
within set 3b swap leaves 10116, 9986
across set 5/4 attach 9557 to 9483
across set 5/3e attach 9557 to 9478
across set 5/3d attach 9557 to 30611
across set 5/3c attach 9557 to 37347
across set 5/3b attach 9557 to 9986
across set 5/3a attach 9557 to 9365
across set 5/2 attach 9557 to 9358
across set 5/1 attach 9557 to 13616
across set 3d/3c attach 30608 to 37347
across set 3d/3b attach 30608 to 9986
across set 3d/3a attach 30608 to 9365
across set 3d/2 attach 30608 to 9358
across set 3d/1 attach 30608 to 13616
across set 3b/3a attach 10116 to 9365
across set 3b/2 attach 10116 to 9358
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name operations
across set 3b/1 attach 10116 to 13616
across set 3a/2 attach 42254 to 9358
across set 3a/1 attach 42254 to 13616
across set 2/1 attach 9371 to 13616
across set 1/6d attach 9315 to 9598
across set 2/6d attach 9371 to 9598
across set 1/3b attach 9315 to 10116
across set 2/3b attach 9371 to 10116
across double1 attach 30608 to 9358; attach 9557 to 9483
across double2 attach 30608 to 9358; attach 9557 to 13616
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Chapter 4
Functional Innovation in the Rab
family of small GTPases
“Population genetic models take such a familiar form that it is easy
to overlook a respect in which they are odd. These models begin with
selection coefficients but say nothing whatever about where these co-
efficients come from. It is vaguely assumed of course that selection
coefficients emerge from the phenotypic effects of mutations [. . . ]. Al-
though this shortcut suffices for many evolutionary questions, it leaves
us in an awkward position when thinking about adaptation.” [1]
—H. Allen Orr, 2005
Abstract Chapter 4
Neofunctionalisation is a popular model to explain the retention of
gene duplicates with new functions, however, it does not explain the
evolution of new functions themselves. Here, we use a pair of subfam-
ilies from the Rab family of small GTPases to ask how mutations can
lead new protein function in the context of gene duplication. Rabs
are protein switches that function as master regulators of vesicular
trafficking. In their active GTP-bound state, they recruit so-called
effector proteins that then exert their function. We hypothesise that
Rabs neofunctionalise by changing these sets of effectors, a model we
refer to as effector switching. First, we demonstrate that Rab11 and
its duplicate Rab25 indeed evolved by neofunctionalisation. Next, we
test our hypothesis about the mechanism of neofunctionalisation by
confirming three predictions of the effector switching model: Rab25
has replacements mostly on its surface, Rab11 and 25 have different
effectors, and Rab25 has been selected for new binding interfaces.
Moreover, we discuss alternative but non-exclusive modes of func-
tional evolution and their support. Finally, we detail the temporal
dynamics of the process. We present indications that Rab25 function
may be different between zebrafish and mammals and has therefore
evolved over an extended period after duplication. In conclusion, we
suggest that our model for the evolution of Rab function represents
a general mechanism for neofunctionalisation particularly attractive
for the important class of protein master regulators.
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4.1 Introduction
E volutionary innovation, i.e. the process by which novel charactersemerge in evolution [2], persists as a fascinating and fundamental
problem in biology [3, 4] transcending the boundaries of biological disci-
plines. At the morphological level, it is one of the defining topics of an
entire field merging evolution and development or EvoDevo [2–4]. At the
molecular level, it is subsumed under or even equivalent to asking how
protein function evolves (see Chapter 1), a question receiving growing
attention as part of what has been coined the “functional synthesis” of
evolutionary and molecular biology [5].
A particularly favourable and frequent condition for the evolution of
novel protein functions—and therefore of upmost importance—is the pres-
ence of redundancy, mostly resulting from duplication of DNA. This con-
nection has been put forth most prominently by Susumo Ohno, who em-
phasised the role of gene duplication as a mechanism to free genes from
functional constraints [6]. Duplicates can thus diverge even through non-
functional intermediates without deleterious effects on fitness, until a new
beneficial function evolves, is picked up by positive selection, and the
gene is ultimately preserved by purifying selection. The resulting model
coined neofunctionalisation therefore provides an evolutionary mechanism
to explain retention of gene duplicates. However, even though functional
innovation is implied by definition, no explicit biochemical mechanism is
given specifying how mutations lead to a new function. In other words,
while neofunctionalisation explains the evolutionary emergence of genes
with new functions, the model is not concerned with the emergence of
new functions themselves.
Here, we ask how mutations lead to new protein function in the context
of neofunctionalisation. While “[i]t is more important to understand the
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general than the particular, [. . . ] the first is achieved only through the
second” [7] and we therefore study the question focussing on Rab small
GTPases as a model gene family. Rabs are an especially interesting system
for various reasons.
Firstly, Rabs frequently neofunctionalise. The Rab family is large and
grew from roughly 20 Rab subfamilies in the last common ancestor of ani-
mals [8] to 44 subfamilies and over 60 genes in humans. The evidence that
those duplications represent neofunctionalisations is threefold. Primarily,
the available functional annotation of Rabs supports a conserved core of
ancient Rabs with equivalent or equal functions all over the eukaryotic tree
of life. The functional characterisation of some Metazoan subfamilies that
emerged later by duplication found distinct functions different from those
of the subfamilies they are derived from (see e.g. Figure 1.5). Next, the
overall patterns of Rab family evolution are not consistent with sub- and
rather suggest neofunctionalisation, both in terms of sequence divergence
and tissue specificity of expression (see Chapter 2) [8]. Lastly, at least one
clear case of neofunctionalisation has been experimentally established and
studied, the evolution of a catalytically inactive Rab6 duplicate that lost
Golgi localisation and functions in cell cycle progression at the centrosome
instead [9]. Secondly, Rabs are a promising model system to study the pro-
cess of neofunctionalisation because they are protein switches. As such,
they are subject to a diverse set of constraints, for example flexibility, sta-
bility, multispecificity and enzyme function. The impact of these factors
on the evolution of function is interesting to consider. Thirdly, Rabs are
master regulators of vesicular trafficking and essential for the organisa-
tion of the endomembrane system. They are markers for many organelles
and transport pathways, and therefore allow to indirectly study one of the
hallmarks of the Eukaryotic cell, its extensive membranous compartments.
Finally, due to their importance a rich body of work has contributed public
data on sequence, structure and function, including expression, localisa-
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tion and interactions that may be integrated in an evolutionary analysis.
Here, we address the hypothesis that Rabs neofunctionalise by chang-
ing their set of binding proteins. The hypothesis is based on the known
biochemistry of Rabs: as depicted for example in Figure 1.4, Rabs exert
their function via effector proteins that by definition recognise the GTP-
bound form specifically and are recruited to the compartment the active
Rab is attached to. Hence, an intuitive hypothesis is that altering this
set of effectors represents a way that evolution tinkers with Rab function.
Subsequently, we refer to this process as effector switching. Alternatively,
other possibilities to evolve Rab function may be for example by affecting
the interactions with GAPs and GEFs that activate and inactivate Rabs
or by changes in overall tissue-specificity. These options are also briefly
considered.
While the above hypothesis can in principal be tested for any pair of
Rab duplicates, in the remainder of the chapter we focus on the ancestral
Rab11 and Rab25 that emerged from the former by duplication at the
base of jawed vertebrates. There are three major reasons for this choice.
First and foremost, as far as we can tell from the analysis presented in
Chapter 2, the patterns of evolution do not differ between the human Rab
subfamilies [8]. Hence, we expect the results presented for the pair of sub-
families Rab11 and 25 to be general and also apply to most other cases
of Rab neofunctionalisation, at least in Metazoa. Note that exceptions
do exist: as already mentioned, in at least one case a Rab6 gained a new
function by losing its catalytic activity, a scenario clearly and fundamen-
tally different from our hypothesis [9]. However, as it is to the best of
our knowledge the only documented case in animal Rabs we expect this
evolutionary path to be rare and therefore represent an exception rather
than the rule. Second, both Rab11 and Rab25 have been extensively stud-
ied. They function at recycling endosomes, many effectors are known, and
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three crystals of Rab11 bound to an effector have been published so far.
Additionally, both Rab11 and Rab25 play a role in various diseases, most
importantly Rab25 which has been implicated in cancer progression (see
references [10, 11] for reviews). A third and more practical reason is that
the duplication that gave rise to Rab25 is not yet too remote to analyse
patterns of synonymous and nonsynonymous substitutions, which allow
to generate hypothesis about past positive selection. Generally, for events
beyond this time frame too many synonymous substitution have occurred
and the resulting saturation precludes the reliable estimation of the rates
required for the analysis.
In the following, we begin by establishing a gene phylogeny of some
animal Rab11 and 25 sequences. This tree allows us to confirm that the
pattern of sequence evolution is indeed best explained by a process of
neofunctionalisation. As part if this, we map the sites that show signs
of positive selection in the lineage leading to the extant human Rab25.
Next, we test our hypothesis about the mechanism of neofunctionalisa-
tion by verifying and confirming three predictions of the proposed effector
switching model: Rab25 has replacements mostly on its surface, Rab11
and 25 have different effectors, and Rab25 has been selected for new bind-
ing interfaces. Additionally, we discuss the support for alternative but
non-exclusive modes of functional evolution in Rab25. Finally, we present
indications that the function of Rab25 may be different between zebrafish
and mammals and has therefore not ceased to evolve after duplication.
In conclusion, we suggest that our model for the evolution of Rab func-
tion represents a general mechanism for neofunctionalisation particularly
attractive for the important class of protein master regulators.
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4.2 Results / Discussion
4.2.1 Rab25 evolved by neofunctionalisation
To ensure that Rab11 and 25 represent a valid model system to test our
hypothesis, we begin by confirming that Rab25 indeed evolved by ne-
ofunctionalisation. We consider two different levels: function, including
intracellular localisation and tissue specificity of expression, and sequence.
The neofunctionalisation model makes two predictions about the func-
tion of involved Rabs. One one hand, one should find that the function
of Rab11 outside jawed vertebrates, i.e. in those organisms that branched
off before the emergence of Rab25, is equivalent or the same as in jawed
vertebrates where Rab11 coexists with Rab25. We can test this prediction
by reviewing published data on the function of Rab11 in mammals and for
example in budding yeast. After its initial discovery [12, 13], mammalian
Rab11 has been found to localise both to the trans-Golgi network [14]
and recycling endosomes [15] where it functions in the secretory pathway.
The direct functional comparison between Rab11 and its yeast orthologs
ypt31/32 is complicated by the fact that there is no one to one relation-
ship between the compartments of the endocytic and secretory pathways
in mammals and budding yeast (see e.g. reference [16]). Yet, the localisa-
tion of ypt31/32 at the trans-Golgi and their involvement in secretion [17]
and recycling [18] clearly indicate functional equivalence and homology.
On the other hand, neofunctionalisation predicts that Rab25 should have
a distinct function, different from Rab11. The first indication that this
is indeed the case dates back to the identification and first description
of Rab25: while Rab11 is ubiquitously expressed [19], Rab25 shows a re-
stricted epithelial distribution [20]. Subsequently, Rab25 has been found to
co-localise with Rab11 at recycling endosomes, however, functional char-
acterisation pointed to related but distinct functions [21].
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The second level of predictions from neofunctionalisation relate to se-
quence divergence and the selective regimes causing it. Gene copies evolv-
ing via subfunctionalisation each experience relaxed purifying selection
and one therefore expects divergence in both sequences relative to the
common ancestor. In contrast, neofunctionalisation predicts only one copy
to diverge, and unlike subfunctionalisation under the influence of positive
selection. We first consider sequence divergence independently of the evo-
lutionary forces. Figure 2.6 suggests the latter of the above patterns,
however, divergence cannot be assessed properly due to the categorical
classification into subfamilies. Therefore, we analysed divergence after
duplication directly by reconstructing the ancestral sequences before du-
plication in a phylogentic framework (see Subsection 4.4.2 in Materials and
Methods for details). Figure 4.1 summarises the results. We observe that
Rab11 barely changes after Rab25 emerges (96% identical to the extant
human Rab11a), while the gene copy that gives rise to Rab25 shows impor-
tant sequence divergence after duplication (40% of Rab25 sites have been
replaced in humans compared to the last common ancestor of Rab11a/25).
This pattern clearly points towards neofunctionalisation. The last predic-
tion to be confirmed is that the observed divergence in Rab25 is at least
partly caused by positive selection. Using the gene tree already presented
in Figure 4.1, we detect statistical signatures in extant sequences most
likely left by past positive selection acting all over the branch leading to
the human Rab25 sequence (shown in Figure 4.2).
Hence, functional data for Rab11 and 25, sequence divergence pat-
terns in both Rabs, and the selective regimes under which Rab25 evolved
all conform to the predictions made by the neofunctionalisation model.
Therefore, we conclude that the pair Rab11/25 indeed represents a valid
model system to test our hypothesis about the mechanisms of functional
evolution in the context of neofunctionalisation.
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4.2.2 Rab25 function evolved by effector switching
Given that Rab25 evolved from Rab11 by neofunctionalisation, we can
now test the effector switching model that we propose for this process.
Our hypothesis is that Rab25 gained a new function by changing its set of
effectors that it initially inherited from Rab11. Effector switching makes
at least three predictions that we address in turn.
First, Rab25 should have replacements mostly on its surface, as we
expect that these replacements represent a more direct way to alter in-
teraction interfaces and as a result the set of interactors. Accepting this
reasoning and because we suggest that gain and loss of interactions pro-
vides the beneficial function required as part of the neofunctionalisation
model, we expect in particular that sites showing signs of positive selec-
tion preferentially localise to the protein surface. Second, altering the set
of effectors in evolution should have the clear consequence that extant
Rab11 and Rab25 do not interact with the same set of effectors. Third
and elaborating on the previous two points, we should see that the inter-
action interfaces of effectors not shared by Rab11 and Rab25 have been
shaped by positive selection.
The next paragraphs present data in favour of each of these predic-
tions. Therefore, we find no evidence to reject our hypothesis from which
we conclude that effector switching represents a promising mechanism to
explain Rab25 neofunctionalisation. In the last paragraph we briefly com-
ment on alternative but non-exclusive modes of functional evolution and
Figure 4.2 (preceding page): Positive selection on Rab25 —Traces of past
positive selection on the six different branches leading from the emergence of
Rab25 by duplication from an ancestral Rab11a (see Figure 4.1) to the extant
Rab25 sequence in humans. The branch labels 1−6 refer to the gene tree on
the upper left. The darker the area below the sequence corresponding to a
particular site and branch, the stronger the evidence that positive selection
indeed acted there (see Subsection 4.4.3 for details).
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their support, namely via changes in intracellular localisation, regulation
by GAPs and GEFs and overall tissue-specificity.
Rab25 has replacements mostly on its surface
Although Rabs are small and the majority of the residues localises to
the surface, Figure 4.3 confirms a significant association between surface
residues and those that have been replaced in Rab25 during its evolution
from the common ancestor of Rab11 and 25. This association is even
clearer when differing residues are restricted only to those that show signs
of positive selection, as all of them lie on the surface of the Rab25 molecule.
These results support the notion that Rab25 evolved its function by
altering interaction interfaces located on the surface, rather than for exam-
ple aspects of its structure like stability or flexibility that are determined
mostly by internal interactions between buried residues. Furthermore,
these alterations of the interaction interfaces have been driven by posi-
tive selection and therefore had to have beneficial functional effects. This
represents a powerful way to test the effector switching model, however,
so far no actual effectors are considered and it thus remains to be shown
that specific interactions are indeed affected by the observed changes of
the surface residues. Next, we therefore review the known Rab11 and 25
effectors.
Rab11 and 25 have different effectors
Probably the most intuitive prediction from the effector switching model
is that pairs of Rabs that evolved by duplication and neofunctionalisation
should interact with different sets of effectors. This can be tested by
reviewing the literature on known Rab11 and Rab25 effectors. Note that
this small-scale approach is expected to miss actual effectors that have
currently not yet been described. However, for the sake of testing our
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model it is enough if at least one interaction specific to either Rab11 or 25
has been found. Figure 4.4 summarises the current set of known Rab11
and 25 effectors, revealing that both Rab11- and Rab25-specific effectors
exist in agreement with the effector switching model.
This represents a necessary condition following from the model pro-
posed here. Finally, we combine both of the above aspects and test if
specific interactions can be shown to have been lost or gained in Rab25.
Rab25 has been selected for new binding interfaces
The availability of detailed structural information on some of the interac-
tions reviewed above allows to verify if loss and/or gain of these interac-
tions has specifically been driven by positive selection. Finding evidence
for positive selection is a powerful conceptual tool as it allows to conclude
that switching effectors had beneficial functional effects. In the context of
neofunctionalisation, loss and/or gain of effectors therefore becomes the
mechanism by which a new function evolves, which is precisely what we
propose to be the dominant form of functional evolution in Rabs. As
shown in Figure 4.4, structural details about the interaction are known
for four effectors. Unfortunately, these do not include a Rab11-specific
effector, which may have allowed to ask if active loss of interactions (i.e.
driven by positive selection) takes part in the neofunctionalisation process.
We briefly comment on each of the effectors in turn, beginning with the
most revealing one: the Rab25-specific Integrin β1-subunit (ITGB1).
Using chimera, the interaction interface between Rab25 and ITGB1
has been mapped to the Rab25 hypervariable C-terminal region starting
around residue 170. The Rab hypervariable termini are unstructured re-
gions that do not adopt a stable fold and are therefore usually excluded
from crystallographic analysis. Figure 4.2 reveals that this region is heav-
ily shaped by positive selection. Hence, despite the lack of resolution at
the residue-level, it is reasonable to assume that the formation of the in-
185
EXOC6/
SEC15A
FIP3/
ARFO1/eferin
RAB11FIP1/
RCP
FIP4/
ARFO2 MYO5B
RAB6IP1/
DENND5A
FIP2
FIP5/
RIP11
ITGB1
Rab11
Rab25
RAB3IP/RABIN8
PI4KB
WDR44/
Rabphilin-11
SH3TC2
Rab25?
RAB3IL1/
GRAB
Figure 4.4: Rab25 both lost and gained effectors after duplication from a
Rab11 —Currently known Rab11 and 25 effectors. The dashed box com-
prises proteins for which the inability to interact with Rab25 has not
been demonstrated. Effectors in red have been crystallised together with
Rab11 [23–26], additionally a Rab25-FIP2 crystal has been published [27].
ITGB1 is highlighted in orange to indicate that a less detailed mapping of
the interaction interface with Rab25 based on chimeras exists [28]. Addi-
tional effectors are RAB11FIP1/RCP [29], FIP2 [29, 30], FIP3/ARFO1/eferin
[29, 31], FIP4/ARFO2 [32, 33], FIP5/RIP11 [29, 30, 34], MYO5B [35, 36],
RAB3IP/RABIN8 [30], RAB3IL1/GRAB [37], RAB6IP1/DENND5A [38], SH3TC2
[39], EXOC6/SEC15A [40], PI4KB [41], WDR44/Rabphilin-11 [42]. Abbrevia-
tions: Integrin β1 subunit (ITGB1), Rab11 family interacting protein 1
(RAB11FIP1), Rab-coupling protein (RCP), Arfophilin-1 (ARFO1), Rab11-
interacting protein (RIP11), Unconventional myosin-Vb (MYO5B), Rab3A-
interacting-like protein 1 (RAB3IL1), guanine nucleotide exchange factor
for Rab3a (GRAB), DENN domain-containing protein 5A (DENND5A), SH3
domain and tetratricopeptide repeat-containing protein 2 (SH3TC2), Exo-
cyst complex component Sec15A (EXOC6), Phosphatidylinositol 4-kinase β
(PI4KB), WD repeat-containing protein 44 (WDR44)
teraction between Rab25 and ITGB1 has been driven by positive selection,
confirming the prediction of the effector switching model. To add confi-
dence that formation of the binding site was indeed driven by selection on
186
the Rab sequence rather than by evolution of the complementary inter-
face in the binding partner, we asked if ITGB1 is also found outside jawed
vertebrates. Figure 4.5 shows that this is the case, which suggests that
Rab25 evolved a binding site to an existing evolutionarily constrained pro-
tein and renders the possibility that the observed selection in the Rab25
C-terminus is entirely unrelated to binding ITGB1 less likely.
Interactions conserved amongst Rab11 and 25 are less interesting to
validate the effector switching model, however, they nonetheless reveal an
interesting pattern. The interaction with FIP2 is mediated amongst oth-
ers by residues around the switch region differing between Rab11 and 25
[23, 24, 27], some of which we found to that have experienced positive
selection. However, although the characterisation of the Rab25-FIP2 in-
teraction found a threefold reduced affinity of Rab25 to FIP2 compared
to Rab11, the molecular basis of this drop in affinity remains elusive. As
the authors point out, this is because the divergent residues do not alter
the number of polar contacts, i.e. electrostatics and hydrogen bonds [27].
Here, we analysed the interaction of Rab25 with FIP3, an effector which
has solely been crystallised bound to Rab11. We scanned the replaced
residues that show signs of positive selection and that are involved in the
interaction at least in Rab11 for their putative impact on the interaction.
Figure 4.6 presents evidence that Rab25 may also have reduced affinity to
FIP3, caused by the loss of a critical van der Waals interaction stabilising
the C-terminal helical element of the Rab-binding domain of FIP3 that
forms a hook-like structure [25]. An intriguing possibility that remains to
be investigated is that this putative structural mechanism also provides
the basis for the reduced affinity of Rab25 to FIP2. This finding is in-
teresting in the context of Rab25 neofunctionalisation as it implies that
some of the conserved effectors evolved reduced affinities to Rab25 driven
by positive selection. Several possibilities exist for the beneficial func-
187
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BBH
source
ortholog
Figure 4.5: Phylogenetic profile of Rab11/25 effectors—Phylogenetic pro-
file of the currently published Rab11/25 effectors (see Figure 4.4) in all
species covered by the sequences analysed in Figures 4.1 and 4.2. When-
ever no BBH is found, it is checked whether an ortholog is annotated in En-
sembl Compara [43] (see Subsection 4.4.4 for details on BBHs and orthologs).
Abbreviation: Bidirectional Best Hit (BBH)
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tional effects of a reduction, for example reduced cross-talk with Rab11
also suggested in reference [27] (see also the discussion about loss of in-
teractions in Subsection 1.2.1) or the resulting higher specificity of Rab25
to its other effectors. Obviously, these speculations are only warranted
if our interpretations of the structural data we present in Figure 4.6 are
validated.
In summary, we confirm the central prediction of the effector switching
model that the gain of a new Rab25-specific effector had a beneficial func-
tional effect and therefore represents at least part of the mechanism by
which Rab25 evolved a new function. Although no structural data on lost
effectors is available, tinkering with the strength of conserved interactions
may also be part of this mechanism.
Alternative modes of Rab25 functional evolution
The above data supports our hypothesis of effector switching as a mech-
anism for neofunctionalisation. However, other non-exclusive modes of
functional evolution may also contribute the the overall process of neofunc-
tionalisation. At least three possibilities are supported by the available
functional information on Rab25.
First, as discussed in Subsection 1.2.1 every protein functions in a
cellular context primarily defined by its intracellular localisation, which
determines for example which other proteins it can interact with. Hence,
altering the localisation of a protein represents an interesting mechanism
to evolve function [45, 46]. The Rab11 effector PI4KB has been shown to
be sufficient for the localisation of Rab11 to the Golgi [41]. While there
is no definite negative evidence, it is likely that Rab25 lost the ability to
interact with PI4KB (see Figure 4.4). Hence, this would have resulted also
in loss of Rab25 localisation to the Golgi, which unlike Rab11 is indeed
exclusively found at recycling endosomes. Effector switching can thus
indirectly explain other aspects of functional evolution in Rabs such as
189
3.8Å
β2
Fip3
Rab11a
Rab25
/
Figure 4.6: Putative structural basis for reduced affinity of Rab25 to FIP3
compared to Rab11 —Rab25 loses a potentially critical van der Waals inter-
action between an Alanine (residue 50 in Figure 4.2) and a Valine in FIP3
by replacement with a Serine (residues with side-chains shown in stick rep-
resentation). The interaction stabilises the C-terminal helical element of
the Rab-binding domain of FIP3 (region in front after the turn, before the
highlighted Valine residue) that forms a hook-like structure. Rab11 inter-
acting with FIP3 [25] and Rab25 (interacting with FIP2, only the Rab shown
[27]) have been overlaid without additional structural modelling (RMSD of
superposition 0.484). Measurement between Rab11 Alanine and FIP3 Valine
reveals ideal distance for van der Waals interaction. The interaction and
its loss is additionally corroborated by the destabilisation of the interaction
upon A50S replacement in Rab11 predicted to be 0.71 ∆∆GBind (kcal/mol)
which is in agreement with loss of one van der Waals interaction (computa-
tion by BeAtMuSiC (version 1.0) [44]). Overlay, measurment and graphical
representation have been done in PyMOL. PDB accessions: 3TSO (human
Rab25), 2D7C (human Rab11, FIP3). Abbreviations: root mean square devi-
ation (RMSD)
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relocalisation.
Second, Rabs are part of complex networks that regulate the Rab itself
via the action of GAPs and GEFs and couples them to other compartments,
pathways and corresponding Rabs by what has been coined Rab cascades
(see [47] for review). It appears natural that changing the interactions with
these regulatory proteins affects the function of a Rab. Indeed, one of the
few known regulators of Rab11, the GAP Ecotropic viral integration site 5
protein homolog (EVI5), does not interact with Rab25 [48, 49]. Hence, loss
of the interaction with EVI5 may have provided a mechanism for functional
evolution of Rab25 by allowing for a Rab11-independent regulation. Fur-
thermore, several Rab11 effectors are known to be GEFs for other Rabs:
RAB3IP/RABIN8 for Rab8 [50], RAB3IL1/GRAB for Rab8 [51] and Rab3a
[52], and RAB6IP1/DENND5A for Rab39 [53]. At least RAB3IP/RABIN8 and
RAB3IL1/GRAB are known not to interact with Rab25 (see Figure 4.4),
and loss of these interactions therefore abolished cross-talk with Rab8
and 3a and their pathways. As a result, Rab25 was freed from regulatory
constraints. Hence, a more general version of the effector switching model
also covering the interactions with regulatory proteins accounts for an even
greater mechanistic diversity involved in the evolution of Rab function.
Third, as already mentioned several times Rab25 has lost expression
in all but epithelial cells compared to the ubiquitous expression profile
of Rab11. Figure 2.8 shows that increasing tissue-specificity is a general
phenomenon observed for all Metazoan-specific Rab subfamilies [8]. Hence,
a sharpening expression profile represents another dimension of functional
evolution well supported in the case of Rab25.
In conclusion, the above examples emphasise that besides the bio-
chemical level we focus on with our effector switching model, neofunction-
alisation also has a cell biological (localisation) and physiological (tissue
specificity) dimension. Moreover, these different levels can be linked in
non-trivial ways, as exemplified by localisation and regulatory coupling
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which are achieved by the interaction with effector proteins.
4.2.3 Rab25 function evolved even long after duplication
A distinct question from the actual mechanism by which function evolved
is to ask about the temporal dynamics of this process. In the case of
Rabs, this is particularly interesting as the general consensus states that
Rab function is stable even over long evolutionary time periods. The ques-
tion to what extent this is indeed the case becomes relevant for example to
interpret the bioinformatic annotation of the Rab family in new species:
in Chapter 2, we argue that classifying a Rab sequence is a strong func-
tional statement ultimately even allowing to infer the presence of entire
compartments and pathways. The availability of functional information
on various model organisms allows to detail the temporal dynamics of
the evolution of function in Rab25. Concretely, we ask if the function of
Rab25 is the same in zebrafish and mammals. As can be seen for example
from the tree in Figure 4.1, the fish clade is the first one to branch off
and therefore comprises the Rab25 proteins in our dataset that evolved
independently from the mammalian Rab25 for the longest time.
Our approach is to consider two aspects of Rab25 function: the inter-
action with ITGB1 and the pattern of tissue specificity. In order to assess
how likely it is that zebrafish Rab25 interacts with ITGB1, we compared
the C-terminal region which we know harbours the binding site for ITGB1
in mammals [28]. As shown in Figure 4.7a, the termini have highly di-
verged between zebrafish and mammals. They share only around 30%
sequence identity and two indels have occurred. Hence, it is possible that
the binding site evolved later and zebrafish Rab25 does not interact with
ITGB1. We agree that this indirect experiment has limited power, amongst
others because binding sites in unstructured regions are generally less con-
strained and conserved [54]. Secondly, we compared the tissue-specificity
of Rab25 in zebrafish and mammals represented by mouse and human.
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Figure 4.7b summarises data indicating that the loss of Rab25 expres-
sion in heart observed in mammals occurred after the branching of the
fish clade. Again, there may be alternative explanations for this pattern
as epithelial expression is not directly assessed. Yet, both experiments
suggest the hypothesis that Rab25 functions differently in zebrafish and
mammals.
In conclusion, Rab25 function may have evolved for a period largely
extending beyond the time shortly after duplication. This agrees with
the relatively long Rab25 branch highlighted in Figure 4.2 which sug-
gests continuous sequence divergence before the appearance of mammals.
Hence, Rab function at least in non-ancestral subfamilies is more dynamic
than suggested previously for example by successful rescue experiments
between mouse and yeast [59], and may differ qualitatively between or-
ganisms. Bioinformatic annotations can therefore only be interpreted as
rough functional statements.
4.3 Conclusion
In this chapter, we have asked about the mechanisms by which new func-
tions evolve in the context of gene duplication. We used Rab11 and 25
as a model system, which we demonstrate evolved by neofunctionalisa-
tion. We suggested a model of effector switching (summarised in Figure
4.8) which is able to account for the evolutionary patterns we observe in
Rab25. Furthermore, we found that this process took place in a time win-
dow extending far beyond the actual gene duplication that gave rise to
Rab25.
Rabs show an interesting behaviour with respect to the evolution of
their function: on one hand, mainly ancestral Rabs but also for example
Rab25 in mammals are highly constrained, i.e. subject to strong purifying
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Figure 4.7: Zebrafish and mammalian Rab25 may have different func-
tions—(A) Multiple sequence alignment of the C-terminal tail of Rab25 se-
quences in zebrafish, mouse, and human, generated with PRANK [55], colour
and graphical representation by Jalview [56]. (B) Expression of Rab25 in
various tissues in zebrafish, mouse, and human. Rab11 and 25 expression
in mouse assessed by PCR, data replicated from Figure 2.8 [8]. Protein ex-
pression in humans obtained from the Human Protein Atlas [57] (accession
ENSG00000132698). Zebrafish expression from GEO profiles [58], accessions:
heart (32317921, 66454322), liver (11990612), brain (35418821). No data found
on zebrafish lung, spleen, kidney (indicated by white question marks). The
red cross indicates the parsimonious inference of when expression in heart
has been lost.
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Figure 4.8: The effector switching model for Rab neofunctionalisation—
On top, the classical neofunctionalisation model [6] is shown including an
intermediate state between the old and new gene. Below, the proposed
biochemical mechanism for the evolution of a new function is detailed. New
Rab functions evolve by replacements of residues (small circles) that alter
interaction interfaces and ultimately lead to the loss and gain of effectors.
In agreement with the neofunctionalisation model, this process is driven by
positive selection (red circles). Blue and green stand for distinct functions.
The intermediate state included in the above panel represents the possibility
that new Rab functions evolve over an extended period of time starting with
reduction of affinity to existing effectors without having evolved interaction
interfaces to new effectors yet (compare Figures 4.6 and 4.7).
selection, and barely diverge in sequence and function over long periods of
time. On the other hand, Rabs duplicate and neofunctionalise frequently,
resulting in a gene family that roughly tripled its size at least in Meta-
zoan evolution [8]. This represents a striking contrast: functional stasis
on one side and a dynamic family with great innovatory potential on the
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other. An interesting argument made in the context of Hox genes may
be able to resolve this apparent conflict. Due to the strong constraints,
Rabs are not evolvable. Duplications temporarily lift these constraints on
one copy, creating a “window of opportunity” in which the dramatically
increased innovatory potential can be exploited given the right ecological
and developmental conditions [60]. Moreover, as we reviewed in Chapter 1
forming new interactions may not require a lot of mutations which would
allow Rabs to functionally evolve rather easily. This argument opens a
promising avenue for future work on Rabs, namely to investigate possible
agents of selection that link Rab evolution and its impact on intracellular
organisation to the historical ecological and developmental context.
In conclusion, we have presented an integrated evolutionary and bio-
chemical model for neofunctionalisation, addressing both the complemen-
tary aspects of emergence of new genes and new functions. While we
focussed on Rabs, we believe that effector switching provides a promising
basis for a more general model especially well suited for the attractive and
important class of master regulators. These proteins are expected nearly
by definition to exert their function via the interaction with numerous
partners, an archetypical functional paradigm also followed by Rabs. Fu-
ture work will therefore focus on different families of master regulators
with aim to confirm and generalise the model corroborated here for Rabs
only.
4.4 Materials and Methods
4.4.1 Alignment and gene tree
The protein sequences corresponding to the accessions listed in Table
4.1 were multiply aligned with PRANK [61] and a preliminary gene tree
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generated with PhyML [62]. The resulting tree clearly showed three well
supported clades corresponding to Rab11a, Rab11b and Rab25. Each of
these clades was manually reconciled based on the species tree provided
by Ensembl [63] (shown as part of Figure 4.5). The branch lengths of the
reconciled gene tree were obtained on the fixed reconciled topology with
PhyML. Next, the multiple sequence alignment (MSA) was recomputed
with PRANK providing the reconciled gene tree as input. Lastly, the re-
sulting MSA was trimmed using ZORRO [64] with standard parameters and
providing the reconciled gene tree as input.
4.4.2 Ancestral sequence reconstruction
First, the protein alignments described above were translated into codon
alignments with Pal2Nal [65]. Then, ancestral sequences were reconstructed
on these and the reconciled gene tree also described in Subsection 4.4.1 us-
ing PAML (version 4.6) [66] under a branch-site model. The entire branch
from the initial duplication to the extant human Rab25 sequence was
marked as foreground (highlighted in red in Figure 4.1), i.e. allowed to
evolve with ω (defined as the nonsynonymous to synonymous substitution
rate ratio) greater than one.
4.4.3 Past episodic positive selection
The presence of sites that evolved under positive selection in the fore-
ground branches was tested using the standard Branch-Site Test of Pos-
itive Selection [67, 68] as implemented by PAML (version 4.6) [66]. The
likelihood ratio test (LRT) was considered significant when above 2.71 cor-
responding to p < 0.05. In case of a significant test, the putative sites
were obtained by Bayes Empirical Bayes [69]. We used a relatively low
threshold, 0.7, where usually 0.95 is common. However, we tested all
intervals defined by every pairwise choice of branch labeled by 1 − 6 in
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Figure 4.2 as foreground and therefore expect to exclude potential false
positives by only considering sites that are above the likelihood threshold
of 0.7 in more than one case. We note that we failed to apply a multiple
testing correction for the LRT, however, we do not expect this to influence
our results. Nonetheless, future versions will include the correct procedure
advised in reference [70].
In each case, the reconciled topology was used as input rather than
a common maximum likelihood tree. Branch lengths are estimated by
PAML. This choice follows from the experiments presented in Chapter 3
suggesting that tree quality is a critical parameter for the inference of sites
that evolved under episodic positive selection.
4.4.4 Bidirectional Best Hits and orthologs
Bidirectional Best Hits (BBHs) are computed with Blast [71] (e-value
threshold 10−3) respecting two additional constraints defined by the IN-
PARANOID project [72]: coverage, i.e. 50% of the residues must be covered
by the local alignment, and overlap, meaning that 25% of the residues
must be aligned [73]. Additionally, in case of zero e-values all hits are
kept, meaning that one-to-many and even many-to-many relationships
are possible although the intuitive definition of BBHs seems to exclude
this possibility. Orthologs from Ensembl Compara [43] are obtained by
retrieving pairs of leaves whose last common ancestor in the gene trees is
marked as a speciation event.
4.A Supplementary tables
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Table 4.1: List of Rab11 and Rab25 sequences used in phylogenetic analy-
sis.—The initial annotations of Rab sequences were generated by the Rabifier
(see Chapter 2) [8] on full genomes downloaded from the Ensembl (version
70) [63] and Ensembl Genomes (version 17) [74] databases. Apparently trun-
cated sequences and other outliers visually identified in the multiple sequence
alignment and through long branches in the gene tree (see Subsection 4.4.1)
were removed.
Ensembl accession species Rab subfamily
ENSOCUT00000005636 Oryctolagus cuniculus Rab25
ENSXETT00000054294 Xenopus tropicalis Rab11
ENSSSCT00000007117 Sus scrofa Rab25
ENSSTOT00000015254 Ictidomys tridecemlineatus Rab11
ENSLACT00000019294 Latimeria chalumnae Rab11
ENSMODT00000004807 Monodelphis domestica Rab11
ENSSSCT00000024720 Sus scrofa Rab11
ENSTRUT00000026540 Takifugu rubripes Rab11
ENSPTRT00000045045 Pan troglodytes Rab25
ENSSHAT00000007680 Sarcophilus harrisii Rab11
ENSAMET00000015643 Ailuropoda melanoleuca Rab25
ENSCINT00000023970 Ciona intestinalis Rab11
ENSORLT00000019146 Oryzias latipes Rab11
ENSCAFT00000048184 Canis familiaris Rab11
ENSMMUT00000031379 Macaca mulatta Rab25
ENSORLT00000022954 Oryzias latipes Rab11
ENSXETT00000044022 Xenopus tropicalis Rab25
ENSLACT00000012758 Latimeria chalumnae Rab25
ENSGACT00000017553 Gasterosteus aculeatus Rab25
ENSGACT00000020470 Gasterosteus aculeatus Rab11
ENSPPYT00000007758 Pongo abelii Rab11
ENSPSIT00000011394 Pelodiscus sinensis Rab11
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Ensembl accession species Rab subfamily
ENSTGUT00000003823 Taeniopygia guttata Rab25
ENSTRUT00000000486 Takifugu rubripes Rab11
ENST00000261890 Homo sapiens Rab11
ENSTRUT00000046937 Takifugu rubripes Rab11
ENSGGOT00000014301 Gorilla gorilla Rab11
ENSPMAT00000010308 Petromyzon marinus Rab11
ENSBTAT00000003206 Bos taurus Rab11
ENSRNOT00000010197 Rattus norvegicus Rab11
ENSOPRT00000004669 Ochotona princeps Rab11
ENSAMET00000005460 Ailuropoda melanoleuca Rab11
ENSTGUT00000000085 Taeniopygia guttata Rab11
ENSMUST00000172298 Mus musculus Rab11
ENSCPOT00000006527 Cavia porcellus Rab11
ENSSHAT00000015768 Sarcophilus harrisii Rab25
ENSLACT00000013937 Latimeria chalumnae Rab11
ENSSTOT00000008074 Ictidomys tridecemlineatus Rab11
ENSBTAT00000025235 Bos taurus Rab11
ENSXETT00000014541 Xenopus tropicalis Rab11
ENSTRUT00000046916 Takifugu rubripes Rab11
ENSGMOT00000008127 Gadus morhua Rab11
ENSORLT00000019171 Oryzias latipes Rab11
ENSLAFT00000011417 Loxodonta africana Rab11
ENSFCAT00000015220 Felis catus Rab11
ENST00000361084 Homo sapiens Rab25
ENSFCAT00000025321 Felis catus Rab11
ENSOCUT00000014754 Oryctolagus cuniculus Rab11
ENSCPOT00000028204 Cavia porcellus Rab11
ENSSTOT00000000636 Ictidomys tridecemlineatus Rab25
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Ensembl accession species Rab subfamily
ENSPTRT00000019157 Pan troglodytes Rab11
ENSNLET00000002364 Nomascus leucogenys Rab11
ENSCJAT00000015098 Callithrix jacchus Rab25
ENSOPRT00000002901 Ochotona princeps Rab25
ENSGMOT00000010104 Gadus morhua Rab11
ENSPSIT00000014617 Pelodiscus sinensis Rab25
ENSRNOT00000015598 Rattus norvegicus Rab11
ENSPPYT00000011079 Pongo abelii Rab11
ENSMMUT00000011193 Macaca mulatta Rab11
ENSLAFT00000013596 Loxodonta africana Rab11
ENSPTRT00000013265 Pan troglodytes Rab11
ENSFCAT00000011777 Felis catus Rab25
ENSPSIT00000013351 Pelodiscus sinensis Rab11
ENSMUST00000057373 Mus musculus Rab11
ENSAMET00000003419 Ailuropoda melanoleuca Rab11
ENSSHAT00000007917 Sarcophilus harrisii Rab11
ENSNLET00000016408 Nomascus leucogenys Rab11
ENSGACT00000006586 Gasterosteus aculeatus Rab25
ENSMMUT00000014295 Macaca mulatta Rab11
ENSGMOT00000004555 Gadus morhua Rab11
ENSPPYT00000000878 Pongo abelii Rab25
ENSOGAT00000007646 Otolemur garnettii Rab11
ENSCAFT00000026699 Canis familiaris Rab25
ENSORLT00000020191 Oryzias latipes Rab25
ENSOGAT00000016959 Otolemur garnettii Rab25
ENSGGOT00000014564 Gorilla gorilla Rab11
ENSRNOT00000032355 Rattus norvegicus Rab25
ENST00000328024 Homo sapiens Rab11
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Ensembl accession species Rab subfamily
ENSGGOT00000006848 Gorilla gorilla Rab25
ENSGACT00000017634 Gasterosteus aculeatus Rab11
ENSCJAT00000014411 Callithrix jacchus Rab11
ENSCAFT00000027321 Canis familiaris Rab11
ENSOGAT00000003230 Otolemur garnettii Rab11
ENSMUST00000008745 Mus musculus Rab25
ENSORLT00000015209 Oryzias latipes Rab25
ENSMODT00000012486 Monodelphis domestica Rab11
ENSSSCT00000014854 Sus scrofa Rab11
ENSBTAT00000025170 Bos taurus Rab25
ENSTGUT00000009676 Taeniopygia guttata Rab11
ENSMODT00000021525 Monodelphis domestica Rab25
ENSLAFT00000009222 Loxodonta africana Rab25
ENSNLET00000015706 Nomascus leucogenys Rab25
ENSTRUT00000018665 Takifugu rubripes Rab25
ENSTRUT00000037427 Takifugu rubripes Rab25
ENSCPOT00000002505 Cavia porcellus Rab25
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Chapter 5
Conclusion
“Nothing retains the form that seems its own, and Na-
ture, the renewer of all things, continually changes every
form into some other shape.” [1, book XV, verse 252]
—Ovid, 8AD
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H ow does protein function evolve? This is the fundamental questionwe have asked in this thesis, using the Rab family of small GTPases
as a model system.
We began most generally in Chapter 1 by charting the phenotypic
space of protein function and reviewing some previous work on the evolu-
tionary dynamics of proteins through that space. We distinguished three
levels, genetics, biochemistry and evolution, all of which are pertinent to
the question how protein function evolves. They cover distinct but re-
lated aspects of the phenomenon. We focussed our discussion around the
biochemical level, as protein function itself is commonly receiving least at-
tention in studies on protein evolution. At the same time, the “function”
of a protein at the level of biochemistry is less complex and interconnected
than at higher levels of biological organisation like the cell or the multi-
cellular organism. Therefore, biochemistry represents a natural starting
point to integrate function and evolution [2, 3]. At the end of Chapter
1, we introduced the Rab family of small GTPases as a promising model
system to contribute to the understanding of the evolution of function.
However, while the rest of the thesis focusses on Rabs, the scope of our
conclusions are broader.
Evolution is dynamic, and understanding dynamics requires compar-
ing. Comparative approaches in Biology have a long tradition, and start
with a simple question: “what is there?”. We therefore began our anal-
ysis of the evolution of function in Rabs by establishing the patterns of
Rab evolution. Doing so posed the first challenge, how to identify and
classify Rabs in the many—with exception of some model organisms—
incomplete, badly annotated and constantly updated genomes. We solved
this problem in Chapter 2 by designing a bioinformatic tool dedicated to
the detection and annotation of Rabs in whole genomes that we coined
the Rabifier. While ‘annotation’ may seem a rather prosaic preoccupa-
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tion to most including myself, all following analyses are dependent on the
quality of the data set of Rabs. The Rabifier thus remains an apt solution
to an important problem and a major deliverable of this thesis. At the
end of Chapter 2 stands a map of the Rab universe, and emerging from
it the old model of neofunctionalisation [4] as the new hypothesis about
the dominant process of functional evolution in Rabs. To a ‘Rabologist’,
this is no striking news, as the ongoing functional characterisation since
the early 1980’s continuously expands the functional repertoire of the Rab
family and thus leaves little doubt that new functions must have evolved
at some point. However, it is the process itself that is interesting in the
context of this thesis, and less so its precise functional outcome.
Even more than for the comparative study of pattern, analysing an evo-
lutionary process can only be done in the context of a phylogeny [5]. Rabs
however turn out to be a challenging family for phylogenetic methods.
Their sequences are short and consist nearly exclusively of very conserved
or highly divergent parts. As a result, Rabs carry little phylogenetic in-
formation that can be exploited for gene tree inference. Yet, a gene tree is
strictly required for example to verify one of the central predictions of the
neofunctionalisation model, that divergence in sequence and function is
driven by positive selection. This problem motivated the work presented
in Chapter 3. While the effects of various factors relating to sequences
and alignments on the standard approach to test for past positive selec-
tion have been recognised and studied, the gene tree had so far received
no attention and it remained unclear if tree topology is important at all.
Motivated by the expectation of topologically erroneous trees for Rabs
and the need to detect selection, we therefore tested if the gene tree has
any impact at all on the quality of the inference of sites under positive
selection. Using simulated sequences, we indeed found a negative effect
of erroneous gene trees. Because this result is based on simulations, it is
not specific to Rabs and holds for any protein family. As a consequence
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of the findings in Chapter 3, the following phylogenetic experiments were
all performed based on a manually reconciled tree topology. While we
did not show that reconciled trees are better, in the case of Rabs we ex-
pect them to more adequately reflect the true historical gene divergence
patterns than trees inferred for example by Maximum Likelihood.
Finally, Chapter 4 addresses the core issue, the biochemical mechanism
behind neofunctionalisation. The latter had been found to describe the
evolution of the Rab family in Chapter 2. Our approach is that of classical
hypothesis testing. Based on the review of some of what is known about
the evolution of function and in particular of the biochemistry and cell
biology of Rab function in Chapter 1, we propose and test a model we
coin ‘effector switching’. The reasoning is straight-forward. The most fre-
quent evolutionary mechanism to evolve function is altering interactions,
and Rabs are known to mediate their function by interaction with effectors
that are recruited to the membranous compartments. Hence, we suggest
that Rabs evolve by altering their set of effectors. We test our hypothesis
by successfully verifying three predictions of effector switching for a repre-
sentative pair of Rab subfamilies, Rab11 and 25. Furthermore, we discuss
extensions of the simple model restricted to interactions with effectors:
some effectors determine Rab subcellular localisation, other interactions
have regulatory roles for the Rab itself and others, and finally restriction
of expression profiles to certain tissues provide additional mechanisms for
the evolution of function at the level of Rab biochemistry, cell biology
and physiology. In conclusion, Chapter 4 begins to answer how protein
function evolves in Rabs, putting forth a basic but general mechanistic
scaffold that can easily be extended to account for additional more spe-
cific phenomena.
Concluding, what have we learned about the evolution of function?
By our choice of model system, we have focussed on proteins that func-
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tion as master regulators, and our contribution is thus most relevant to
proteins following this functional paradigm. First, master regulators are
commonly subject to strong evolutionary constraints, and gene duplication
is therefore expected to play an important role in the functional evolution
of this class of proteins. After duplication, the former strength of these
constraints is no more inversely related to innovatory potential or evolv-
ability. Second, almost by definition master regulators have to interact
with numerous partners to exert the high-level control of cellular and or-
ganismal processes. Loss of some of these interactions and gain of others
therefore represents a general mechanism for the evolution of function in
these proteins.
5.1 Outlook
The work presented here will continue in three different ways. First and
as an immediate goal, several technical aspects can be improved. This
most importantly concerns the Rabifier. The initial design of the Rabifier
was facing the classical tradeoff in algorithm and tool design: speed ver-
sus accuracy. While bioinformatic approaches are generally less accurate,
they are much faster. On the other hand, phylogenetic tools are believed
to be more accurate but do generally not scale well to data sets containing
more than a hundred sequences. The underlying difference is that phylo-
genetic tools implement an explicit model of sequence evolution, usually
taking the form of a continuous-time Markov process branching over a
tree. While this means that computationally expensive operations like
matrix inversions become necessary, bioinformatic tools are based most of
the time on efficient pattern-matching algorithms on sequences that rarely
exceed quadratic running time complexity. Several developments in recent
years open new avenues and offer a way forward. Most importantly, these
include phylogenetic tools that are based to a large extent on precomputed
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results. In the context of the Rabifier, ‘phylogenetic sequence placement’
as implemented by PAGAN [6] is particularly interesting. Given a precom-
puted multiple sequence alignment and tree, new sequences are placed
considering phylogenetic relatedness and added to the precomputed align-
ment and tree without need to recompute them. Therefore, this hybrid
approach provides a potentially accurate way to classify a sequence as part
of a subfamily represented by a clade in a phylogenetic tree without sac-
rificing speed. The implementation of this and other minor improvements
is planned as part of a Rabifier version 2.
Second, a mid-term goal is to apply the model for evolution of func-
tion presented here in a predictive manner. While we tested several conse-
quences of ‘effector switching’ on existing data in Chapter 4 and failed to
disproof it, the ultimate demonstration of usefulness and a great boost in
confidence about its adequacy is to be gained from predicting yet unknown
aspects of Rab function and confirm those experimentally. A promising
pair of Rabs is Rab6 and 41: Rab41 is the evolutionarily most recent
addition to the Rab family in humans [7] and very little is known about
this protein. Since its identification [8], we are only aware of one dedi-
cated functional study on Rab41 [9]. Starting from known Rab6 effectors
and regulators, predicting residues that show signs of positive selection in
Rab41 may generate hypotheses about the loss and gain of interactions.
However, new types of experiments potentially including explicit struc-
tural modelling may become necessary to grant enough confidence in the
predictions and justify the investment into experimental validation. A
different way forward is to focus on protein families other than Rabs. As
already discussed above, we believe that effector switching is be a general
model applicable to other master regulators. The ability to understand
and predict the evolution of function in other proteins would underline
the value of our contribution.
Third, the most exciting goal is to use Rabs as markers to bridge
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levels and inquire into the evolution of the Endomembrane System and
cellular organisation per se. This is surely most ambitious and there-
fore a long-term goal, potentially requiring to integrate the evolutionary
analysis of other important gene families involved in vesicular trafficking
such as SNAREs. However, a small step in that direction has already been
made in Chapter 2: analysing the expansion of the Rab family at the base
of Metazoa and mapping the new Rabs into their functional categories
suggested that regulated secretion greatly diversified and complexified in
animal evolution. Another interesting suggestion is the extrapolation of
the mode of gene evolution to organelle evolution: the organelle paral-
ogy model proposes that new organelles evolve by a process equivalent
to duplication-divergence of genes [10]. The great challenge now is to go
beyond these correlations, and design models and experiments that are
able to contribute to a mechanistic understanding of cellular evolution. In
other words, Rabs may be have the potential to be founding members of
a new evolutionary cell biology.
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Summary
“Es ist schon alles gesagt, nur noch nicht von allen.”
(‘Everything has been said, but not yet by everyone.’)
—Karl Valentin
vi
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Summary
W hy does a protein function the way it does? The question provokesdifferent answers. For example, one could invoke the biochemistry
of the protein, the cellular network it is part of, the evolutionary forces that
shaped the sequence or its importance for organismal survival. The type of
reply will most likely depend on who is asked: a biochemist or cell biologist
may be inclined to answer in terms of the first two possibilities, whereas
an evolutionary biologist probably prefers the latter two. It is clear that
all interpretations are correct, the difference merely reflects the focus of
biological disciplines on distinct causes of a biological phenomenon. Each
of the aspects are important and may be studied independently, yet, all
are required for a complete understanding [1].
The appeal of the above reasoning has long been recognised, but actual
examples of research integrating multiple disciplines and causes of a phe-
nomenon are still underrepresented. This has at least two reasons: first,
the undeniable success that biology had so far studying causes of biolog-
ical phenomena in isolation, and more pragmatically, the broad expertise
required to bridge the highly intricate and specialised disciplines. How-
ever, research programmes are now settling into mainstream that stress
the mutual benefit and unique value of integrative approaches, such as
evolutionary biochemistry [2] and evolutionary cell biology [3] which have
been identified as part of a larger “functional synthesis” [4]. The times
seem promising for such a synthesis: not only have innovative formal and
experimental strategies contributed to form its methodological founda-
tion, but the general availability and burgeoning of public molecular data
greatly facilitate research bridging the disciplines.
Here, I follow the functional synthesis and ask a question that falls
squarely between the disciplines: how does protein function evolve?
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The question of how function evolves is a founding theme of an en-
tire discipline, evolutionary physiology, one of the earliest formulations
of an integrative research programme [5, 6]. More recently, the question
is also gaining fundamental importance for functional genomics. Due to
the ever-growing throughput of genome sequencing, the bottleneck shifted
from data gathering to its functional annotation. The predominant strat-
egy for functional annotation is transfer of existing annotations applying
the “guilt by association” principle [7]. However, this is becoming insuf-
ficient mostly due to the fact that by definition ‘transfer’ cannot predict
true functional novelty, and as a result the fraction of uncharacterised
genes grows [8]. A deeper understanding of how function evolves has the
potential to assist and guide functional genomic efforts.
In this thesis, I focus on the Rab family of small GTPases as a model
system. Rabs are an essential family of master regulators of vesicular
trafficking in eukaryotes, the largest family within the Ras superfamily of
small GTPases. In human, there are more than 60 Rab genes that fall into
roughly 45 subfamilies, each of which reside on characteristic organelles
and their respective vesicles and regulate the distinct steps of vesicular
trafficking, i.e. cargo selection, budding, scission, transport, tethering and
fusion. Rabs function as molecular switches that cycle between a GTP-
bound ‘on’, and GDP-bound ‘off’ state. In their GTP-bound state, they
recruit a set of effectors that usually exert a function, for example the
Retromer complex [9], members of all classes of molecular motors [10] or
the Exocyst complex [11]. Rab sequences are usually well conserved but for
the two so-called hypervariable termini that significantly diverged between
different Rab subfamilies.
Rabs are in many ways well suited to ask questions about the evolution
of function. They are an essential family and therefore found in all eukary-
otes sequenced so far providing an abundance of sequence data to work
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with. Due to their importance, they have been extensively characterised
and a rich body of experimental studies and data is publicly available. In
general, Rab function shows impressive stability throughout evolution, for
example, the mouse Rab1 is still able to rescue a Rab1 knockout in yeast
[12]. Even without ability to rescue, orthologous Rabs have usually been
found to perform equivalent functions at corresponding compartments in
all eukaryotes. In contrast to the functional stasis, the composition and
size of the family greatly varies throughout the eukaryotic tree of life,
implying the existence of numerous lineage-specific gene losses and dupli-
cations and therefore potentially interesting functional changes. For these
reasons, the evolution of Rab function mostly becomes a question of how
Rabs evolve after gene duplication, for which classical evolutionary models
exist [13]. Lastly, Rabs function by transient protein-protein interactions
with numerous effectors, which may be archetypical for master-regulators.
To the best of my knowledge, this can be considered a different ‘functional
paradigm’ than most of the proteins that have been studied so far with
respect to their functional evolution. These include for example histori-
cally well-studied proteins like haemoglobins [14] and Cytochrome c [15],
proteins that are characterised by exquisite affinity to a specific ligand like
metabolic enzymes [16, 17] or hormone receptors [18, 19], but also tran-
scription factors [20, 21] that possibly come closest to Rabs in the way
they function.
I divide the question how Rab function evolves in two parts and present
the results separately: after reviewing the relevant literature on Rab func-
tion in the introductory Chapter 1, I describe the patterns of Rab family
evolution in Chapter 2. Based on these observations, I infer the evolu-
tionary processes that may have generated the observed patterns in the
second part consisting of Chapters 3 and 4.
Chapter 2 tackles the bioinformatic problem of large scale annotation
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of the Rab family across all sequenced eukaryotic genomes. Annotating
Rabs has been a laborious manual task because of the high similarity
amongst all members of the Ras-superfamily of small GTPases and the
lack of a well-annotated reference set of Rabs to transfer annotations. I
develope, validate and benchmarke the ‘Rabifier’, an automated bioin-
formatic pipeline for the identification and classification of Rabs, which
achieves up to 90% classification accuracy. I cataloge roughly 8.000 Rabs
from 247 genomes covering the entire eukaryotic tree. The full Rab
database and a web tool implementing the pipeline are publicly available
at www.RabDB.org. For the first time, I describe and analyse the evolu-
tion of Rabs in a dataset covering the whole eukaryotic phylogeny. I find a
highly dynamic family undergoing frequent taxon-specific expansions and
losses. I date the origin of human subfamilies using phylogenetic profil-
ing, which enlarges the Rab repertoire of the Last Eukaryotic Common
Ancestor to additionally include Rab14, 32 and RabL4. Furthermore, a
functional survey of the Choanoflagellate Monosiga brevicollis Rab fam-
ily pinpoints the changes that accompanied the emergence of Metazoan
multicellularity, mainly an important expansion and specialisation of the
secretory pathway. Lastly, I establish tissue specificity in expression of
mouse Rabs using public microarray data. I conclude by hypothesising
that neofunctionalisation (rather than the alternative dosage- and sub-
functionalisation models) best explains the emergence of new human Rab
subfamilies. Neofunctionalisation predicts that one copy remains func-
tionally unaltered, while the other copy accumulates mutations that are
going to bring about a new beneficial function which is going to be driven
to fixation by positive selection [22].
Chapter 3 addresses a technical problem resulting from verifying the
major prediction of the neofunctionalisation model: the past action of
positive selection on Rab, which is detected in a phylogenetic framework
based on gene trees. However, Rabs are particularly challenging for gene
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tree inference methods, as Rab sequences carry little phylogenetic signal
due to their shortness and structure consisting only of highly conserved
and highly divergent parts. I therefore begin by asserting if the gene tree
has any effect on the inference of positive selection at all. The Branch-Site
Test of Positive Selection [23, 24] is a standard approach to detect episodic
positive selection in a priori specified branches. In this chapter, I ask if
errors in the topology of the gene tree have any influence on its ability to
infer positively selected sites. Using simulated sequences, I compare the
results obtained for the true and erroneous topologies, and find a strong
linear effect on the ability to predict sites if the tree changes how long
sequences are inferred to have experienced selection. Moreover, I show by
reanalysing a previously published data set that the choice of gene tree
alters the results not only for simulated but also for actual sequences. This
is the first time a clear effect of the gene tree topology on the inference
of positive selection is demonstrated. I conclude that the gene tree is an
important factor for the branch-site analysis of positive selection that has
so far been overlooked. As a consequence, the following analyses are based
on manually curated Rab phylogenies.
Chapter 4 addresses the neofunctionalisation hypothesis put forth at
the end of Chapter 2 and finally answers how Rab function evolves. Ne-
ofunctionalisation is a classical model to explain the emergence of novel
gene functions. Its original emphasis was to propose a mechanism that
could account for a mutational path between two proteins that included
mutations disrupting the original function. The resulting problem why
those intermediates would not immediately be purged by purifying selec-
tion is elegantly solved by the redundancy introduced via gene duplication.
However, while the model solves the evolutionary problem, the biochemi-
cal or cell biological dimension of the problem is neglected, and thecrucial
functional challenge remains disguised as a tacit assumption: how can
mutations lead to a new function? Here, I address this question for Rab
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GTPases. First, I confirm based on public functional and sequence data
that the Rab family frequently expands by neofunctionalisation. I iden-
tify the interactions with effectors as the central aspect of Rab function,
and therefore hypothesise that Rabs gain new functions by changing their
set of effectors. I verify the necessary condition that related Rab sub-
families have overlapping sets of effectors by surveying the known effector
interactions. Finally, I focus on the vertebrate subfamily Rab25, which
evolved from a duplicated Rab11. In accordance with my hypothesis,
I discover signatures of selection in the binding interfaces of these two
Rab subfamilies. This suggests a scenario where shortly after duplication
Rab11-specific interactions are lost and new interfaces to Rab25-specific
effectors are formed and fixed by positive selection. Furthermore, I find
a trend at the organismal level to reduce the breadth of tissue expression
of new Rab subfamilies established concurrently with the alterations of
the set of effectors. These results open the functional “black box” of the
original neofunctionalisation model and showcase how mutations can lead
to new function. Rabs are a particularly relevant model system, as their
evolution is tightly linked to that of the eukaryotic cell itself due to their
central importance for the endomembrane system and intracellular organ-
isation in general.
The last chapter concludes by summarising the results and discussing
the implications of this case study for the evolution of function in general.
In particular, at least for Metazoan Rabs I find an interesting contrast
between functional stasis maintained by strong purifying selection on one
hand, and frequent duplications and neofunctionalisation on the other. It
is interesting to speculate that this observation is explained by the vast
interaction network Rabs are part of that renders any alteration disastrous
for the organism. However, that it is for the same reason that duplicates
easily form new interactions and therefore show the great potential for
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functional innovation that played its part in shaping the Metazoan cell as
we know it.
Resumo
Porque é que uma protéına funciona de uma determinada forma? Esta
pergunta suscita diferentes respostas. Por exemplo, poder-se-ia invocar
a sua estrutura bioqúımica, as vias celulares a que pertence, as forças
evolutivas que moldaram a sequência ou a sua importância para a sobre-
vivência do organismo. A resposta irá provavelmente depender de quem
for inquirido: um bioqúımico ou um biólogo celular estariam mais incli-
nados a considerar as duas primeiras possibilidades, enquanto um biólogo
evolucionista preferiria as duas últimas. Ambas as interpretações estariam
correctas, baseando-se, no entanto, no estudo de diferentes causas para o
mesmo fenómeno biológico. Cada um destes aspectos é importante e pode
ser estudado independentemente. No entanto, todos eles são necessários
para que haja um completo entendimento do problema [1].
A importância do argumento supramencionado foi há muito recon-
hecida. Contudo, estudos integrando múltiplas facetas e disciplinas estão
ainda sub-representados. Isto deve-se a pelo menos dois motivos: primeiro,
o sucesso inegável que a biologia tem tido a estudar as causas dos fenómenos
biológicos isoladamente; segundo, e mais pragmático, é o vasto conheci-
mento necessário para conectar disciplinas altamente complexas e espe-
cializadas. Não obstante, o crescente interesse em programas de inves-
tigação considerando abordagens integrativas realça o benef́ıcio mútuo e
valor único destas, como por exemplo, bioqúımica evolutiva [2] e biolo-
gia celular evolutiva [3], que foram apontadas como parte de uma grande
“śıntese funciona”’ [4]. O momento parece promissor para tal śıntese: não
só foram criadas estratégias inovadoras, teóricas e experimentais, que têm
contribúıdo para a sua base metodológica, mas também a maior disponi-
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bilidade e crescimento de dados moleculares publicamente acesśıveis têm
facilitado a conexão destas disciplinas.
Aqui, no seguimento da śıntese funcional, tenciono responder a uma
pergunta que se centraliza entre as disciplinas: como é que a função das
protéınas evolve? Esta questão é um tema fundador de toda uma disci-
plina, Fisiologia Evolutiva, pioneira na investigação integrativa e interdis-
ciplinar [5, 6]. Recentemente, esta questão tornou-se fundamental também
para a disciplina de Genómica Funcional. Devido aos avanços tecnológicos
na sequenciação genómica, o passo limitante passou da obtenção para a
anotação funcional de dados. A estratégia predominante para a anotação
funcional é a transferência da anotação já existente, aplicando o prinćıpio
de “culpa por associação” [7]. Mas este tem-se revelado insuficiente prin-
cipalmente porque, por definição, uma “transferência” não pode predi-
zer novas funções génicas, e como consequência, a fracção de genes não
caracterizados aumenta [8]. A compreensão aprofundada da evolução da
função proteica pode fornecer importantes pistas para a problemática da
Genómica Funcional.
Na presente tese, foquei-me nas protéınas Rab, uma famı́lia proteica
de pequenas GTPases, como um sistema-modelo. As protéınas Rab são
uma das principais famı́lias reguladoras do tráfego vesicular em eucar-
iotas, assim como a maior famı́lia dentro da superfamı́lia de pequenas
GTPases Ras. Existem, em humanos, mais de 60 genes Rab, categoriza-
dos em aproximadamente 45 subfamı́lias, cada uma localizada num deter-
minado organelo e respectivas veśıculas. Desta forma, as protéınas Rab
são responsáveis pela regulação das diferentes etapas do tráfego vesicular,
i.e., selecção da carga, budding, cisão, transporte, ancoramento e fusão
vesicular. As protéınas Rab funcionam como interruptores moleculares;
ligam-se a GDP ou GTP, adquirindo uma conformação inactiva ou activa,
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respectivamente. Quando se encontram ligadas a GTP, i.e. sob a forma
activa, recrutam conjuntos de moléculas efectoras, tais como o complexo
Retromer [9], vários membros de todas as classes de protéınas motoras
[10] ou o complexo Exocisto [11]. As sequências das protéınas Rab são
geralmente bem conservadas, à excepção de dois terminais hipervariáveis
que divergem significativamente entre as diferentes subfamı́lias de Rabs.
As protéınas Rab são, por diversos motivos, uma ferramenta adequada
para investigar a evolução da função proteica. Estas são uma famı́lia essen-
cial ao funcionamento celular e, desta forma, estão presentes em todos
os organismos eucariotas até agora sequenciados, fornecendo assim nu-
merosas sequências para análise. Devido à sua importância, as protéınas
Rab encontram-se extensamente caracterizadas, existindo um grande vol-
ume de dados e estudos experimentais acesśıveis publicamente. Em geral,
estas protéınas apresentam uma estabilidade evolutiva extraordinária. Por
exemplo, a Rab1 de ratinho é capaz de resgatar o fenótipo provocado
pelo knockout de Rab1 em levedura [12]. Mesmo não tendo prova experi-
mental desta capacidade de resgate para todas as Rabs, os ortólogos das
Rabs, na maioria das vezes, exercem funções equivalentes nos comparti-
mentos correspondentes em todos os organismos eucariotas. Opostamente
a esta imutabilidade funcional, a composição e tamanho da famı́lia varia
grandemente ao longo da árvore dos eucariotas, sugerindo a existência de
numerosas perdas e duplicações de genes e por isso potenciais alterações
interessantes a ńıvel funcional. Por estas razões, a evolução da função
nas protéınas Rab torna-se maioritariamente uma questão de como estas
evolvem após a sua duplicação, para a qual existem modelos evolutivos
clássicos [13]. Por último, as protéınas Rab estabelecem interacções tran-
sientes protéına-protéına com várias protéınas efectoras, que podem ser
o arquétipo do regulador mestre. Tanto quanto sei, este facto representa
um paradigma funcional diferente, quando comparado com a evolução fun-
cional da maior parte das protéınas já estudadas. Estas incluem, por ex-
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emplo: as famı́lias das hemoglobinas [14] e Cytochrome C [15], protéınas
que são caracterizadas pela sua afinidade a um ligando espećıfico como
as enzimas metabólicas [16, 17]; mas também factores de transcrição [20,
21] que possivelmente se mais se assemelham a Rabs no modo como fun-
cionam.
Este trabalho será composto por duas partes. Na primeira parte, farei
uma revisão da literatura relevante acerca da função das protéınas Rab,
no Caṕıtulo 1, e descrevo os padrões evolutivos desta famı́lia, no Caṕıtulo
2. A segunda parte consistirá na inferência dos processos evolutivos que
poderão ter originado os padrões observados (Caṕıtulos 3 e 4).
O caṕıtulo 2 aborda o problema bioinformático de anotação em larga
escala da famı́lia das protéınas Rab entre todos os genomas de organ-
ismos eucariotas sequenciados. A anotação das protéınas Rab foi uma
tarefa manual trabalhosa devido à elevada semelhança entre todos os
membros da superfamı́lia Ras de pequenas GTPases assim como devido
à ausência de um grupo-referência das protéınas Rab bem anotado para
proceder com a transferência de anotações. Eu desenvolvi, validei e fiz
o benchmark da pipeline bioinformática Rabifier, automatizada para a
identificação e classificação de protéınas Rab, que atinge até 90% de pre-
cisão. Adicionalmente, cataloguei cerca de 8.000 Rabs de 247 genomas,
abrangendo todas as famı́lias de organismos eucariotas. A base de da-
dos das protéınas Rab e a web tool implementada com a pipeline estão
publicamente acesśıveis em www.RabDB.org. Pela primeira vez, descrevi
e analisei a evolução das protéınas Rab utilizando um conjunto de da-
dos que engloba toda a filogenia eucariota. Assim, deparei-me com uma
famı́lia proteica extremamente dinâmica, que sofreu frequentes expansões
e perdas em táxon espećıficos. Estabeleci a datação da origem das sub-
famı́lias das protéınas Rab em humano baseando-me em perfis filogenéticos
que permitiram aumentar o repertório do último ancestral comum eucari-
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ota (Last Eukaryotic Common Ancestor) das protéınas Rab, adicionando
Rab14, Rab32 e RabL4. Além disso, uma análise funcional da famı́lia
proteica Rab presente no coanoflagelado Monosiga brevicollis exemplifica
precisamente as alterações que acompanharam o surgimento da multicelu-
laridade nos Metazoa, evidenciando uma forte expansão e especialização
da via secretora. Por último, estabeleci a especificidade da expressão das
protéınas Rab em diferentes tecidos de ratinho, utilizando dados públicos
de microarrays. Eu concluo com a hipótese de que a neofuncionalização
(em vez dos modelos alternativos de dosagem e subfuncionalização) ex-
plica melhor o surgimento de novas subfamı́lias de Rabs em humanos. O
modelo de neofuncionalização prediz que, após um evento de duplicação
génica, uma cópia permanece funcionalmente inalterada, enquanto que a
outra acumula mutações que irão resultar numa nova função. Caso esta
seja benéfica será fixada por selecção positiva [22].
No caṕıtulo 3 abordei um problema técnico que surgiu da verificação
das previsões do modelo de neofuncionalização: a acção da anterior se-
lecção positiva nas protéınas Rab que é detectada num enquadramento
filogenético baseado em árvores de genes. As protéınas Rab são um
desafio para os métodos de inferência de árvores de genes dado que as
suas sequências apresentam um fraco sinal filogenético, uma vez que são
protéınas pequenas e possuem uma estrutura que consiste em regiões muito
conservadas e regiões muito divergentes. Desta forma, comecei por ver-
ificar se a árvore de genes teria alguma influência na inferência de se-
lecção positiva, utilizando o teste Branch-Site Test of Positive Selection
[23, 24]. Este teste é a abordagem padrão para a detecção de selecção
positiva episódica em ramos especificados a priori. Posteriormente, pre-
tendi esclarecer se erros na topologia da árvore de genes teriam alguma
influência na sua capacidade de inferir locais positivamente seleccionados.
Utilizando simulação de sequências, comparei os resultados obtidos em
topologias verdadeiras e erróneas e encontrei uma forte correlação linear
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na capacidade de predizer locais consoante a árvore é modificada para
inferir como sequências longas foram sujeitas a pressão selectiva. Além
disso, através da re-análise de dados previamente publicados, mostrei que
a escolha da árvore de genes altera os resultados não só para sequências
simuladas mas também para sequências verdadeiras. Esta é a primeira vez
que um efeito evidente da topologia da árvore de genes na inferência de
selecção positiva é demonstrado. Com base nos resultados obtidos, conclúı
que a árvore de genes é um factor determinante para a previsão de locais
sujeitos a selecção positiva, aspecto que tem sido negligenciado. Conse-
quentemente, as análises seguintes basearam-se em filogenias das protéınas
Rab manualmente curadas.
O Caṕıtulo 4 aborda a hipótese da neofuncionalização mencionada no
final do caṕıtulo 2 e finalmente responde a como as protéınas Rab evolvem.
Neofuncionalização é um modelo clássico que explica o surgimento de no-
vas funções génicas. O seu objectivo original foi propor um mecanismo que
considerava uma via mutacional entre duas protéınas incluindo protéınas
em estados intermediários com mutações que alteravam a sua função orig-
inal. O problema resultante destas protéınas intermediárias não serem
imediatamente removidas através de uma selecção purificadora é elegan-
temente resolvido pela redundância introduzida aquando da duplicação de
genes. No entanto, enquanto que o modelo de neofuncionalização resolve
o problema evolucionista, a problemática a ńıvel bioqúımico ou celular
continua por explicar, e o desafio funcional crucial permanece, mascarado
por uma suposição tácita: como podem as mutações levar a uma nova
função? Aqui, eu abordo esta questão para as protéınas Rab. Primeiro,
confirmei, baseado em dados públicos, de sequências e funcionais, que
a famı́lia proteica Rab expande frequentemente por neofuncionalização.
Para além disso, identifiquei as suas interacções com moléculas efectoras
como o aspecto central da função das Rabs. Assim, proponho a hipótese de
que as protéınas Rab adquirem novas funções através da alteração do con-
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junto de moléculas efectoras com que interagem. Através da comparação
da interacção das protéınas Rab com efectores já estudados, verifiquei a
condição fundamental de que subfamı́lias de protéınas Rab relacionadas
entre si possuem conjuntos de moléculas efectoras comuns. Finalmente,
foquei-me na subfamı́lia Rab25, em vertebrados, que evoluiu de uma du-
plicação do gene codificante para a protéına Rab11. Em concordância
com a hipótese proposta, identifiquei traços de selecção nas interfaces de
ligação destas duas subfamı́lias de Rabs. Isto sugere um cenário em que,
pouco tempo após a duplicação, as interacções espećıficas à Rab11 foram
perdidas e novas interacções com efectores espećıficos da Rab25 foram
formadas e fixadas por selecção positiva. Adicionalmente, encontrei uma
tendência ao ńıvel do organismo para reduzir a amplitude da expressão
tecidual de novas subfamı́lias de protéınas Rab estabelecidas simultanea-
mente com as alterações do conjunto de efectores. Estes resultados põem
a descoberto o modelo de neofuncionalização original e demonstram como
as mutações podem levar a uma nova função. As protéınas Rab são um
sistema modelo particularmente relevante, uma vez que a sua evolução
está fortemente interligada com a da própria célula eucariota devido ao
seu papel fulcral no sistema endomembranar e organização intracelular.
No último caṕıtulo sumarizei os resultados obtidos e discuti as im-
plicações do estudo das protéınas Rab para a evolução generalizada da
função proteica. Em particular, pelo menos para as protéınas Rab em
Metazoa, há um contraste intrigante entre a manutenção de uma home-
ostase funcional por evolução fortemente purificadora, e frequentes du-
plicações seguidas de processos de neofuncionalização. É interessante es-
pecular que esta observação poderá ser explicada pela vasta rede de in-
teracções em que as protéınas Rab participam. Sendo a sua função fun-
damental para a célula, a sua alteração revelar-se ia desastrosa para o
organismo. No entanto, é pela mesma razão que os eventos de duplicação
xx
favorecem a criação de novas interacções protéına-protéına, mostrando as-
sim um grande potencial para a inovação funcional que desempenhou o
seu papel na modelação da célula metazoária como a conhecemos.
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